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 10
 INTRODUCTION 
 
When the full complement of 46 human chromosomes was discovered by Tjio and Levan in 
1956 [1], a new research avenue opened: the exploration of the relationship between 
chromosomal abnormalities and diseases. Almost half a century later, enforced with banding 
techniques from the 1970’s and in situ hybridisation technologies developed in the last 25 
years, the field of human cytogenetics continues to link chromosomal defects with disease. 
Next to its contribution to understanding the causes of constitutional diseases, cytogenetics 
plays significant role in cancer research and diagnosis. It is very well established that there are 
typical chromosomal changes associated with several cancers, notably leukaemia’s and 
lymphoma’s [2]. Although a simple linear relationship between chromosomal abnormality 
and malignancy is far from obvious for solid tumours, cytogenetics remains an important 
research tool in studying cancer. 
Cytogenetics can now extract far more information about the human genome than just 
chromosome number. Each chromosome can be easily recognised on basis of fluorescence in 
situ hybridisation colour and highly rearranged tumour cells can be karyotyped rapidly. Also 
subtle alterations in chromosome composition can now be detected and analysed for their 
association with disease. The latest technical developments allow high-resolution genome-
wide screening for the losses or gains of chromosomal material. By cross referencing 
cytogenetic alterations with the human genome sequence one can rapidly obtain information 
on the actual genes that are structurally disrupted or altered in copy number and thus obtain 
clues regarding the molecular basis of the disease. 
This thesis contributes to development and application in molecular cytogenetics. In particular 
it deals with a new approach of multi-colour fluorescence in situ hybridisation, a novel way of 
chromosome preparation and their application in clinical cytogenetics and cancer research. 
 
1.1 FISH and molecular cytogenetics 
Fluorescence in situ hybridisation (FISH) analysis of chromosomes began when classical 
cytogenetics was combined with recombinant DNA technology to form a new discipline 
called molecular cytogenetics. Prior to FISH, more cumbersome methods were used to 
perform in situ hybridisation (ISH) using radioactive nucleic acid probes for detection of 
specific DNA or RNA sequences in metaphase chromosomes or interphase [3]. The use of 
non-radioactive probes became feasible in the early 1980s when methods for labelling nucleic 
acids with fluorochromes and haptens such as biotin became available [4,5], which was 
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followed shortly by application in cytogenetic analysis [6-9]. Introduction of fluorochromes 
as hybridisation reporter molecules constituted a quantum leap forward in resolution and ease 
of experimentation. It paved the way for a plethora of applications in genetics, cell- and 
microbiology, including those employing modern day microarray technologies. 
The first conjugation of a fluorochrome to a nucleic acid hybridisation probe for use in ISH 
was accomplished in 1980, when 3’ end RNA labelling with fluorochromes was used to probe 
for mitochondrial repeat DNA sequences in the kinetoplast of Critidia fasciculata [5]. 
Following the introduction of chemical modification of polynucleotides with 
acetylaminofluorene [7] and mercury [6], amino-allyl modified mono-nucleotide triphophates 
were used to conjugate (an array of) haptens or fluorochromes to the nucleic acid building 
blocks [4]. DNA and RNA polymerases such as Escherischia coli polymerase 1, Thermus 
aquaticus DNA polymerase and bacteriophage RNA polymerase as well as terminal 
deoxynucleotide transferase accept these modified nucleotides, allowing enzymatic labelling 
of polynucleotides.  
 Over the last two decades many FISH variants emerged, which together with chromatin 
decondensation techniques led to a wide spectrum of methods with distinct sensitivity and 
resolution properties [10]. 
At present DNA-FISH has detection sensitivity of single copy targets of 1-2 kb in size 
[11,12]. Given the resolution of light microscopy and the state of chromatin condensation, 
resolution of DNA-FISH varies from 3 Mb in case of chromosomes [13], 200 kb for 
interphase nuclei [14] to 1 kb when applied to fully decondensed chromatin [15]. These 
resolution and sensitivity specifications have expanded the application range of cytogenetic 
analysis. To answer the specific cytogenetic questions it is essential to choose the correct 
technique and in this respect, the choice of the probe/target combination is of paramount 
importance. A wide range of probes can be used, from whole genomes to small cloned probes 
(1-10 kb) and synthetic oligonucleotides (20-50 nucleotides). There are broadly three types of 
probes, named after the nature of their target, each with a different range of applications. 
Repetitive sequence probes: Repetitive sequence probes target chromosomal regions that 
contain short sequences, which are present in many hundreds to thousands of copies, e.g. 
chromosome-specific centromeric and pan-telomeric probes. Chromosome centromeres 
contain one or more families of satellite DNA, the most abundant of which is alpha-satellite 
DNA. Alpha-satellite DNA subsets on different chromosomes have different restriction 
enzyme site patterns, facilitating the cloning and characterization of chromosome-specific 
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 centromeric probes for all human chromosomes. This type of probe, as cloned sequence or 
chemically synthesized oligonucleotide is most useful for rapid enumeration of numerical 
chromosomal abnormalities in either metaphase or interphase. Pan-centromeric probes, which 
target all human centromeres, are also available. Pan-telomeric probes target the tandemly 
repeated (TTAGGG) sequences present on all human chromosome ends  
Locus-specific (unique sequence) probes: Locus-specific probes target specific sequences 
present in only one copy on a chromosome. These sequences are cloned in a variety of 
vectors, from plasmids (~1-10 kb) to the larger PAC, YAC and BAC vectors (~80 kb-1 Mb). 
Genomic cloned probes, however, often contained dispersedly occurring repeat sequences 
such as the Alu sequence that make them prone to high background fluorescence. Suppression 
hybridisation by pre- or co-hybridisation with unlabeled repetitive nucleic acids (i.c. the so-
called C0t = 1 fraction) to compete for non-specific binding sites overcame this problem [7]. It 
permits investigators to FISH for any region of the genome, particularly using BACs and 
PACs, which have high detection efficiency. Such probes are now routinely used to screen for 
specific chromosomal translocations, inversions or deletions in both interphase and 
metaphase. The suppression hybridisation also allowed so-called whole chromosome painting 
[16] and comparative genomic hybridisation (CGH) [17] . 
Whole-chromosome painting probes Whole-chromosome painting probes (WCPs) are 
complex DNA probes derived from a single type of chromosome. These are usually flow-
sorted or microdisected chromosomes, amplified by cloning or more recently by degenerate 
oligonucleotide primer-PCR (DOP-PCR) [18] to generate a “paint”, which in combination 
with suppression hybridisation, highlights the entire chromosome, except for the repeat 
regions. Chromosome arm-specific paints and region-specific paints, generated by 
chromosome microdissection are also available. This type of probe is most useful for whole 
genome screening for structural and numerical chromosome rearrangements in metaphase. 
WCPs are not so well suited for the assessment of chromosome abnormalities in interphase.  
The versatility of FISH is exemplified by its successful use in the study of the location of 
DNA sequences on metaphase chromosomes and in DNA fibres, in DNA copy number 
assessment by CGH and in the analysis of RNA expression in cell nuclei and cytoplasma. 
FISH is readily adaptable to a variety of clinical specimen such as pathology tissue sections 
and cytological smears. Some of the significant advances in FISH technology across the past 
two decades have been suppression hybridisation [16], simultaneous multicolour FISH 
[19,20] cumulating in molecular karyotyping [21-23], fibre FISH [24-27], chromosomal 
comparative genomic hybridisation (CGH) [17] and CGH on microarrays [28].  
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1.2 Multi-colour FISH 
An important aspect of employing fluorochromes instead of radioisotopes in ISH was the 
aptitude for simultaneous visualisation of different targets. In the 1980’s early 90’s the 
number of reporter molecules uniquely identifiable through filter-based microscopy was 
essentially limited to five, necessitating combinatorial and ratio-labelling schemes to increase 
multiplicity [19]. In the combinatorial approach, the different probes are labelled with unique 
combinations of haptens or fluorochromes to be identified on basis of a unique spectral 
signature leading to 2n – 1 informative binary combinations, where n is the number of 
different fluorochromes [20,23,29]. Probe identification can also be brought about by ratio-
labelling, where ratio of fluorescence colour intensities, rather than the mere presence or 
absence is the basis of classification [19,23]. This way 12 chromosomes could be uniquely 
identified with only three fluorochromes [30]. The introduction of a Sagnac interferometer to 
create spectra of each pixel in the charged-coupled device or CCD imaging device mounted 
on the microscope enabled Schrock et al. [21] to accomplish full molecular karyotyping with 
24 WCPs using combinatorial FISH with 5 dyes and spectral deconvolution. In the same 
period, Ward and co-workers, using improved filter-based digital fluorescence microscopy 
accomplished the same [22]. Considering the diagnostic scope of molecular cytogenetics and 
the need for more colours to reveal more targets, such as chromosome arms and specific 
regions, Tanke et al. introduced in 1999 a novel combination of combinatorial (binary) and 
ratio labelling strategy, dubbed COBRA-FISH, which allowed identification of 24 targets 
using only 4 fluorochromes [31]. 
 
1.3 pq-COBRA-FISH 
COBRA-FISH stands for COmbinatorial Binary RAtio labelling, where the combinatorial and 
ratio labelling have been combined to increase the FISH multiplicity. In this approach probes 
are ratio-labelled with a pair of fluorochromes to distinguish, for example, 5 different targets 
on basis of their ratios. Hence, by pair wise-ratio labelling with 3 fluorochromes, sets of 12 
ratio-labelled probes can be generated (see Figure 1, bottom triangle). To achieve higher 
multiplicity the same 3 fluorochromes are used to ratio-label additional sets of 12 probes in an 
identical fashion. These two sets are then discriminated by an additional spectrally distinct 
fluorochrome, referred to as the binary label. Thus by binary-ratio-labelling, 24 targets can be 
discriminated with only 4 fluorochromes. Obviously, COBRA is capable of generating higher 
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 multiplicities by expanding the number of binary labels (Figure 1) and increasing the number 
of ratio-labels, including triple labelled ones. 
In this thesis (see Chapter 2), a second binary 
label was used to expand the number of targets 
to 48 for differentiation of all human 
chromosome arms. The technique was dubbed 
pq-COBRA-FISH. It was accomplished in a 
manner slightly different from the scheme 
depicted in Figure 1. The microdissected 
chromosome q arms after DOP-PCR 
amplification are labelled with a 5th 
fluorochrome, spectrally distinct from the 4 fluorochromes used for the WCPs. After co-
hybridisation with the COBRA-FISH WCPs sets, presence or absence of the 2nd binary label 
thus identifies the p or q identity of a chromosome. This strategy proved to enhance, for 
example, the assignment of the chromosomal translocations to specific chromosome arms and 
detection for pericentric inversion that cannot be detected using WCPs.  
Figure 1: The generic nature of COBRA 
Although the resolution of such FISH is not sufficient enough to correctly assign each 
rearrangement to specific band, a combination of the DAPI image and additional 
hybridisations with locus specific probes can match the resolution of high resolution banding 
techniques. The presence of signals from major pseudo-autosomal region PAR1 and PAR2 on 
X chromosome has given an idea concerning the resolution of pq-COBRA-FISH. PAR1 (2.6 
Mb) mapping on Xp22 [32] and PAR2 (320 kb) on Xq28 [33] contain sequences that are 
homologous with Y sequences. Due to differential labelling of the X and Y chromosomes 
paints these regions on X chromosomes are visible indicating that resolution of pq-COBRA-
FISH is in the order of magnitude of 2 Mb. 
Multi-colour karyotyping technologies have proven to be very useful in prenatal, postnatal 
and cancer cytogenetics, because it is possible to screen the entire (patient) genome in a 
labour-efficient manner. 
 
1.4 Monofunctional fluorescent cis-platin compounds for labelling DNA 
FISH is crucially dependent on DNA labelling techniques. Basically, chemical and enzymatic 
polynucleotide modification can be distinguished. The enzymatic procedures, which use 
modified precursor of DNA or RNA, have gained great popularity, partly because they could 
be fitted neatly in the format of well-accepted radio-isotopic labelling procedures. Yet, there 
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are several favourable features to chemical modifications. First there is no issue of enzyme 
stability, second up- or down scaling is easy; third the purity of probe is less critical; fourth 
chemical methods are usually fast and easy to perform; fifth different types of nucleic acids 
can be labelled in the same format and sixth the process of labelling in principle does not lead 
to fragmentation or positional labelling bias as occurs in enzymatic procedure. 
A relative newcomer in chemical labelling polynucleotides is cis-platin labelling; 
commercially known as Universal Linkage System (ULS) [34]. The system is a universal in 
the sense that it can be used to modify biomolecules of different nature with a variety of 
labels. It is based on the stable coordinative binding properties of a platinum complex to 
sulphur and nitrogen-donors present in proteins, nucleic acids, nucleotide analogous and 
vitamins. The reagent essentially consists of a square, planar Pt(II) complex, stabilised by 
chelating diamine. One of the two remaining coordination sites is labelled with a marker 
molecule, being a hapten, a fluorochrome or an enzyme (a structure formula is given in Figure 
2) [35]. 
In nucleic acid labelling, the hapten- and fluorochrome labelled monofunctional platinum 
reagents reacts predominantly at the N7 of the guanine-base, although other bases can be 
labelled too. In order to prepare probes with optimal fluorescence and hybridisation 
properties, about 1-2% of the nucleotides are modified with cis-platin [36]. cis-platin labelled 
probes have been successfully used in FISH [34,37] and microarray applications [38,39] and 
provide a sensitivity comparable with enzymatic probe labelling methods. 
 
Figure 2: Structural formula of labelled mono-functional cis-platin. X is the leaving group 
upon coordinative binding to N7 of guanine residues. R represents haptens or fluorochromes. 
 
Pt
H2N NH2
NH2X
H
N
O
R
 
 
The ease with which the marker molecule R can be changed in the cis-platin labelling system 
provides versatility in the multi-colour applications such as molecular karyotyping by 
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 COBRA-FISH. In the experimental practice of this thesis, WCPs and chromosome arms 
DNAs destined to specific colour are labelled together, with only the concentration of each 
probe being varied to obtain the desired ratios and binary codes.  
 
2. pq-COBRA-FISH in a case of acute myeloid leukaemia  
The role of cytogenetics in determining the biologic basis of acute myeloid leukaemia (AML) 
and acute lymphoblastic leukaemia (ALL) is now widely recognized. By identifying acquired 
chromosome aberrations that recur in AML and ALL and providing precise chromosomal 
location of breakpoints in leukaemia associated translocations and inversions, cytogenetics 
aided in cloning of many genes whose activation or fusion with other genes contributes to the 
neoplastic process [40]. Further characterization of these genes revealed that they are often 
involved directly or indirectly in the development and homeostasis of normal blood cells, and 
that abnormal protein products of fusion genes created by specific translocations and 
inversions can deregulate proliferation, differentiation or programmed cell death (apoptosis) 
of blood cell precursors [41]. This has paved the way to design novel therapeutic agents 
targeting specific genetic abnormalities in the Bcr–Abl tyrosine kinase inhibitor that 
suppresses proliferation of cells harbouring the BCR–ABL fusion gene created by t(9;22) 
(q34;q11.2), a recurrent chromosome aberration in chronic myelogenous leukaemia (CML) 
and ALL [42].  
Cytogenetic analysis is now routine part of clinical haematological practice. Specific 
chromosome aberrations and their molecular counterparts have been included in the World 
Health Organization (WHO) classification of haematologic malignancies, and together with 
morphology, immunophenotype and clinical features they are used to define distinct disease 
entities [43,44]. Pre-treatment cytogenetic findings have been repeatedly shown to be among 
the most important, independent prognostic factors in AML [45,46]. Consequently, 
cytogenetic analysis is considered mandatory for many clinical trials and are currently used to 
stratify patients for different types of therapy [47-49]. 
Clonal chromosome abnormalities are consistently found in the majority of AML patients at 
diagnosis, but the cytogenetic picture of AML remains complex. To date, approximately 200 
different structural and numerical aberrations such as reciprocal translocations, inversions, 
insertions, deletions, unbalanced translocations, isochromosomes, isodicentric chromosomes, 
isolated trisomies and monosomies have been found to be recurring chromosome changes in 
AML [47,50-52]. Many of these aberrations are very rare, being so far detected in a few 
patients worldwide. The prognostic importance of less frequent recurrent aberrations, both 
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primary and secondary, is still unknown. Valk et al.  recently have shown the importance of  
employing gene-expression profiling in classifying AML patients in genetically defined 
groups which not only aided in sub-classification but also revealed novel clusters with adverse 
prognosis [53].  
Continuing cytogenetic studies are thus necessary to accrue enough patients with these rare 
abnormalities to define conclusively their impact on complete remission rates, remission 
duration and survival, and to resolve discrepancies in prognostic categorization of some of the 
more frequent aberrations that currently exist among the major cytogenetic risk-assignment 
systems. Such studies will uncover new recurrent aberrations as they are identified by whole 
genome wide screening techniques such as molecular karyotyping. [54-58].  
In this context, using pq-COBRA-FISH as a whole genome screening technique a novel 
translocation was detected in an AML patient (Chapter 3). This new chromosomal 
abnormality involved chromosomes 6q and 14q with the breakpoint on BCL11B gene 
(14q32), homologous to BCL11A (2p13), which has been implicated in chronic lymphocytic 
leukaemia (CLL) [59,60]. This case report draws attention to the possible role of this gene in 
aetiology of haematological malignancies and offers a candidate gene for AML. 
 
3. pq-COBRA-FISH in postnatal cytogenetics 
Since the discovery, by Zech and Caspersson [61,62] that appropriate staining results in a 
banded appearance of chromosomes, various methods for banding of metaphase 
chromosomes have been used as standard techniques in pre- and postnatal diagnostic 
applications. Giemsa bands obtained by digestion of the chromosomes by the proteolytic 
enzyme trypsin (GTG-bands) [63] are the most widely used for routine chromosome analysis 
in clinical laboratories. However, GTG-banding can achieve a resolution of a single-band 
level, approximately 5–10 Mb, making it difficult to interpret subtle chromosomal 
rearrangements. Also identification of complex translocations and small markers pose a 
problem, even with high resolution banding technique (±850 kb). The use of FISH in clinical 
diagnostic laboratories has made it possible to accurately characterize many marker 
chromosomes [64]. Their origin can be determined through the use of single- or dual-colour 
FISH using centromeric and/or WCPs [65,66]. Characterization of these markers involves 
testing a number of probes, either singly or two at a time, where the choice of probes is 
usually made according to their reported frequency in the literature or according to any G-
banded patterns that may be present. While in many instances the origin of the marker is 
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 accurately determined, it is a time-consuming approach. In addition, the lack of full 
characterization of complex markers prohibits their correlation with a specific phenotype, 
which for example in case of prenatal diagnosis can cause counselling problems [64,67].  
One of the benefits of molecular karyotyping techniques such as pq-COBRA-FISH lies in 
diagnosis of patients with abnormal phenotypes, suggestive of chromosomal abnormalities, 
where GTG-banding is normal. Often these patients have no clear diagnosis and genetic 
counselling is based on empirical data.  
In chapter 3 of this thesis, an investigation is presented that was designed to see if pq-
COBRA-FISH indeed is capable of detecting chromosomal aberrations in patients with 
apparently normal karyotype. For this purpose, pq-COBRA-FISH has been applied on 10 
familial and 11 isolated case of patients with phenotypes suggestive of chromosomal 
abnormality but with normal GTG-banding. In this study pq-COBRA-FISH detected 
chromosomal abnormalities in 2 cases, in subtelomeric regions, which solely based on GTG-
banding would have been classified as with genetically unknown origin. 
Another benefit of pq-COBRA-FISH lies in its ability to identify origins of marker 
chromosomes. Also in chapter 3 a study involving a patient with multiple supernumerary ring 
chromosomes, pq-COBRA-FISH has been used to elaborate on the origin of such markers. In 
such cases, albeit very rare [68,69], conventional cytogenetic techniques are unable to 
elucidate further the genetic constitution of patients and consequently the mechanism of such 
phenomenon remains elusive. Genome wide analysis such as pq-COBRA-FISH can elucidate 
the origin and nature of such markers and provide data to describe a possible mechanism for 
the formation of such marker chromosomes [70].  
 
4. Chromosomal instability in cancer and the role of molecular karyotyping 
Cancer cells have defects in regulatory circuits that govern the regulation of genes involved in 
cell proliferation, apoptosis, genome stability, angiogenesis, invasion and metastasis [71]. The 
discovery and the assessment of the functional importance of such genes are essential for 
understanding the biology of cancer, its diagnosis and therapy development. There are 
numerous factors and mechanisms that can result in variant gene function: polymorphisms, 
changes in chromosome and gene copy number and structure, mutations and epigenetic 
modifications are amongst known factors. One thing that is inherent to malignant 
transformation, albeit substantially variable between tumours, is chromosomal aberrations 
[72-74]. 
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Acquisition of chromosomal aberrations is one of the mechanisms by which cells can 
accumulate genetic alterations [75]. The great variability in chromosomal aberrations 
observed in solid tumours might be linked to the fact that tumours are initiated through 
different mechanisms or the manner in which genome stability is compromised [76]. The 
solid tumour types associated with chromosomal aberrations show also different degree of 
chromosomal aberrations in their different stages of progression, implicating that the tumours 
acquire more chromosomal abnormalities as they progress [77]. In other words they display 
chromosomal instability. 
In view of the relative ease with which even complex karyotypes can be resolved by pq-
COBRA-FISH and similar techniques, it is attractive to apply such techniques to find 
recurrent aberration in solid tumours (as it is the case with leukaemia’s and lymphoma’s). If 
chromosomal aberrations exist that are fundamental to tumorigenesis and tumour progression 
their classification and their distinction from irrelevant ones would require building up very 
large databases as aimed at by the Mitelman Database of Chromosome Aberrations in Cancer 
(http://cgap.nci.nih.gov/Chromosomes/Mitelman) [50].  
Indeed several studies are directed towards identification of genes that are directly or 
indirectly involved in chromosome (mis)segregation and ultimately chromosome instability 
[77-81]. One may take the view that gene mutations that cause chromosomal instability confer 
a “chromosome mutator phenotype”, by analogy to Loeb et al.’s ‘DNA mutator phenotype’ 
hypothesis [82]. In this context a study has been carried out (chapter 4) on possible 
involvement of the hSNF5 gene in maintaining genome stability. hSNF5 is a core component 
of the SWI/SNF ATP-dependent chromatin-remodelling complex and known as a tumour 
suppressor that is inactivated in malignant rhabdoid tumours (MRTs) [83,84]. By re-
introducing wild type and various mutant hSNF5 in MRT cells that are homozygously deleted 
for hSNF5 and applying pq-COBRA-FISH to metaphase spreads of these cells we could show 
that hSNF5 has a role to play in ploidy control next to its established role in controlling gene 
expression in eukaryotic cells.  
 
5. Premature Chromosome Condensation (PCC) increases efficiency of molecular 
karyotyping 
Cytogenetics has become an intricate part of experimental methods used for the study of 
cancer development and progression. However, the great majority of the accumulated 
karyotypic data is still based on haematologic malignancies, which have relatively low 
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 contribution to human cancer morbidity and mortality. The under-representation of karyotypic 
data of solid tumours is still caused by analytical and methodological problems as described 
by Teyssier et al. in 1989 [85], however, in karyotyping significant advances have been made. 
Because only cells in mitosis are amenable to full karyotyping, the cancer cell samples need 
very often enrichment for mitotic cells by culturing and mitotic arrest.  This raises concerns of 
preferential clonal expansions and introduction of unrelated chromosomal rearrangements. 
Furthermore, the mitotic index and the chromosome quality of solid tumours, in particular 
epithelial neoplasms, are often sub-optimal, resulting in partial karyotypic information. 
Moreover and in contrast to the haematological disorders, which often contain few 
cytogenetic changes, most solid tumours can have a multitude of aberrations [73]. The 
karyotypic complexity can be so massive that (classical) karyotypic analysis becomes 
impractical. Furthermore, a growing number of epithelial tumours, in particular carcinomas of 
the oral cavity [86,87], colon [88], skin [89], and breast [90] seem to be characterised by 
clonal karyotypic heterogeneity, complicating the analysis and the interpretation of the data 
[91].  
The introduction of molecular karyotyping by FISH has essentially taken away much of the 
karyotyping problem. Thus analysis of complex karyotypes is not the Achilles’ heel of cancer 
cytogenetics anymore. The problems associated with culturing, however, remain. It is highly 
desirable, therefore, to have operational techniques that allow efficient (molecular) 
karyotyping of interphase cancer cells, the importance of which is described in the former 
paragraph.  
Faced with the problem of not being able to visualise the radiation-induced, initial (e.g. 
unrepaired) chromosome damage, Johnson and Rao construed in 1970 a technique, which can 
force cells in interphase to condense their chromosomes. Their technique is called premature 
chromosome condensation (PCC). It is based on fusion of mitotic cells such as Chinese 
hamster ovary cells with the interphase target cells. Sendai virus was initially used as the 
fusogenic agent [92]. Interphase chromosome condensation of the target cell is thought to be 
brought about by p34cdc2-cyclin B kinase activity [93] and other mitosis promoting factors 
donated by the mitotic fusion partner. However, even by introduction of more convenient 
polyethyleneglycol-based fusion protocols [94], a number of technical problems, such as low 
fusion frequency of the mitotic inducer cells with target cells, cell line dependent fusion 
conditions and difficulty of the  procedure have limited the application of PCC in cancer 
cytogenetics.  
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Over the past years, it has been shown that inhibitors of type-1 and type-2A protein 
phosphatases can be used to induce PCC in proliferating cells [95-99]. These studies 
evaluated chromosome aberration analysis in PCC spreads obtained by okadaic acid (OA) 
[100] or calyculin A (CA) (see Figure 3) [101]. It was also shown that limited incubation of 
tumour cell lines in a cell culture medium containing OA or CA results in PCC induction 
[99,102]. 
This thesis follows up on these observations concerning PCC with phosphatase inhibitors to 
facilitate molecular cytogenetics studies in cancer research. In preliminary work it was shown 
that after a short term culturing of 2 days of polyps isolated from patients suffering from 
colorectal cancer, chromosome spreads can be harvested for analysis using CA-induced PCC. 
The classical approach of colcemid treatment failed to result in any metaphase.  
Further results obtained with cell lines, showed that CA treatment can yield many more 
analysable chromosome spreads in cell lines than metaphase arrest (Chapter 5) thus providing 
new potential for increased throughput of karyotyping cancers.  
 
Figure 3: Calyculin A (C50H81N4O15P) was initially isolated from the marine sponge 
Discodermia calyx. It is a very potent, cell-permeable protein phosphatases inhibitor and 
extremely specific for type-1 and type-2A protein phosphatases among other acidic, alkaline 
and protein phosphatases [101].  
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 6. PCC and pq-COBRA-FISH enables karyotyping of G1 and G2 cells 
Apart from increasing karyotyping efficiency, premature chromosome condensation brings 
another important research capacity. PCC results in chromosome spreads with specific 
morphologies that represent the different stages of the cell cycle. Thus PCC permits in 
principle molecular cytogenetic analysis of cells that are at the G1 and G2 stages of the cell 
cycle. S-phase cells can be detected morphologically after PCC, but not karyotyped. As 
accumulation of chromosome abnormalities is a hallmark of cancer development and 
progression [77], comparison of karyotypes of M cells with those of G1- or G2-cells can offer 
insight into chromosome evolution and allow testing of the just-right instability hypothesis 
[82] described on the forthcoming pages. 
To further understand the efficiencies of PCC at the various cell cycle stages and the cell-type 
dependence, a basic study was initiated which used mouse embryonic fibroblasts (MEFs) and 
mouse embryonic stem cells (mouse ES cells) in absence and presence of synchronising 
drugs. Results lead us to conclude that morphology of CA-induced PCC spreads 
quantitatively reflect the G1-, S- and G2-phases of the cell cycle, that these cells in these 
phases undergo chromosome condensation after CA addition at an efficiency > 10 %. In 
contrast CA cannot cause premature chromosome condensation of G0 cells. 
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Scope of this thesis 
 
Human cytogenetics is and remains an important clinical diagnostic and research tool. In the 
50 years since the first description of the correct number of chromosomes in the human 
complement, the field of human cytogenetics has witnessed several methodological 
breakthroughs. Banding- and FISH methodology are exemplary in this respect. This thesis 
gives in its first Chapter a brief overview of FISH with focus on multi-colour FISH for 
molecular cytogenetics and briefly touches upon the subjects of the other chapters. Chapter 2 
then describes further development of a FISH technique called COBRA-FISH (an acronym 
for COmbined Binary RAtio labelling FISH) to the point that all human chromosome arms 
can be uniquely recognized in a single FISH experiment. It expanded the multiplicity of 
multi-colour FISH from 24 to 48 and is referred to as pq-COBRA-FISH.   
As described in the first of the three articles of Chapter 3, which deals with application of pq-
COBRA-FISH in clinical human cytogenetics, pq-COBRA-FISH is very well capable of 
detecting chromosomal rearrangements in individuals with unclear karyotype or abnormal 
phenotype and normal G-banding. It therefore contributes to conclusive diagnosis, genetic 
counselling and improved estimation of recurrence risk. In the second article of Chapter 3, a 
case of acute myelocytic leukaemia with a normal karyotype was studied. The positional 
information provided by a single pq-COBRA FISH experiment rapidly led to the 
identification of a novel translocation involving the BCL11B gene. Finally, in the third article 
of Chapter 3, pq-COBRA FISH along with other FISH technologies contributed to 
identification of the chromosomal make-up of supernumerary ring chromosomes in a patient 
with multiple congenital abnormalities. 
In Chapter 4, pq-COBRA-FISH was used as a tool in basic cancer research. In this 
experimental work, a patient-derived cell line lacking wild type hSNF5 a core component of 
SWI/SNF ATP-dependent chromatin remodelling complex, was used to express the wild type 
hSNF5 or mutant hSNF5 gene. The pq-COBRA-FISH revealed a novel role of hSNF5: ploidy 
control. Thus, hSNF5 may play a role in induction of chromosomal instability, a characteristic 
of many solid tumours.  
As outlined in Chapter 1, cytogenetics of solid tumours is hampered by insufficient 
availability of representative cell material of analysable quality. In brief, culturing is needed, 
which may introduce irrelevant chromosomal rearrangements and preferential clonal 
expansion. Furthermore, the quality of chromosome spreads of solid tumour cells is often 
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 poor making it difficult to karyotype by G-banding. Also mitotic indices are often low. 
Finally, the karyotypes are complex. Multi-colour FISH can alleviate the analytical problems 
to some extent, but the problem of culture artefacts and low yield of chromosome spreads 
remains. In Chapter 5 a chemically induced premature chromosome condensation (PCC) 
technique has been investigated to find ways to overcome the latter problems. As described in 
the first article in Chapter 5, this technique employs the properties of a protein phosphatase 
inhibitor, calyculin A, to induce mitosis-like processes which among others leads to 
condensation of chromosomes of non-mitotic cells. With a number of cancer cell lines and 
colon cancer biopsies it is shown that PCC has a high yield of analysable chromosome 
spreads compared to standard and conventional technique using colcemid for arresting mitotic 
cells. A minimal culture period proved necessary, but this period is < 2 days, limiting the 
chance for artefactual chromosome rearrangement and clonal expansion. The combination of 
calyculin A induced PCC with pq-COBRA-FISH enabled the analysis of the full 
chromosomal complement of cells in the G1- and G2-phase of the cell cycle, as they were 
recognizable by their, respectively, uni- and bivalent character. The second article of Chapter 
5 investigates the efficiencies with which calyculin A can induce condensation of 
chromosomes in the different phases of the cell cycle, as quantified by DNA flow cytometry. 
The data indicate that calyculin A induces chromosome condensation at the G1-, S- and G2- 
stages of cell cycle but not at the G0. 
In Chapter 6, the molecular cytogenetic work presented in this thesis is critically discussed in 
perspective of other techniques that allow genome-wide analysis and benefits are outlined in 
relation to its contribution to understanding the molecular basis of genetic diseases. 
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Differentially Painting Human Chromosome Arms
with Combined Binary Ratio-labeling Fluorescence
In Situ Hybridization
Joop Wiegant,1 Vladimir Bezrookove,1 Carla Rosenberg,1 Hans J. Tanke,1
Anton K. Raap,1,3 Hongen Zhang,2 Michael Bittner,2 Jeffrey M. Trent,2
and Paul Meltzer2
1Laboratory for Cytochemistry and Cytometry, Department of Molecular Cell Biology, Leiden University Medical Center,
Leiden, The Netherlands; 2Laboratory of Cancer Genetics, National Human Genome Research Institute,
National Institutes of Health, Bethesda, Maryland 20892 USA
Recently we developed a novel strategy for differentially painting all 24 human chromosomes. It is termed
COBRA–FISH, short for combined binary ratio labeling–fluorescence in situ hybridization. COBRA–FISH is
distinct from the pure combinatorial approach in that only 4 instead of 5 fluorophores are needed to achieve
color discrimination of 24 targets. Furthermore, multiplicity can be increased to 48 by introduction of a fifth
fluorophore. Here we show that color identification by COBRA–FISH of all of the p and q arms of human
chromosomes is feasible, and we apply the technique for detecting and elucidating intra- and interchromosomal
rearrangements. Compared with 24-color whole chromosome painting FISH, PQ-COBRA–FISH considerably
enhances the ability to determine the composition of rearranged chromosomes as demonstrated by the
identification of pericentric inversions and isochromosomes as well as the elucidation of the arm identity of
chromosomal material involved in complex translocations that occur in solid tumors.
Combinatorial fluorescence in situ hybridization
(FISH) of the DNA of the 24 different human chromo-
somes with 5 fluorophores in conjunction with spec-
tral or filter-based microscopic imaging (Schrock et al.
1996; Speicher et al. 1996) has greatly advanced mo-
lecular cytogenetic analysis of chromosomes (Ried et
al.1998). Use of 5 fluorophores allows the identifica-
tion of up to 31 different chromosomal targets on the
basis of color combinations. Recently, we developed
combinatorial binary ratio labeling (COBRA) FISH as
an alternative multi-color FISH technique (Tanke et al.
1999), which uses 4 fluorochromes to achieve a multi-
plicity of 24, allowing FISH karyotyping with whole
chromosomal paint probes. The multiplexing capacity
of COBRA–FISH can be increased to 48 by introduction
of a fifth fluorophore. Here we show that COBRA–FISH
allows color discrimination of all of the p and q arms
and apply the technique for detecting and elucidating
intra- and interchromosomal rearrangements.
RESULTS AND DISCUSSION
We have determined previously that with two fluoro-
phores, five different targets are identifiable on the ba-
sis of FISH intensity ratios, that is, the ratio-resolution
is at least five. Hence, by pairwise ratio labeling with 3
fluorophores, 12 ratio-labeled probes can be differen-
tiated. To achieve higher multiplicities, the same 3
fluorophores are used to ratio label additional sets of
12 probes in an identical fashion. The sets of ratio-
labeled probes are discriminated by the presence or ab-
sence of additional, spectrally distinct fluorophores re-
ferred to as binary labels. For 24-color FISH, 2 sets of 12
ratio-labeled probes and one binary label are needed,
whereas for 48-color FISH, 2 binary labels are required
(Tanke et al. 1999).
We reasoned that if all q arm paints, labeled with
the second binary label, would efficiently hybridize si-
multaneously with 2 2 12 COBRA-labeled whole chro-
mosomal paint (WCP) sets, a chromosomal region
would be uniquely assigned to a given chromosome on
the basis of its WCP ratio and presence or absence of
the first binary label. The arm identity would then be
provided by the presence or absence of the second bi-
nary label.
As shown in Figure 1, with normal metaphase
chromosomes, this strategy correctly identifies p and q
arms. Interestingly, sequences present in the Y paints
disturbed the COBRA–FISH signals at regions of ho-
mology on the X. We observed that the tip of Xp de-
viates from the FISH color composition of the major
part of the X chromosome. The major pseudoautoso-
mal region PAR1 (2.6 Mb) maps to the tip of Xp
(Xp22). Additionally, at Xq13, where homology with Y
3Corresponding author.
E-MAIL a.k.raap@lumc.nl; FAX 31-71-5276180.
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Figure 1 Chromosomal arms differentially painted by PQ-COBRA–FISH. PQ-COBRA–FISH to normal male metaphase chromosomes. (A)
shows the superimposed, pseudocolor images of the three fluorophores used for ratio labeling the WCPs in a karyogram format. The first
binary label (B) differentiates the two identically ratio-labeled WCP sets. The karyogram was generated automatically on the basis of
chromosomal WCP–FISH ratios and the presence (odd numbered chromosomes plus Y) or absence (even numbered chromosomes plus
X) of the first binary color. The second binary label, differentiating p and q arms, is displayed in C. All q arm paints were labeled with the
second binary label, except for chromosomes 4 and 7, for which p arm paints were used. Note the disturbance of the COBRA–FISH signals
on the X chromosome by the Y paint.
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sequences is known to exist, Y signals were observed.
Signal disturbance by Y paints was never observed at
Xq28, where the minor pseudo-autosomal region maps
(PAR2; 320 kb). Conversely, we similarly observed in
male metaphases PAR1 at the tip of Yp, but not PAR2
on Yq.
After having established that PQ-COBRA–FISH cor-
rectly identifies all arms in normal metaphases, we ap-
plied it to the detection of intrachromosomal rear-
rangements and for the elucidation of a complex can-
cer karyotype. The two examples in Figure 2 illustrate
cases of intrachromosomal rearrangements, which re-
sult in derivatives with morphologies similar to their
normal homologs, and which would not be detectable
by FISH without arm-specific libraries. Figure 3 exem-
plifies the ability to efficiently elucidate, in a single
FISH experiment, rearrangements such as isochromo-
somes, deletions, and complex translocations in cancer
karyotypes. On basis of these results and those of >20
PQ-COBRA–FISH experiments with highly complex
cancer karyotypes (results not shown), we conclude
that compared with 24-color chromosome painting,
PQ-COBRA–FISH considerably enhances the ability to
determine the composition of rearranged chromo-
somes.
It is evident that the main advantage of COBRA–
FISH—as a generic FISH technique—over mere combi-
natorial FISH is that with less primary fluorophores,
more FISH colors can be generated. Here we have
shown that by COBRA–FISH, differential painting of
the p and q arms is feasible with five fluorophores
only. It seems to require only small steps to reach mul-
tiplicities of 96 and 192 by introduction of additional
binary fluorophores.
Ledbetter (Ledbetter 1992) discussed the cycle of
technology development and application of multi-
color FISH, which at that time had a multiplicity of
seven (Nederlof et al. 1990; Ried et al. 1992; Wiegant et
al. 1993). Ledbetter predicted correctly that further de-
velopment of FISH methodology as well as hard- and
software for digital imaging should allow simultaneous
visualization of 24 chromosomes in different colors.
Here we have shown that 48-color FISH is feasible. It is
likely that further cycles of technology development
and application will push FISH multiplicity further,
possibly to a point that high-resolution, molecular-
banding procedures by FISH can be developd.
MATERIALS AND METHODS
DNA Labeling and FISH
WCP-DNAs were obtained from Cytocell (Banbury, UK) or
kindly donated by Nigel Carter (Sanger Center, Cambridge,
UK). Chromosome arm-specific paints were generated by mi-
crodissection and DOP–PCR as described (Guan et al. 1996).
For labeling the WCPs and arm paints, we used either chemi-
cal ULS labeling after DOP–PCR or enzymatic labeling during
DOP–PCR. Results obtained with both labeling methods were
identical. For example, the ULS experiment of Figure 1 was
initially performed with enzymatically labeled probes with
identical results. For chemical ULS labeling, the WCP sets and
the arm paints were labeled in five separate labeling reactions.
To this end, optimized amounts of each unlabeled (DOP–PCR
amplified) paint destined to get the same ULS label were
mixed and reacted with the appropriate ULS label. After Qia-
gen column purification, the five labeled DNA solutions were
mixed and a 32 excess of human Cot-1 DNA was added. After
ethanol precipitation, the DNA was dissolved in a hybridiza-
tion mixture. Subsequent FISH was as described previously
(Tanke et al. 1999), with the exception that hybridization
times were reduced from 5 to 2 days. For ratiolabeling, we
used Diethylaminocoumarin (DEAC)-ULS, Cy3-ULS, and Cy5-
ULS. As first and second binary ULS labels, OregonGreen- and
dinitrophenyl (DNP)-ULS were used. All ULS labels were gen-
erous gifts from Kreatech BV (Amsterdam, The Netherlands).
The DNP moiety was visualized with a biotinated anti-DNP
antibody and LaserPro IR790-conjugated Streptavidin (Mo-
lecular Probes).
For enzymatic labeling, each probe was labeled sepa-
rately by incorporating the requisite labeled dUTP during
DOP–PCR. Optimized amounts of Qiagen column-purified
DNA were mixed, Cot-1 DNA was added, and after ethanol
precipitation, the probe mix was dissolved in hybridization
solution. Fluorescein-dUTP, Lissamine-dUTP, and Cy5-dUTP
were used for ratio labeling WCPs. Dig-dUTP and biotin-dUTP
were used as first and second binary labels. Dig was detected
with mouse monoclonal anti-dig and a DEAC-conjugated
anti-mouse Ig. The imaging and image processing of the
WCP-COBRA–FISH was essentially as described previously
Figure 2 Intrachromosomal rearrangements detected by PQ-COBRA –FISH. (A) An inversion of chromosome 12 in a normal carrier. In
this balanced rearrangement, the distal region of the long arm is positioned on the end of the short arm of the rearranged chromosome.
The segment of the short arm transferred to the long arm of the inv(12) could not be detected by us, nor in the original study by
conventional cytogenetics or FISH with distal markers (Speleman et al 1993). (B) A der(1), composed exclusively of 1q material in a
cervical cancer cell line with a complex karyotype. For each normal and rearranged homolog, the sequence of display is ratio image, the
q arm paint (second binary label) and the thresholded image of the q-arm paint.
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Figure 3 PQ-COBRA–FISH of a complex cancer karyotype This near-tetraploid cancer cell shows a range of 2–6 copies of each
chromosome and 10 structural rearrangements. (A,B,C) The ratio-, first- and second-binary images of PQ- COBRA–FISH of the nonrear-
ranged chromosomes. In contrast to Fig. 1, the first binary label is on the even numbered and X chromosomes. (D) The rearranged
chromosomes present in the same cell. The rearrangements include two isochromosomes, a deletion, the two products of a reciprocal
translocation [t(2;3)], four unbalanced translocations involving two chromosomes, and one three-way translocation. The composition of
the rearranged chromosomes is shown next to the chromosomes. The t(2;5) illustrates how the binary colors discriminate chromosome
number and arm identity of chromosomes that carry the same ratio-label.
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(Tanke et al 1999). For imaging the second binary label (La-
serPro), an extra filter set [(excitation and emission maxima at
740, respectively, 780 nm (Omega)] was used.
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Abstract Cytogenetic studies in a patient with acute myelocytic leukemia (AML) revealed as the sole karyo-
typic alteration a half-cryptic rearrangement, identified with 48-color combined binary ratio-labeled
fluorescence in situ hybridization (pq-COBRA-FISH) as a reciprocal t(6;14)(q?;q?). The breakpoints
were later assigned on the basis of G-banding to t(6;14)(q25~q26;q32). FISH experiments using
genomic probes showed that the breakpoint on 14q32.2 was within bacterial artificial chromosome
RP11-782I5 and revealed BCL11B as the only candidate gene in the region. BCL11B is a homolog
to BCL11A (2p13), a highly conserved gene implicated in mouse and human leukemias. To our
knowledge, this is the first report implicating BCL11B in hematological malignancies. Because of lack
of material, the translocation partner remains unknown.  2004 Elsevier Inc. All rights reserved.1. Introduction
Cytogenetic analysis is a valuable determinant in the
diagnosis of patients with acute myelocytic leukemia
(AML). It not only provides an important basis for clinical
management, but can also lead to recognition of leukemo-
genic pathways, potentially increasing the prospects of
target-specific therapy [1–3]. Up to 40%–50% of adult AML
patients, however, present normal karyotypes [1,2]. It has
long been postulated that these apparently normal karyo-
types in AML may harbor unidentified rearrangements [4].
In a percentage of these cases, rearrangements are missed
because of poor chromosome morphology or complexity of
karyotypes, in which different multicolor FISH approaches
[5–7] have proven useful in elucidating hematological karyo-
types [8,9]. Alternatively, some rearrangements might be
below the resolution level of conventional cytogenetics but
could possibly be revealed with molecular [10,11] or molecu-
lar cytogenetic [12] methods. We describe the use of molec-
ular karyotyping to elucidate a half-cryptic rearrangement,
leading to the identification of BCL11B as a gene involved
in AML.
* Corresponding author. Tel.:31-71-5276184; fax:31-71-5276180.
E-mail address: c.rosenberg@lumc.nl (C. Rosenberg).392. Case report
A 54-year-old man was admitted to Leiden University
Medical Center with suspected acute leukemia. His medical
history was unremarkable except for a surgically corrected
umbilical hernia. He had experienced general malaise for
about a month, with swollen cervical lymph nodes and a
sore throat, which did not respond to antibiotics. He had
been a heavy smoker and had previously worked in the
chemical cleaning industry. Blood tests showed leukocytosis
and physical examination showed pallor, a palpable spleen
of 5 cm under his ribcage, corrected umbilical hernia, and
generalized lymphadenopathy.
Upon admission, laboratory analysis of the patient’s bone
marrow showed hypercellularity with more than 95% blasts
with sporadic erythropoietic, granulopoietic, and megakary-
opoietic cells. Sixty percent of the blasts were diffusely posi-
tive for myeloperoxidase (MPO). Cell markers were positive
for CD13 (90%), CD43 (73%), CD117 (50%), HLA-DR
(45%), and TdT (38%). Some of the CD34 cells were posi-
tive also for CD33 and MPO, in all conclusive for the diagno-
sis of AML-M1 per the French–American–British (FAB)
classification.
Treatment consisted of leukapheresis and randomized
chemotherapy according to the LAM-12 protocol (EORTC
06991—European Organization for Research and Treatment
of Cancer), with no significant complications during the
course of therapy. Bone marrow examination at day 32 of
induction therapy showed 13% blasts. Reinduction therapy
started at day 43. Bone marrow examination 30 days after
completion of therapy (day 72) showed 40% blasts, and 3%
in peripheral blood, indicating that the disease was refractory
to chemotherapy. Cytogenetic analyses were performed with
the bone marrow samples collected at admission and at days
32 and 73.
The patient was treated with allogeneic peripheral blood
stem cell transplantation (PBSCT). The conditioning regi-
men consisted of cyclophosphamide and total body irradia-
tion. Hematopoietic recovery was satisfactory 17 days after
stem cell infusion, and the post-transplantation period was
complicated only by skin graft-versus-host disease; however,
the leukemia relapsed 127 days post PBSCT. Further treat-
ment was of no avail and leukemia persisted with further
complications. The patient’s condition continued to deterio-
rate, and he died 80 days after relapse of the leukemia.
3. Materials and methods
3.1. Molecular and cytogenetic studies
Bone marrow samples were collected at the time of the
diagnosis, after 30 days of induction therapy, and after
30 days of reinduction therapy. The samples were cultured
in Amniogrow medium (Cytocell, Banbury, Oxfordshire,
UK), and mitoses were harvested after 24 hours according
to standard cytogenetic techniques. Cytogenetic analysis was
performed on GTG-banded chromosomes, and 20–30 cells
were fully analyzed for each bone marrow sample.
Metaphases derived from bone marrow of the patient and
collected prior to induction therapy were hybridized with
48-color combined binary ratio-labeled fluorescence in situ
hybridization (pq-COBRA-FISH), a technique in which
every chromosome arm is identified by a different color
combination. Labeling, hybridization, and immunostaining
were performed as previously described [13]. After a
t(6;14)(q?;q?) translocation was identified with multicolor
FISH, the rearrangement was verified by using whole chro-
mosome painting probes (WCPs) for chromosomes 6 and
14, in combination with probes specific for subtelomeric
sequences for 6q (RP11-57H4) and 14q (RP11-820M16)
[14,15]. This combination of painting and subtelomeric
probes was also used to screen the half-cryptic re-
arrangement 30 days after reinduction therapy (day 73).
3.2. Mapping the rearrangement
To map the breakpoint on chromosome 14, we initially
narrowed the interval of the breakpoint to 14q32.2, in a
region of 0.68 Mb; as landmark probes we used 14 probes
spread over ~10 Mb, including ELK2P1 (alias ELK2) and
AKT1, two protooncogenes that have been postulated as
candidates in reported cases involving childhood leukemia40with apparently similar chromosomal rearrangement [16–
18]. We further mapped the breakpoint by successive FISH
experiments using probe combinations from a contig of four
BACs (RP11-50K24, RP11-876E22, RP11-782I5, and
RP11-450C22) spanning a 0.68-Mb region proximal to
ELK2P1 and AKT1 (December 2001 and June 2002 freeze
of the Human Genome working draft, http://genome.
ucsc.edu). A schematic representation is shown in Fig. 1.
All genomic probes were purchased from ResGen Invitrogen
(Carlsbad, CA). WCPs for chromosomes 6 and 14 were
cohybridized with the genomic probes to allow a clear identi-
fication of the rearranged chromosomes and their normal
homologs. Except for the probes used for the 48-color
COBRA-FISH, probes were labeled with single fluoro-
chromes either with nick translation or during degenerate
oligonucleotide-primed polymerase chain reaction (DOP-
PCR).
Digital fluorescence imaging was performed using a Leica
DM-RXA epifluorescence microscope (Leica, Wetzla, Ger-
many) equipped with a 100-W mercury lamp and com-
puter-controlled filter rotor with excitation and emission
filters matching the fluorochromes used. Image analysis was
performed with software implemented on a Power Macin-
tosh 8100 microcomputer designed to recognize and use
ratio labeling as base of chromosome classification [7].
4. Results
4.1. Karyotype
G-banding analysis of the bone marrow sample collected
prior treatment revealed additional material on the long arm
of chromosome 14. The add(14) was present in all the cells
analyzed, but the nature of the rearrangement could not be
elucidated. Forty-eight-color COBRA-FISH in metaphases
from the same preparation revealed a reciprocal transloca-
tion between chromosomes 6q and 14q, in which only
der(14) could be ascertained with conventional cytogenetics
(Fig. 2A, B). The rearrangement was confirmed by hybridiz-
ing chromosome preparations from the patient with combi-
nations of whole chromosome painting and subtelomeric
probes for the chromosomes involved (Fig. 2C). The karyo-
type of the bone marrow sample, described according to
International System for Human Nomenclature (ISCN
1995) guidelines [19], was 46,XY,add(14)(q32).ish t(6;14)
(q25~q26;q32)(wcp6,wcp14;wcp6,wcp14).
G-banding analyses of the bone marrow sample collected
30 days after induction therapy showed the persistence of
the rearrangement in the majority of the cells. The cyto-
genetic analysis was repeated 30 days after reinduction
therapy. G-banding analyses failed to detect abnormalities,
possibly due to the high degree of condensation of the chro-
mosomes in this last preparation, but screening of the re-
arrangement using the combination of painting and
subtelomeric probes for chromosomes 6 and 14 revealed the
Fig. 1. Schematic representation of band 14q32.2, the position of the genomic probes used to map the breakpoint on der(14), and indication of which
probes map to der(6) or der(14). The arrow indicates the breakpoint, which maps within RP11-782I5.
Fig. 2. Characterization of the t(6;14) using multicolor FISH. (A) Image of a metaphase from the patient hybridized with COBRA-FISH probes; the arrows
point to der(6) and der(14). (B) detailed image of the der(6), der(14), and their normal homologs. (C) Results of the hybridization using WCPs for
chromosomes 6 (red) and 14 (blue) in combination with subtelomeric probes for 6q (green) and 14q (white). Panels B and C show the normal homologs
on the left and rearranged chromosomes on the right.
Fig. 3. FISH results of WCPs for chromosomes 6 (cyan) and 14 (blue), in combination with genomic probes spanning the BCL11B region. (A) RP11-782I5
(green) and RP11-450C22 (red). The probe RP11-450C22 maps to the normal 14 homolog, but it is absent on der(14) and fully translocated to the der(6).
The more centromeric probe RP11-782I5 can be seen on the normal 14 homolog, on the der(6), but also on der(14) in metaphases with optimal
spread. The split signal from RP11-782I5 indicates that the breakpoint on chromosome 14 is within this BAC, and that most of the signal is translocated
to der(6). (B) Hybridizations with RP11-50K24 (green) and RP11-876E22 (red) show that both signals are on chromosomes 14.41
t(6;14) in 10 out of 21 cells analyzed; the others showed a
normal karyotype.
The patient presented a specific t(6;14) as the sole re-
arrangement in the malignant cells. The subsequent analyses
of bone marrow samples after treatments showed that the
clone with t(6;14) persisted in high frequency and without
further detectable changes, confirming that the disease was
refractory to chemotherapy.
4.2. Mapping the breakpoint
FISH results from the hybridization of a pool of geno-
mic probes spanning the 14q32 region revealed that the
breakpoint was proximal to two protooncogenes previously
suggested, ELK2P1 and AKT1, and narrowed the breakpoint
to a 0.68-Mb region on 14q32.2. The breakpoint was mapped
on BAC RP11-782I5, which resulted in split signal in meta-
phases with optimal spread and hybridization (Fig. 3). In
accordance, the adjacent probe RP11-876E22, which pre-
sented a small overlap with the split BAC, showed hybridiza-
tion signal only on der(14). The available sequence of the
BAC insert (http://genome.usc.edu) indicates that BCL11B
is the only known or predicted gene in the region [20].
5. Discussion
We reported here an AML patient with the malignant
cells carrying a novel rearrangement, a t(6;14)(q25~q26;
q32.2). The breakpoint on chromosome 14 was narrowed
with FISH to a single BAC containing the BCL11B gene
(Figs. 1 and 3). Lack of further material precluded either
narrowing the rearrangement on chromosome arm 6q or
investigating the expression of BCL11B. Translocation
(6;14)(q25;q32) has been previously reported in two cases
of hematological malignancies, one involving a childhood
acute mixed lineage leukemia (AMLL) and the other an acute
nonlymphoblastic leukemia (ANLL) [16–18]. The AML of
our patient (M1) and the rearrangement described here at
the cytogenetic level are compatible with these reported
cases, and it is plausible not only that all these patients
carry similar chromosomal rearrangements but also that the
presence of either mixed lineage or myelocytic lineage in
a predefined FAB classification is related to the age of the
patients.
The present study is the first report implicating
BCL11B (OMIM 606558) in AML. The BCL11B gene codes
for an 823-amino-acid protein, which presents 61% homol-
ogy to the protein product of BCL11A (2p13; OMIM 600557)
overall, but 95% homology in their zinc finger domains.
BCL11A is a highly conserved gene across a wide range of
species, and is rearranged and overexpressed in some chronic
lymphocytic leukemia (CLL) patients [21,22].
This report calls attention to the possible role of BCL11B
in the etiology of hematological malignancies and provides a
candidate gene for AML (especially FAB-M1 cases), ANLL,
and AMLL with apparently normal karyotypes.42Acknowledgments
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Abstract The simultaneous identification, by fluores-
cence in situ hybridisation (FISH), of each chromosome
in a distinct colour became feasible a few years ago. The
key question in the application of this and many other de-
velopments in molecular cytogenetics to clinical situa-
tions is whether the results add significant further infor-
mation that is relevant to the diagnosis. So far, limited
data exist regarding how much improvement the tech-
nique brings to the diagnosis of phenotypically abnormal
individuals in whom no abnormalities have been detected
by conventional G-banding analysis. Because of the lack
of a conclusive diagnosis, genetic counselling, estimation
of recurrence risk and prenatal diagnosis of these individ-
uals and their relatives is problematic. We report a study
with 24-colour whole-chromosome painting of 10 familial
and 11 isolated cases with abnormal phenotypes and nor-
mal G-banding karyotypes. Previously undetected unbal-
anced translocations were revealed in two cases. The
value and current cost-effectiveness of multicolour FISH
for cytogenetic diagnosis is discussed.
Introduction
Chromosome banding is the standard approach for identi-
fying chromosome abnormalities. During the last decade,
fluorescence in situ hybridisation (FISH) has increasingly
been used as an adjunct to detect and further elucidate chro-
mosome rearrangements. Chromosome-specific libraries
are especially suitable for determining the origin of uniden-
tified material in chromosome rearrangements (Lichter et
al. 1988; Pinkel et al. 1988). Recently, two independent
groups have achieved the goal of simultaneously visualiz-
ing each of the human chromosomes in a different colour
(Schröck et al. 1996; Speicher et al. 1996) by combining
more than one fluorochrome in a probe (combinatorial la-
belling; Nederlof et al. 1990). We have recently reported
the labelling of libraries by an alternative procedure that
expands the resulting number of colours by also using ra-
tio labelling (COmbined Binary RAtio labelling – COBRA;
Tanke et al. 1999). This procedure enables the detection
of all 43 chromosome-arms of the karyotype in different
colours (Wiegant et al. 2000).
The benefits of performing multicolour painting proce-
dures on karyotypes that are found to be abnormal but that
are not completely elucidated by conventional banding
techniques are well established and have been illustrated
both in clinical (Haddad et al. 1998; Schröck et al. 1997)
and in cancer (Ariyama et al. 1998; Macville et al. 1999;
Padilla-Nash et al. 1999; Rao et al. 1998; Veldman et al.
1997) situations. In these cases, the use of multicolour
FISH replaces the tedious and laborious consecutive hy-
bridisations of specific paints. A different situation ap-
plies to patients with abnormal phenotypes suggestive of
chromosomal abnormalities, but in whom normal GTG-
banding karyotypes have been found. These patients have
no clear diagnosis, and genetic counselling is often based
solely on empirical data. Multicolour FISH analysis can
contribute to the diagnosis of those patients with appar-
ently normal karyotypes that display abnormalities in the
range of the resolution of chromosome libraries. We have,
therefore, applied 24-colour FISH to investigate 10 famil-
ial and 11 isolated cases of patients with phenotypes sug-
gestive of a chromosome abnormality, but with normal
karyotypes by G-banding.
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Materials and methods
Patient ascertainment and sample preparation
All patients from this study were initially referred for cytogenetic
investigation to the Clinical Cytogenetic Department at the Leiden
University Medical Center. The patients were subsequently re-
ferred to us for multicolour FISH analysis, because their pheno-
types were highly suggestive of chromosome abnormalities, but
their karyotypes by conventional GTG-banding were normal.
Metaphases from peripheral blood lymphocytes for karyotypic
analyses were prepared according to standard procedures.
Multicolour chromosome-specific FISH
The 24-colour FISH experiments were performed as described
(Tanke et al. 1999). The whole-chromosome painting probes were
obtained in collaboration with Cytocell (Adderbury, Banbury,
UK). The probes were further amplified in our laboratory by stan-
dard universal degenerate oligonucleotide-primed polymerase chain
reaction (DOP-PCR; Carter et al. 1992; Telenius et al. 1992a,
1992b) and chemically labelled by using the Universal Linkage
System (ULS-Kreatech Diagnostics, Amsterdam, The Nether-
lands). In contrast to the combinatorial procedures, which use five
fluorochromes, the COBRA-FISH approach applied here uses just
four fluorochromes to generate the 24 colours needed to identify
every chromosome (COBRA; Tanke et al. 1999). Three fluoro-
chromes (DEAC, Cy3, Cy5) are used to generate 12 different
colours on the basis of ratio labelling: each chromosome probe is
labelled either with one fluorochrome or different ratios of two flu-
orochromes. The remaining 12 chromosomes are labelled exactly
in the same fashion but are differentiated from the first set of chro-
mosomes by the addition of a fourth fluorochrome, rhodamine-
green. Chromosomes were counterstained with 4,6-diamidino-2-
phenylindole.
Digital fluorescence imaging was performed by using a Leica
DM-RXA epifluorescence microscope (Leica, Wetzlar, Germany)
equipped with a 100-W mercury lamp and computer-controlled fil-
ter rotor with excitation and emission filters for the visualization of
DEAC, Cy3, Cy5 and rhodamine-green. Grey-level images of each
fluorochrome were collected and superimposed in different pseudo-
colours, to build up a colour image. Image analyses were per-
formed with software implemented on a Power Macintosh 8100
designed to recognize, and to use as base of chromosome classifi-
cation, ratio-labelling (J. Vrolijk et al., in preparation).
FISH with subtelomeric and band-specific probes
To confirm and characterize further a t(4;5) found by multicolour
FISH (see case 7), subtelomeric probes for chromosome 4pter
(pC847.351) and 4qter (p2663) (chromoprobe T4p&4q dual label;
Cytocell, Oxfordshire, UK) and band-specific for 5p15.32–15.33
(cCI5–47; and 5p15.2 (CDCR; LSI D5S721/D5S23; Vysis Downer
Grove, Ill., USA) were used. For the t(1;3) (see case 21), subtelo-
meric sequences of 1q (160H23), 3p (1186B18) and 3q (196B4),
kindly provided by Dr. J. Flint (National Institutes of Health and
Institute of Molecular Medicine Collaboration 1996), were used.
FISH of these single copy sequences was performed according to
our standard procedures (Rosenberg et al. 1995, 1998a, 1998b).
Case reports and results
Most patients in this study presented with mental impair-
ment associated with dysmorphic features or congenital
abnormalities but a few cases with other indications, such
as multiple abortions, were also included. Three of the af-
fected children (cases 8, 10 and 14) were newborns and
no evaluation of their mental capacity has yet been under-
taken.
The cases were classified as “isolated” (i.e. only one
affected individual in the family) or “familial” (i.e. more
than one affected individual in the family). Multiple spon-
taneous abortions within a family were also classified as
familial. The clinical indications for the cytogenetic
analyses are presented in Tables 1 (familial cases) and 2
(isolated cases).
Table 1 Familial cases: a
summary of the clinical histo-
ries is presented. The individu-
als displayed in bold represent
genetic links among the af-
fected relatives and were stud-
ied both by GTG-banding
analyses and 24-colour FISH
Case Clinical history and indication for chromosome analyses
1 Female with two sons (both 46,XY) with mild mental retardation, serious behaviour and learn-
ing problems, and mild dysmorphic features. Her sister has two daughters with mental retarda-
tion. Fragile-X syndrome was ruled out by DNA studies
2 Female with 5 spontaneous abortions and a daughter (46,XX) affected with mental retardation, 
dysmorphic features and epilepsy. One of her sisters is also mentally retarded, with a similar 
phenotype to her daughter
3 Couple with 2 abortions, one child with anencephaly and unilateral polydactily detected in 
uterus (pregnancy terminated), and one child (46,XY) with mental retardation and multiple con-
genital abnormalities
4 Consanguineous couple with 2 deceased children and 2 sons (both 46,XY) affected with men-
tal retardation and different multiple congenital abnormalities
5 Couple with 4 consecutive miscarriages in the second trimester
6 Couple with 2 children with different heart abnormalities. The oldest was a boy (deceased) and 
the second is a girl (46,XX, with no deletion detected with 22q11 FISH-specific probes)
7 Couple with 2-year-old girl with psychomotor retardation and dysmorphic features (see Results)
8 Female with 6 spontaneous abortions from her first husband, and a newborn son (46,XY) with 
dysmorphic features from her second husband
9 Couple with 3 children with different degrees of mental retardation and behavioural problems. 
Fragile-X syndrome was ruled out by DNA studies in the most retarded son (46,XY)
10 Newborn boy with multiple congenital abnormalities. One brother (46,XY) of the father has 3 
affected children (two of them were karyotyped, no abnormalities detected); another brother has 
2 children also affected. All 5 affected children present a similar phenotype, with mental retar-
dation and multiple congenital abnormalities
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In the isolated cases, the affected individuals were
studied by GTG-banding and muticolour-FISH. In the fa-
milial cases, at least one affected individual in the family
was studied by GTG-banding. In addition, the normal par-
ents who represented obligatory links between affected
family members (one or both parents, depending on the
pedigree) were studied both by GTG-banding and by mul-
ticolour-FISH, since they are obligatory carriers of the pu-
tative rearrangement. The investigation of the potential
carrier is advantageous because the probability of detect-
ing a rearrangement in the balanced form is higher. Table
1 includes the information about the affected individuals
in the families studied by conventional cytogenetics and
indicates, in bold, the normal relatives studied by conven-
tional cytogenetics and multicolour-FISH.
The FISH experiments were performed with 24 colours
(i.e. chromosome-specific painting). In two cases (cases 7
and 21), rearrangements were revealed by multicolour-
FISH. These cases were also analysed by 43-colour FISH
(both chromosome- and arm-specific painting) to deter-
mine which chromosome arms were involved in the re-
arrangements. These two cases are reported in detail below.
Case 7
A couple was referred for genetic counselling because
they had a daughter with severe psychomotor retardation,
microcephaly and dysmorphic features. The girl was born
prematurely after 31 weeks gestation with a birth weight
of 850 g. There was no previous history of mental retar-
dation and/or congenital birth defects in the family. Her
karyotype was 46,XX and metabolic investigations were
normal. Both parents also showed a normal karyotype by
conventional analysis. Twenty-four colour FISH in
metaphases from the father did not reveal any abnormali-
ties, but metaphases from the mother showed a der(4)
with extra material, which originated from chromosome 5
on the terminal part of the long arm. Two normal chromo-
somes 5 were present (Fig.1a, b).
Metaphases from the daughter were then investigated
by 43-colour FISH (both chromosome- and arm-specific),
Table 2 Isolated cases: the
clinical indication for chromo-
some analyses of the affected
individuals. All individuals had
a normal GTG-banded karyo-
type and were studied by 24-
colour FISH
Case Indication for chromosome analyses Complementary molecular or FISH analyses
11 Three-year-old girl with Catel-Manzke 
syndrome (case described in Kant et al. 1998)
12 Two-year-old girl with mental retardation,  No deletion detected with FISH probes 
heart defect and dysmorphic features specific for either Williams or Rubinstein-
Taybi syndromes
13 Four-year-old boy with mental retardation, 
autistiform behaviour and multiple congenital 
abnormalities
14 Newborn girl with dysmorphic features and 
in whom a large hygroma in uterus was  
detected during the pregnancy 
15 One-year-old boy with psychomotor retardation, No deletion detected with FISH probes 
failure to thrive, microcephaly and dysmorphic specific for Wolf-Hirschhorn-syndrome
features
16 Fifty-one-year-old male with mild mental No deletion detected with FISH probes 
retardation, aggressive behaviour, macro- specific for Smith-Magenis syndrome. 
cephaly and dysmorphic features Fragile-X syndrome was ruled out by DNA
studies
17 Six-year-old boy with mental retardation and FISH for deletion 22q11 was normal
multiple congenital abnormalities
18 Fifteen-year-old boy with mental retardation, No deletion detected with FISH probes 
autistic behaviour and dysmorphic features specific for Smith-Magenis. Fragile-X 
syndrome was ruled out by DNA studies
19 Five-year-old boy with testis regression 
syndrome, neutropenia and feeding problems
20 Two-year-old girl with mental retardation and 
dysmorphic features
21 Three-year-old girl with severe mental retar-
dation and multiple congenital abnormalities 
(see Results)
Fig.1a–e Characterization of the der(4)t(4;5) found in the af-
fected girl and in her mother in case 7. a Twenty-four colour karyo-
type of the mother. b The der(4) (right) and its normal homologue
by 24-colour FISH. c Subtelomeric probes for 4p (green) and 4q
(red) showing that the 4qter sequence is absent on the der(4)
(right). d Band-specific probe for 5p15.32–15.33, demonstrating
the presence of 5p sequences on der(4) (right). e der(4) (right) and
its normal homologue (left), showing that an extra faint dark band
can be visualised on the terminal long arm of der(4) by high reso-
lution G-banding
Fig.2a–d Characterization of the der(1)t(1;3) in patient 21.
a Twenty-four colour karyotype. b The der(1) (right) and its nor-
mal homologue by 24-colour FISH. c Subtelomeric probes for 3p
(blue), 3q (green) and 1q (red) showing that 1qter is lost and 3qter
is present in the der(1) (right). d Der(1) and its normal homologue
showing that no detectable difference can be seen between them by
high resolution G-banding
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which revealed that the der(4)t(4;5) was also present in
the affected child and that the additional chromosome 5
material originated from the short arm. The rearrangement
was also confirmed and shown to be unbalanced both in
the mother and in the daughter by the use of subtelomeric
probes for chromosomes 4 (Fig.1c) and 5 (Fig.1d), and
by two-colour hybridisation with chromosome 4 and 5 li-
braries. Provided with the knowledge of the unbalanced
translocation, re-examination of the chromosomes of the
mother and the daughter by high-resolution banding al-
lowed the der(4) to be identified (Fig.1e). FISH analysis
with band-specific probes in combination with conven-
tional GTG-banding was used to determine the break-
points. Both mother and daughter presented the unbal-
anced karyotype 46,XX,der(4)t(4;5)(q34;p15.1). Physical
examination of the mother showed that she had borderline
intelligence and some mild dysmorphic features.
Case 21
A child was referred for cytogenetic studies because of
dysmorphic facial features, microcephaly, abnormal posi-
tion of the feet, callosal agenesis and malrotation of the
bowel. Shortly after birth, she experienced convulsions
and attacks of apnoea with cyanosis. An isolated complex
III deficiency was detected in muscle, but not in skin fi-
broblasts. The karyotype was 46,XX.
At the age of 2.5 years, the child was re-evaluated be-
cause the parents required pre-natal diagnosis. She pre-
sented with severe psychomotor retardation, hypotonia,
microcephaly and dysmorphic features of face, hands and
feet. The multiple abnormalities could not be completely
explained by the OXPHOS (oxidative phosphorylation in
the mitochondria) disorder of muscle, so 24-colour FISH
was performed both in the patient and her parents.
Twenty-four colour FISH revealed no abnormalities in
the metaphases from the parents. However, a very small
band on the end of the long arm of chromosome 1 was de-
tected in the metaphases from the child (Fig.2a, b); this
band was suspected of being derived from chromosome 3.
A hybridisation with 43-colours (chromosome- and arm-
specific probes) confirmed the existence of the transloca-
tion but the band was too small to determine from which
arm it was derived. Subtelomeric probes for 1q, 3p and 3q
demonstrated that the translocated material on chro-
mosome 1 was derived from the terminal long arm of
chromosome 3 (Fig.2c). The unbalanced rearrange-
ment resulted in partial trisomy 3 and monosomy 1 and
the final karyotype of the child was described as
46,XX,der(1)t(1;3)(q44;q29). Even after characterizing
the rearrangement by FISH, the rearranged chromosome
could not be visualized by GTG-banding (Fig.2c).
Discussion
In the last decade, molecular cytogenetic developments
have resulted in numerous tools that are available as an
adjunct to classical cytogenetics. In contrast to most other
FISH techniques, 24-colour chromosome hybridisations
are suitable for screening chromosome abnormalities over
the whole genome and no candidate rearrangement has to
be defined a priori. The decision of whether to use the dif-
ferent FISH resources is dependant not only upon the
technical skills of the laboratory, the costs involved and
the intensity of labour, but also on the probability that the
investigation will provide useful extra diagnostic informa-
tion. We have studied 10 familial and 11 sporadic cases of
patients with abnormal phenotype and normal GTG-band-
ing karyotype by multicolour-FISH.
In two cases (cases 7 and 21), chromosomal abnormal-
ities that were not detected by GTG-banding were de-
tected by multicolour-FISH. In case 7, both the mother
and daughter were affected but the mother presented a
much milder phenotype than her daughter. Although the
phenotypes of the mother and daughter greatly differ in
severity, no difference in the chromosome rearrangements
was detected. It remains unclear whether these clinical
differences are attributable to variable expressivity regu-
lated by genes outside the rearrangement or whether the
rearrangement differs at the molecular level between the
mother and daughter. The abnormality in case 21 was de-
termined to be de novo, because the parents were found
not to be carriers.
For the two families found by FISH to be carrying a
cryptic rearrangement, the significance of the FISH re-
sults for genetic counselling and future prenatal diagnosis
is evident. In those cases with an abnormal phenotype and
no diagnosis, estimation of risks of affected individuals in
the family is based entirely on empirical data. The risk is
based upon the parameters of chromosomic, genic and en-
vironmental causes, which contribute to abnormal pheno-
types in a large sample of individuals. If an abnormality is
revealed, then the potential status of carriers among the
relatives can be determined.
The combination of both chromosome- and arm-spe-
cific painting (43-colour hybridisation; Wiegant et al.
2000) was used in the two cases in which abnormal karyo-
types were found by the 24-colour FISH, in order to de-
termine the chromosome-arm material involved in the re-
arrangements. We were able to determine the arm of ori-
gin with arm-specific paintings in case 7 but, in case 21,
the translocated piece was too small and the arm of origin
was only determined after the use of subtelomeric probes.
The 43-colour hybridisation, in addition to identifying the
chromosome-arm material involved in interchromosomal
rearrangements, is also able to enhance the probability of
detecting an intrachromosomal rearrangement, such as a
pericentric inversion. In the cases studied here, however,
the karyotypes are not complex and the chance of finding
rearrangements is low; therefore, the use of 19 additional
arm-specific libraries (for all non-achrocentric chromo-
somes) represents a significant increase in both costs and
labour, without a concomitant improvement in diagnostic
quality.
Although GTG-banding karyotyping and multicolour-
FISH provide resolution in the same order of magnitude
(i.e. a few megabases), rearranged chromosomes that by
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GTG-banding either result in a similar banding pattern to
their non-rearranged homologues or are too small to be
ascertained are sometimes visible by FISH. The transloca-
tion (4;5) reported in case 7 was visible only with high-
resolution banding and after the rearrangement was de-
tected by FISH. The translocation (1;3) (case 21) was not
visible by GTG-banding, even after FISH had localised
the rearrangement. How often multicolour-FISH can de-
tect a rearrangement in an apparently normal karyotype is
a key question in making a clinical decision whether to
perform the examination.
The resulting frequency of chromosome rearrange-
ments detected by FISH in this study was 2 out of 21 in-
dependent cases. If only those cases with well-diagnosed
mental impairment are included, this figure is 2/15, al-
though three newborn children (cases 8, 10 and 14) might
eventually be diagnosed as having mental impairment
when they are old enough to be evaluated. The frequency
of 2/21 is similar to the 2/20 found in the only other study
reporting multicolour-FISH in affected individuals with
normal GTG-banding karyotypes (Uhrig et al. 1999). It is
interesting to note that both of the rearrangements de-
tected in our study are subtelomeric. A lower frequency
but in the same order of magnitude (6%) has been de-
tected in a study of subtelomeric regions involving the use
of variable numbers of tandem repeats to investigate a
population with mental retardation (Flint et al. 1995). A
more precise frequency might result if a larger number of
samples are examined and also if the different clinical in-
dications, such as multiple abortions and mental retarda-
tion either with or without other associated abnormalities,
are investigated separately. Because of the amount of
DNA and multiple fluorochromes required, 24-colour
FISH is among the most expensive and labour-demanding
of the FISH techniques. Although costs might differ de-
pending on the specific procedures of the laboratory, it ap-
proximately doubles the cost of a cytogenetic diagnosis. It
is also important to compare the genome-screening effi-
ciency of chromosome- or arm-specific painting FISH
with other diagnostic possibilities, such as subtelomeric
probes. The data derived from this and similar studies
should help in making the decision of when, and which,
molecular cytogenetic tools should be used in clinical di-
agnosis.
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We describe a patient with multiple conge-
nital abnormalities exhibiting 2–5 super-
numerary chromosomes per cells. A variety
of FISH techniques were used to demon-
strate that the markers are probably rings,
lack detectable telomere sequences, and
originate from different non-acrocentric
chromosomes, namely 6, 7, 10, 12, and 19.
Such cases are extremely rare and this is
only the 8th published report of an indivi-
dual presenting three or more supernumer-
ary chromosomes. We reviewed all available
cases of multiple supernumerary chromo-
somes and the collective data indicate that
multiple markers seem always to be rings
of different origin. These results provide
evidence that such multiple ring markers
cannot possibly represent duplication or
recurrenceof anoriginal structural rearran-
gement but must be derived with a common
causality from different chromosomes. Pos-
sible mechanisms for the simultaneous pro-
duction of multiple rings from different
chromosomes are proposed, including the
breakdown and rearrangement of a haploid
complement shortly after fertilization in a
triploid zygote.  2003 Wiley-Liss, Inc.
KEY WORDS: supernumerary chromo-
somes; multicolor FISH
INTRODUCTION
The frequency of supernumerary markers in new-
borns is approximately 3/10,000 [Jacobs, 1990] and ring
chromosomes represent only 8–10% of these [Jacobs,
1981]. The large majority of supernumerary markers
are derived from acrocentric chromosomes [Gravholt
and Friedrich, 1995; Crolla, 1998]. We present here a
clinical report of a patient with up to five supernumerary
chromosomes including the molecular cytogenetic char-
acterization of the rearranged chromosomes by FISH
using a combination of 48-color painting, chromosome-
specific centromere, and all-chromosome telomere
probes. The results suggest that the markers are ring
chromosomes independently derived from different
chromosomes. We present a review of the only seven
other reported cases in which three or more super-
numerary markers were present [Mackie-Ogilvie et al.,
1997] and discuss mechanisms for their origin.
METHODS
Clinical Report
The patient was born at term in 1986, and was the first
child of non-consanguineous parents. The mother was
18-years-old at the time of birth, and the pregnancy was
complicated by hydramnion and moderate hypertension
in the 25th and 35th weeks, respectively. At birth, the
Apgar score was normal, length was 55 cm (90–97
centile), head circumference 37 cm, weight 4,880 g (>97
centile), and placenta weight 1,145 g.
Physical examination showed hypotonia, opisthoto-
nos, broad nasal bridge, large lips, retrognathia, and
proximally implanted thumbs. Auscultation revealed
*Correspondence to: Dr. Carla Rosenberg, Ph.D., Lab. Cyto-
chemistry and Cytometry, Department Molecular Cell Biology—
LUMC, Wassenaarseweg 72, 2333 AL Leiden, The Netherlands.
E-mail: c.rosenberg@lumc.nl
Received 26 November 2002; Accepted 17 February 2003
DOI 10.1002/ajmg.a.20163
 2003 Wiley-Liss, Inc.
57
heart tones on the right side of the thorax and a chest
X-ray disclosed a total situs inversus and an atrium
septal defect (confirmed by ultrasound). I.V.P. showed
renal cysts. A CT-scan of the brain revealed slight
widening of the ventricles, agenesis of the corpus
callosum with normal sulci.
For the first 6 months, the child experienced drinking
problems, oesophageal reflux, vomiting, and apnoeic at-
tacks. Tetraplegia and psychomotor retardation became
gradually apparent. The child died suddenly at home
at the age of 7 months. Permission for post-mortem
examination was not granted.
There was no history of drug abuse, use of medication,
or exposure to chemicals or radiation by the parents
either prior to, or during the pregnancy. Five years later,
the mother delivered a healthy daughter.
Cytogenetic Studies
PHA stimulated lymphocytes and skin fibroblasts
from the patient were cultured and harvested according
to standard techniques. Air-dried slides were banded
using QFQ-, CBG-, DAPI-, and AgNOR-staining, ac-
cording to standard protocols. The karyotypes of the
parents were also examined by CBG-banded meta-
phases.
At the time of diagnosis (1987), fluorescent in situ
hybridization was sequentially performed in lympho-
cyte metaphases from the patient using a series of
alphoid centromere-specific probes. All probes were
biotin-11-dUTP labeled by nick-translation and detect-
ed with two layers of avidin-FITC, according to standard
procedures [Lichter et al., 1988; Pinkel et al., 1988].
Fifteen years later, fibroblasts from the patient were
cultured again and the new chromosome preparations
were examined by using newer molecular cytogenetic
approaches. These included the following.
a. 48-Color chromosome arm specific FISH
painting. Chromosome arm specific painting was
used as a primary screening method to determine the
origin of the markers. The protocols were performed
according to procedures developed in our laboratory
(COBRA-FISH) and described in detailed elsewhere
[Tanke et al., 1999; Bezrookove et al., 2000; Wiegant
et al., 2000].
b. Multicolor FISH using alphoid centromere-
specific sequences. The findings from 48-color
arm-specific FISH allowed us to establish candidate
chromosomes for the origin of the supernumerary
markers. Based on these findings, we selected alphoid
centromere-specific probes to confirm the identity of the
supernumerary markers. Up to five differentially label-
ed sequences were hybridized per time. The alphoid
sequences were labeled by standard nick-translation
with fluorescein-, biotin-, digoxigenin-dUTP (all from
Boehringer Mannheim, Mannheim, Germany), lissa-
mine-dUTP (NEN Life Science Products, Boston, MA),
or cy5-dUTP (Amersham, Amersham, UK). The digox-
igenin and biotin labeled probes were indirectly detect-
ed with diethylaminocoumarin (DEAC) and laserPro
IR790-conjugated streptavidin, respectively (both from
Molecular Probes, Eugene, OR).
c. Hybridizationwith an all-telomere probe. To
investigate the ring status of the markers, we tested
for the presence of telomere sequences using a PNA
telomere-specific probe ((C3TA2)3, a kind gift from
DAKO, Glostrup, Denmark). PNA hybridizations and
washes were performed according to described proce-
dures [de Pauw et al., 1998].
RESULTS
Chromosome analyzes revealed an abnormal karyo-
type in which 2–5 small markers were seen per cell in
addition to a normal 46,XY complement. The frequency
and distribution of the markers in lymphocytes and skin
fibroblasts was very similar: 20% of the cells analyzed
had five markers, 47% had four markers, 29% had three
markers, and 4% had two markers (100 metaphases
from each tissue analyzed). These markers were of dif-
ferent sizes and present in different permutations. The
marker chromosomes could be arbitrarily divided into
two major groups: three larger markers, in the size
range of 17p and 22q, and two much smaller fragments
which resembled double minutes (Fig. 1). Three of the
larger fragments were CBG-positive but all the markers
were found to be negative to AgNOR-, QFQ-, and DA/
DAPI-staining.
The five markers presented a ring-like morphology,
although the ring appearance was more obvious in the
large than in the small markers. Hybridization with a
telomere-repeat probe showed signals at the ends of
every normal chromosome, but no signal was detected in
any of the supernumerary chromosomes (Fig. 2). The
absence of detectable telomere sequences together with
the morphology of the markers strongly indicated that
the markers were ring chromosomes.
Sequential FISH with centromere-specific probes was
performed at the time of diagnosis, in 1987, and identi-
fied two of the markers as being derived from chromo-
somes 7 and 10 (mar(7) and mar(10), respectively).
Several years later, when a new culture of fibroblast was
performed for further molecular cytogenetic studies, it
was noted that a maximum of four markers were de-
tected per cell, suggesting that one of the markers had
been lost in culture. The identity of the markers were
tentatively established by multicolor FISH (Fig. 3), and
confirmed by the use of multicolor hybridization of
centromere-specific sequences (Fig. 4). Two of the large
markers were identified as derivatives of chromosomes 7
and 19 and the small markers as derivatives of chromo-
somes 6 and 12, respectively (the markers are referred to
here as mar(6), mar(7), mar(12), and mar(19)). Because
no specific centromere probe for chromosome 19 is
available, the origin of the mar(19) was confirmed by
the use of whole-chromosome and arm-specific painting
for 19 and 19q, respectively. The results of the painting
hybridization indicated that the mar(19) was composed
mostly or exclusively of material derived from the long
arm of chromosome 19 (Fig. 5a,b).
Mar(10) was not detected in this recent cytogenetic
examination, and is likely to be the large-size marker
which we could not identify in the new fibroblast pre-
paration. Mar(7) showed an increased intensity and size
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of centromere signal compared to the normal homo-
logues, indicating that the marker is either dicentric
or its sequences were amplified. In this more recent
chromosome preparation, mar(6) was present in 68%,
mar(12) in 24%, mar(7) in 18%, and mar(19) in 14% of
the cells.
Chromosome analyzes of both parents revealed nor-
mal karyotypes. It was not possible to obtain new blood
samples from the parents for DNA analyzes and,
therefore, we could not establish the parental origin of
the markers.
DISCUSSION
We describe here a patient with up to five super-
numerary ring markers per cell. Table I summarizes all
cases reported so far of individuals presenting multiple
(two or more) supernumerary ring chromosomes per
cell of different origin. The occurrence of single super-
numerary chromosomes is a relatively rare event in
which rings and non-acrocentric markers represent
a minority amongst them. Interestingly, all cases of
multiple markers were shown to have or were sugges-
tive of a ring morphology, and only a minority was
derived from acrocentric chromosomes (7 markers
originating from acrocentric chromosomes among 41
markers identified by FISH, see Table I).
Instability of ring chromosomes is a possible mechan-
ism for duplication or rearrangement of chromosomes,
and accounts for some reported cases of patients with
two chromosomes of the same origin (e.g., [Fang et al.,
1995] and case 10 from [Callen et al., 1991]). Initially, it
was considered as a possible explanation for multiple
markers of different morphology [Mascarello et al.,
1987; Tozzi et al., 1988], but when the application of
fluorescence in situ hybridization allowed determina-
tion of the origin of these supernumerary markers, it
became clear that nearly all cases with multiple markers
involved different chromosomes and, accordingly, inde-
pendent origins.
Fig. 1. Giemsa staining of a metaphase containing five supernumerary
chromosomes (arrows). The figure shows that the supernumerary chromo-
somes present different morphology.
Fig. 2. Metaphase of the patient hybridized with all-chromosomes
telomere-repeat (PNA) probe. Every chromosome in the picture shows
signals in the terminal regions of the short and long arms, except for the two
supernumerary chromosomes (arrows). The lack of telomeric signal on the
supernumerary chromosomes supports the assumption that they are rings.
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If the findings in our patient represented the inde-
pendent origin of five additional rings, each with a
3104 probability of occurring (see ‘‘Introduction’’),
the combined probability of five supernumerary mar-
kers would be of the order of 1023. The patient
described by Ulmer et al. [1997], who presented up to
eight markers per cell, would have a 1037 chance
of occurring, and the combined probability of eight of
such patients carrying multiple markers, as reported in
the last 15 years, is so immeasurably small that alter-
native mechanisms specifically associated with the
occurrence of multiple ring markers of different origin,
as distinct from those responsible for the formation
of sporadic markers, must exist. These mechanisms
remain elusive, but should account for the two main
features, discussed below:
1. The existence of extra chromosome material avail-
able for rearranging and giving rise to multiple
supernumerary ring markers of independent origin.
2. A mechanism for the simultaneous and preferential
formation of ring chromosomes.
It is tempting to assume that the same mechanism that
leads to extra chromosome material would also result
in preferential ring formation. Whichever mechanism
underlies the formation of multiple rings, it seems to
affect just one haploid set, and the patients still present
a fully intact diploid complement.
Fig. 3. Multicolor FISH (COBRA) to a metaphase of the patient. Each chromosome is identified by a different color. The supernumerary markers (arrows)
display fainter colors due to the small amounts of euchromatic material and, therefore, they are difficult to identify.
Fig. 4. Multicolor hybridization with centromere-specific probes. The
centromeres of chromosomes 10 (pink) and 18 (green) showed only two
signals each (in the normal homologues), while three signals were detected
for chromosomes 6 (blue) and 12 (red) (two in the normal homologues and one
in a marker). The arrows indicate the supernumerary chromosomes which
were shown to be der(6) and der(12), and one which did not hybridize with
any of these centromeric sequences.
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Fertilization involving two spermatozoa frequently
leads to formation of a triploid embryo. Under circum-
stances of a normal fertilization a modest level of asyn-
chrony is frequently observed in the condensation of
chromosomes from the male and female pronuclei just
prior to the first cleavage, with the male chromosomes
being less condensed then those of the female. In the case
of a double fertilization, it is conceivable that one of the
Fig. 5. A metaphase spread showing hybridization with three different
probes. Arrows show the supernumerary chromosomes. Because two of the
probes partially overlap, two images of the metaphase in different com-
binations of fluorescence filters are shown: (a) chromosome painting probes
for 19 (pink) and 22 (green), demonstrating that one of the supernumerary
chromosomes is derived from 19, while the other 3 do not show hybridization
signals. b: Long-arm painting probes (blue) for chromosomes 19 and 22,
demonstrating that the der(19) is composed mostly or totally of long arm
chromosome material.
TABLE I. Overview of all Reported Cases of Multiple (2) Supernumerary Chromosomes of
Different Chromosome Origin
[Mascarello et al., 1987] 0–5 Markers not identified by FISH, but differed in size,
were ring-like and NOR-negative
[Tozzi et al., 1988] 1–5 Markers not identified by FISH, but differed in size,
were ring-like and NOR-negative
[Callen et al., 1991]
Case 3 1–2 r(6); r(X)
[Plattner et al., 1993]
Case 20 1–2 r(18); r(13/21)
Case 21b 0–2 r(12); r(13/21)—markers also present in the mother
Case 22 1–4 r(8); r(14/22); r(15); r(X)
[Mackie-Ogilvie et al., 1997]
Case 1 pre-natal 0–3 r(4); r(17); r(20)
Case 2 0–4 r(4); r(8); r(10); r(X)
[Aalfs et al., 1996] 0–2 r(6); r(9)
[Ulmer et al., 1997] 3–8 Markers originated from X, 1, 3, 11, 14, 20, and 21
(ring appearance)
[Vermeesch et al., 1999] 1–6 r(1); r(2); r(5); r(6); r(12); r(14/22). Demonstrated that
telomeric repeats were absent in the rings and that
centromeres were active
[Shanske et al., 1999] 0–2 r(1); r(16). Rings were present in twins
[Maurer et al., 2001] 0–2 r(6); r(11)
Present case 1–5 r(6); r(7); r(10); r(12); r(19)
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two male pronuclei is seriously retarded relative to
the other male and female pronuclei, such that at the
stage that the latter are entering the first cleavage the
former is still engaged in DNA synthesis. This will lead
to premature chromosome condensation and pulveriza-
tion of the chromosomes in the retarded male pronu-
cleus. As a consequence, chromosome fragments will
frequently result in rings, and those containing centro-
meres will possibly be mitotically competent. Although
this model is speculative, it is one that can be tested
since it predicts that the supernumerary ring chromo-
somes are entirely paternally derived. Regrettably in
our patient, DNA samples for polymorphism analyzes
was unavailable from either parent, but others could
test this possibility in their cases. The availability of
stored or permanent cell material from similar cases as
the one presented here, will be essential to provide more
insight into this phenomenon of how multiple ring
marker chromosomes of independent origin can arise in
the same individual.
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Abstract  
The SNF5 subunit of human SWI/SNF ATP-dependent chromatin-remodeling 
complexes is a tumor-suppressor that is inactivated in malignant rhabdoid tumors (MRTs). 
Here, we report that loss of hSNF5 function in MRT-derived cells leads to polyploidization 
and chromosomal instability. Restoration of hSNF5 expression resulted in the purging of cells 
with an abnormal chromosome number. In contrast, cancer-associated hSNF5 mutants 
harboring specific single amino acid substitutions, exacerbated polyploidization, due to 
abrogated chromosome segregation. These results establish for the first time that polyploidy 
and aneuploidy of tumor cells can result from mutations in a chromatin-remodeling factor.  
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Introduction  
ATP-dependent chromatin-remodeling factors are critical components of the elaborate 
machinery that controls gene expression in eukaryotic cells (Becker and Horz 2002; Narlikar 
et al. 2002). The multi-subunit SWI/SNF complex is the prototypical chromatin-remodeling 
factor, present in all eukaryotes. Several recent studies have implicated human SWI/SNF 
complexes in the control of cellular proliferation and tumor-suppression (Klochendler-Yeivin, 
et al. 2002; Roberts and Orkin 2004). Human SNF5 (hSNF5, a.k.a. Ini1, Baf47 or SmarcB1) 
encodes for a universal core SWI/SNF subunit, and is a tumor-suppressor that is mutated in 
atypical teratoid and malignant rhabdoid tumors (ATRT and MRT) (Versteege et al. 1998; 
Biegel et al. 1999; Klochendler-Yeivin et al. 2002; Roberts and Orkin 2004). These rare but 
aggressive cancers typically arise during early childhood and have a very high lethality. In 
addition to somatic mutations, families with germ-line mutations have been identified. 
Carriers are predisposed to various cancers, including MRTs and tumors of the central 
nervous system (Biegel et al. 1999; Sevenet et al. 1999; Taylor et al. 2000). Consistent with a 
classic tumor-suppressor phenotype, the wild-type allele is either lost or deleted in a large 
proportion of these tumors.  hSNF5 mutations are also associated with a number of neoplasms 
other than ATRTs and MRTs, including chronic myeloid leukemia, medulloblastoma, choroid 
plexus carcinoma and central primitive neurectodermal tumors (Sevenet et al. 1999; Grand et 
al. 1999).   
Gene inactivation studies in mice revealed that, while homozygous SNF5 null mice 
die during early embryogenesis, heterozygous mice survive but are prone to soft tissue tumors 
(Klochendler-Yeivin et al. 2000; Roberts et al. 2000; Guidi et al. 2001; Roberts et al. 2002). 
The remaining SNF5 allele in these tumors is lost, establishing a critical tumor-suppressor 
function for SNF5. The use of a reversible inactivating conditional allele, revealed that loss of 
SNF5 function resulted in a highly penetrant and extremely short latency development of 
cancers, in particular lymphomas or rhabdoid tumors (Roberts et al. 2002).  
Studies on MRT-derived cell lines have yielded important insights into the molecular 
mechanisms of tumor-suppression by SNF5. A number of independent studies found that re-
expression of hSNF5 in MRT cells causes an accumulation in G0/G1, cellular senescence and 
apoptosis (Betz et al. 2002; Ae et al. 2002; Zhang et al. 2002; Versteege et al. 2002; 
Oruetxebarria et al. 2004). These effects are the result of direct transcriptional activation of 
the tumor-suppressor p16
INK4a
 by hSNF5. Critically, p16
INK4a
 induction appears to be both 
necessary and sufficient for reduced cell accumulation and induction of cellular senescence 
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(Oruetxebarria et al. 2004). Thus, one tumor-suppressive function of hSNF5 is growth 
restriction via the 
INK4a
/pRb pathway.  
In addition to uncontrolled cell proliferation, chromosomal instability, which is 
characterized by changes in chromosome number or structure, is a hallmark of many cancers. 
Although still debated, accumulating evidence supports a causal role for chromosome 
instability during early stages of tumor development (Jallepalli and Lengauer 2001; Fodde et 
al. 2001a; Fodde et al. 2001b; Rajagopalan et al. 2003; Rajagopalan et al.  2004; Storchova 
and Pellman 2004). Therefore, we decided to investigate the role of hSNF5 in ploidy control. 
We utilized MRT-derived cells, which lost the hSNF5 gene in the original cancerous lesion, 
to examine the effects of re-expression of hSNF5 on karyotypical variation. Our results 
revealed that hSNF5 induction led to a removal of polyploid and aneuploid cells. In addition, 
we identified gain-of-function mutations in hSNF5, which promoted polyploidization. Our 
results define a novel function for the chromatin remodeling factor hSNF5 in the maintenance 
of numerical chromosome stability  
 
Results and discussion  
hSNF5 deficiency in MRT cells leads to polyploidization  
In the majority of MRTs, hSNF5 is inactivated due to deletions, truncating nonsense 
mutations or frameshift mutations. However, a number of point mutations, resulting in single 
amino acid substitutions (Fig. 1a), have been identified in tumors (Sevenet et al. 1999a; 
Sevenet et al. 1999b). These substitutions include forms of hSNF5 in which either proline 48 
is changed to serine (P48S), argenine 127 to glycine (R127G) or serine 284 to leucine 
S(284L). In addition to these cancer-associated mutations, we also generated a mutant hSNF5 
in which serine 289 was changed to an alanine (S289A). S284 and S289 are located within 
one of the most highly conserved regions of SNF5, which forms part of direct repeat 2 
(RPT2).   
Wild type or mutant hSNF5 was reintroduced in MRT-derived G401 cells, lacking the 
hSNF5 gene. Expression of hSNF5 was under control of the Lac repressor-operator system 
and could be induced by the addition of IPTG (Fig. 1b). Previously, we have used these “Lac-
hSNF5” cells to establish that re-expression of hSNF5 in MRT cells induces a p16
INK4a
-
dependent G0/G1 arrest and cellular senescence (Oruetxebarria et al. 2004). It should be noted 
that following induction, the levels of hSNF5 fall within the normal physiological range 
(Oruetxebarria et al. 2004). Induction of tumor-derived hSNF5 mutants still caused a reduced 
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cell accumulation, albeit not as pronounced as when wild type hSNF5 was expressed (fig 1c). 
As expected, addition of IPTG to “Lac-empty” control cells, lacking the hSNF5 gene, did not 
affect cell accumulation (Oruetxebarria et al. 2004). These results indicated that a failed 
growth arrest might not fully explain the cancer association of these single amino acid 
substitutions in hSNF5.  
DNA staining of cells expressing mutant hSNF5-S284L provided a clue towards other 
processes relevant to tumor suppression by hSNF5 (Fig. 2a). 4 days after induction of hSNF5-
S284L, the majority of cells contained multi-lobed nuclei or sometimes multiple nuclei. The 
dramatic changes in nuclear morphology are illustrated by a combination of DNA staining 
and visualization of cytoskeletal α-tubulin by immunofluorescence (Fig. 2b). In contrast, we 
never observed multi-lobed nuclei after expression of wild type hSNF5, whereas they 
occurred occasionally in cells lacking hSNF5-S284L. Next, we tested if the effects on nuclear 
morphology of the S284L mutation might be dominant in unrelated cells, expressing 
endogenous wild type hSNF5. Indeed, expression of hSNF5-S284L in MRC-5V1 (Fig. 2c) or 
Ad5HER cells (data not shown) also caused the appearance of multi-lobed nuclei, whereas 
over-expression of wild type hSNF5 did not affect nuclear morphology. Thus, the effect of the 
S284L substitution mutation can be dominant and is not restricted to MRT cells. We were 
intrigued by the appearance of multi-lobed nuclei because they can be a feature of polyploid 
cells that have undergone endoreplication (Edgar and Orr-Weaver 2001).   
To test whether hSNF5-S284L might promote polyploidization, we used multicolor 
pq-COBRA-FISH analysis (Wiegant et al. 2000) to determine the full karyotypes of MRT-
derived cells that are either devoid of hSNF5, express wild type hSNF5 or hSNF5-S284L 
(Fig. 2d). About 10 % of Lac-empty cells or Lac-hSNF5 cells before induction, were near 
tetraploid. The remaining cells were in the diploid range of chromosome content, but as 
detailed below, they displayed numerical chromosome aberrations. Strikingly, after 
expression of wild type hSNF5 for 96 hours, the cell population became almost perfectly 
diploid. The purging of polyploid and aneuploid cells suggested a role for hSNF5 both in 
accurate chromosome segregation and in tightening of a mitotic checkpoint. In striking 
contrast, hSNF5S284L expression exacerbated polyploidization and aneuploidy, resulting in 
about 25% of cells in the tetraploid range and almost 10% of cells that were near octaploid. It 
is pertinent to note that, because metaphases were obtained by a colcemid block, the 
karyotypes were derived from cycling, non-arrested cells. Moreover, the presence of octaploid 
cells demonstrated that a significant portion of tetraploid cells did not arrest due to the 
tetraploidy checkpoint but re-entered mitosis. Concomitant with polyploidization we observed 
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centrosome- and spindle amplification, as revealed by staining of γ-tubulin and α-tubulin, 
respectively (Fig. 2e-f). Following hSNF5-S284L induction, the percentage of mitotic cells 
that contain more than 1 spindle increased from about 3% to respectively 22% of cells with 2 
spindles and 11% with more than two spindles. In contrast, mitotic cells that express wild type 
hSNF5 virtually always contain 1 spindle.   
In summary, these results revealed that loss of hSNF5 promotes polyploidization of 
MRT cells. The cancer-associated S284L substitution acts as a gain-of-function mutation that 
exacerbates polyploidization. In contrast, re-expression of wild type hSNF5 promotes 
accurate chromosome segregation and tightening of the mitotic checkpoint. Collectively, 
these observations suggest a critical function for hSNF5 in mitosis.  
 
Mutations in hSNF5 abrogate chromosome segregation.  
To determine at what stage of the cell cycle the hSNF5-S284L induced defect occurs, 
we utilized time-lapse microscopy (Fig. 3a). Cells expressing hSNF5-S284L enter mitosis 
normally, as judged by rounding up of the cells and chromosomal condensation (indicated 
with an arrow). However, a significant proportion of these cells subsequently exited mitosis, 
as illustrated by cell flattening and chromatin de-condensation, but abstain from karyokinesis 
and cytokinesis. In contrast, the majority of cells that do not express hSNF5-S284L progress 
normally through mitosis and cell division. To more precisely monitor and quantify the 
distinct stages of mitosis, we visualized the mitotic spindles by a combination of DNA- and 
α−tubulin staining (Fig. 3b). Compared to cells lacking hSNF5 or expressing wild type 
hSNF5, in hSNF5-S284L expressing cells both anaphase and telophases were 
underrepresented relative to metaphase. The defect precluding anaphase onset appeared to be 
a failure of the mitotic spindle to connect to the kinetochores, as revealed by confocal 
microscopy using CREST (Fodde et al. 2001b) and α−tubulin antibodies to visualize 
kinetochores and spindles, respectively (Fig. 3c). In contrast, in cells expressing wild type 
hSNF5 the spindles provided an orderly connection between metaphase chromosomes and 
centrosomes. Strikingly, the effects of hSNF5-S289A expression were indistinguishable to 
those of hSNF5-S284L, including the appearance of multi-lobed nuclei, centrosome 
amplifications and abortive anaphase (data not shown). It will be of interest to investigate the 
possibility that S284 and S289 might be targets for phosphorylation, regulating the mitotic 
functions of hSNF5. Importantly, our results establish for the first time that mutations in the 
hSNF5 subunit of human SWI/SNF complexes can lead to mitotic defects.  
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hSNF5 is critical for ploidy control and maintenance of numerical chromosome stability  
Recently, there has been increasing support for the notion that polyploidy can lead to 
aneuploidy and contribute to the development of cancer (Storchova and Pellman 2004). To 
explore this notion further, we used pq-COBRA-FISH to determine the effects of cancer-
associated mutations on ploidy distribution (Fig. 4a) and on numerical chromosome variation, 
as determined by the gain or loss of individual chromosomes (Fig. 4b). Examination of cells 
prior to induction of hSNF5 revealed that about 10% of them were about tetraploid. 
Moreover, more than half of the cells analyzed displayed general numerical chromosomal 
aberrations. These observations are consistent with occasional endoreplication and the regular 
gain or loss of chromosomes combined with loosely functioning cell cycle checkpoints. 
Strikingly, after hSNF5 induction virtually all polyploid and aneuploid cells were purged and 
the population of cells became almost perfectly diploid. This dramatic effect of hSNF5 
expression on numerical chromosome instability was highly significant (p< 2.0 x 10
6
), as 
determined by the Mann-Whitney U-test. Thus, restoration of hSNF5 expression in MRT-
derived cells, which lost the hSNF5 gene in the original cancerous lesion, suffices to revert 
chromosomal instability. In contrast, two different cancer-associated hSNF5 substitution 
mutants, hSNF5-P48S and hSNF5-R127G, failed to generate a diploid cell population. 
Expression of hSNF5-S284L not only promoted polyploidization, but also resulted in a 
significant increase of aneuploidy (p< 3.6 x 10
-5
). Likewise, hSNF5-S289A induction gave a 
strikingly similar gain-of-function phenotype, increased polyploidization and frequent loss of 
individual chromosomes (p< 2 x 10
-6
).  
In conclusion, our analysis of both loss-of-function and gain-of-function mutations 
revealed the critical role of hSNF5 in ploidy control and the maintenance of numerical 
chromosome stability. So far, whole genome expression profiling did not uncover hSNF5 
target genes whose mis-expression could explain defective chromosome segregation (our 
unpublished results). Therefore, we favor the hypothesis that hSNF5 executes mitotic 
functions independent of transcriptional regulation. Such functions could, for example, 
include the establishment of a specialized centromeric chromatin structure or the control of 
sister chromatid cohesion and segregation. Support for this notion comes from the co-
localization of hSWI/SNF with kinetochore proteins ((Xue et al. 2000) and our data not 
shown). Moreover, the SWI/SNF-related yeast RSC complex, containing a hSNF5 
orthologue, has been implicated in kinetochore function, cohesion loading onto chromosomal 
arms and 2 micron episome segregation (Wong et al. 2002; Hsu et al. 2003; Huang et al. 
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2004; Baetz et al. Hieter 2004). Using conditional siRNA approaches, we extended our 
analysis to non-MRT cells and again observed polyploidization due to the loss of hSNF5 
(unpublished data). We therefore propose that the mitotic functions of hSNF5 are general and 
not cell-type specific.  
Inactivation of ATP-dependent chromatin remodeling factors has been implicated in 
the development of distinct types of tumors (Klochendler-Yeivin et al. 2002; Roberts and 
Orkin 2004). Recent research has focused mainly on the identification of transcriptional 
circuitries affected by defective SWI/SNF function in disease and development. Here, we 
described a novel role for hSNF5 in maintenance of chromosomal stability. Our results 
revealed that loss of hSNF5 as well as specific gain-of-function mutations lead to an increase 
in polyploidy and aneuploidy. Of particular relevance is our finding that restoration of hSNF5 
expression in MRT-derived cells, which lost the hSNF5 gene in the original cancerous lesion, 
suffices to revert polyploidy and aneuploidy. We propose that inactivation of hSNF5 
promotes tumorigenesis through at least two distinct mechanisms: (1) the previously 
described, compromised transcriptional activation of p16
INK4a
-mediated proliferation control 
(Oruetxebarria et al. 2004). (2) Defective mitosis resulting in polyploidization and numerical 
chromosome instability. This way, mutations in a specific chromatin-remodeling factor may 
give a cell both the selective growth advantage and the genetic instability, necessary for tumor 
initiation and progression.  
 
Materials and Methods 
Cell culture and plasmids Generation of the cell lines was described previously: MRT-
G401 with inducible hSNF5 and mutants (Oruetxebarria et al. 2004), Ad5-HER cells, and 
MRC-5V1. G401 cells are grown in DMEM, pen/strep, 10% FCS, 400ug/ml G418, 75ug/ ml 
Hygromycin, hypoxantine 15ug/ml and thymidin 10ug/ml. Induction of hSNF5 with 5mM 
IPTG. Ad5-HER cells and MRC-5V1 are grown in DMEM, pen/strep, 10% FCS. For the 
construction of the mutants we used QuickChange mutagenesis protocol (Stratagene) and the 
following primers:  
5’-S284L GGACATGTTAGAGAAGGAG; 
3’-S284L CTCCTTCTCTAACATGTCC;  
5’-S289A GGAGAACGCACCAGAGAAG;  
3’-S289A CTTCTCTGGTGCGTTCTCC;  
5’- R127G CAGGGAACAGAAGGCCAAGGGGAACAGCCAGTGGG;  
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3’-CCCACTGGCTGTTCCCCTTGGCCTTCTGTTCCCTG;  
5’-P48S CTGTACAAGAGATACTCCTCACTCTGGAGGCG;  
3’-P48S CGCCTCCAGAGTGAGGAGTATCTCTTGTACAG 
 
Immunofluorescence and time-lapse microscopy   
Cells were grown on cover slips, fixed with 4% paraformaldehyde, permeabilized in 
PBS with 0.1% Triton X100, followed by standard indirect immunofluorescence. Nuclei were 
visualized by DAPI staining. Antibodies used for immunofluorescence and western blot: 
Anti-flag, F3165 Sigma; Anti-α-Tubulin, T5168 Sigma; Anti-γ-Tubulin, T6557 Sigma; anti-
CREST serum was a gift from H.Clevers (Fodde et al. 2001b). To quantify centrosome- and 
spindle amplification by staining of γ-tubulin and α-tubulin, approximately a 1000 mitotic 
cells for each condition were analyzed. Cells for time-lapse microscopy were grown on glass 
bottom culture dishes, 35mm dishes, 10mm glass surface (MatTek corporation USA). Two 
hours before the transfer from incubator to 37°C micoscope medium was changed to HEPES 
buffered DMEM without Phenol red (21063-029 Life Technology). Cells were monitored for 
five hours.  
 
pq-COBRA-FISH and cytogenetic analysis  
Detailed cytogenetic analysis using pq-COBRA-FISH was performed on essentially as 
described previously (Wiegant et al. 2000). Briefly, cells were treated with 0.08 µg/ml 
Colcemid (GIBCO) for 3 hr, harvested and metaphase slides were prepared according to 
standard procedures. ULS reagent for COBRA-FISH was provided by Kreatech 
Biotechnology BV. After hybridization, fluorescence imaging was carried out using a 
specially adapted Leica DM-RXA epifluorescence microscope (Leica, Wetzlar, Germany). 
For each condition 20 to 60 metaphases were analyzed. Using software to recognize and use 
ratio labeling as base of chromosome classification, the detailed karyotype from each 
metaphase was composed. The chromosome copy number was depicted as histograms, and 
the numerical abnormalities presented as percentage of gain and loss for each chromosome, 
for which the nearest ploidy of each cell was considered. The significance of differences in 
total gain or loss of chromosomes under different conditions (e.g. hSNF5 on or off) was 
determined by the Mann-Whitney U-test.   
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Figure legends  
Figure 1. Induction of wild type and mutant hSNF5 in MRT cells. (a) Schematic 
representation of hSNF5 depicting the two repeats (RPT1 and RPT2) and cancer-
associated amino-acid substitutions mutations. (b) Constructs expressing wild type or 
mutant hSNF5-FLAG were introduced in the MRT derived cell line G401 under 
control of the Lac repressor-operator system. Protein expression following induction 
with IPTG was determined by western blotting with anti-FLAG antibodies. c, Cell 
accumulation in the presence (filled circles) or absence (open circles) of IPTG.  
Figure 2. hSNF5-S284L expression induces polyploidisation. (a) DNA staining with 
DAPI revealed the presence of cells with multi-lobed nuclei following induction of 
hSNF5-S284L. (b) Co-staining of DNA with DAPI (blue), and cytoskeletal 
α−Τubulin (red). (c) GFP-hSNF5-S284L, but not GFP-hSNF5 induces multi-lobed 
nuclei in MRC5 cells. The GFP signal (green) identifies the transfected cells. (d) 
Representative examples of pq-COBRA-FISH analysis of Lac-hSNF5-S284L cells. 
di-, tri, tetra- and near octaploid methaphases are shown. Four Y-chromosomes, 
indicative of octaploidy, are indicated by arrows. (e) Representative examples of Lac-
hSNF5-S284L cells with 1, 2 or more mitotic spindles identified by 
immunofluorescence staining of α-Tubulin and DNA. (f) Visualisation of 
centrosomes (arrows) by γ-Tubulin staining    
Figure 3. hSNF5-S284L induction causes an abortive cell cycle. (a) Time-lapse 
microscopy revealed that cells expressing hSNF5-S284L enter mitosis but exit prior 
to cell division. Arrows indicate the position of the condensed chromatin. (b) Under-
representation of ana- and telophase relative to metaphase in cells expressing 
hSNF5S284L. A representative example of each mitotic stage is shown. (c) Failure of 
microtubule-kinetochore association in cells expressing hSNF5-S284L. Kinetochores 
were identified with CREST (red) antibodies and mitotic spindles with α-tubulin 
(green) antibodies.  
Figure 4. Restoration of wild type hSNF5 expression, but not of cancer-associated 
mutants, reverts chromosomal instability. (a) Histogram depicting the frequency of 
cells with a given chromosome number as determined by metaphase analysis using 
pq-COBRA-FISH. The total number of chromosomes per cell was determined either 
before or after the induction of wild type or the indicated hSNF5 mutants. (b) 
Individual chromosome gains or losses before and after expression of wild type or 
mutant hSNF5.  
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Premature Chromosome Condensation Revisited:
A Novel Chemical Approach Permits Efﬁcient
Cytogenetic Analysis of Cancers
Vladimir Bezrookove,1 Ron Smits,2 Gabriela Moeslein,3 Riccardo Fodde,2 Hans Johannes Tanke,1
Anton Klaas Raap,1 and Firouz Darroudi4*
1Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands
2Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands
3Klinik fu¨r Allgemeine und Unfallchirurgie, Du¨sseldorf, Germany
4Department of Toxicogenetics, Leiden University Medical Center, Leiden, The Netherlands
Chemical induction of premature chromosome condensation (PCC) was investigated and optimized to be able to analyze the
chromosomal constitution of cancer cells independent of mitosis and with minimal culture artifacts. A potent protein
phosphatase inhibitor, calyculin A, was used to induce PCC in normal diploid cells, in several established human tumor cell
lines, and in cells isolated from freshly dissected adenomatous polyps of a patient with hereditary colorectal cancer. In parallel,
mitotic arrest was pursued by use of Colcemid. In cell lines, a difference of up to 10-fold was found between frequency of cells
with PCC induced by calyculin A (PCC index) and the mitotic index after treatment with Colcemid. In the fresh tumor
specimens, Colcemid failed to result in metaphase formation, whereas a regimen of 80 nM calyculin A for 75 min, after only
2 days of culturing, resulted in a PCC index of 2–5%. pq-COBRA-FISH (COmbined Binary RAtio labeling–ﬂuorescence in situ
hybridization) was used for a detailed analysis of four cell lines treated with calyculin A, which proved that PCC spreads are
amenable to molecular karyotyping, and a comparison between PCC spreads and metaphases from mitotic arrest revealed no
discrepancies in karyotypes. pq-COBRA-FISH on PCC spreads from fresh colon tumor samples revealed only numerical and
no structural abnormalities. Calyculin A–induced PCC combined with multicolor FISH gives a new opportunity for analysis of
the chromosomal constitution of G1 and G2 cancer cells and may ﬁnd application in the study of the role of chromosome
instability in cancer development. © 2003 Wiley-Liss, Inc.
INTRODUCTION
Cytogenetics of solid tumors in general is nega-
tively affected by culturing artifacts such as pref-
erential clonal expansion and introduction of chro-
mosomal rearrangements. Also, cytogenetic
analysis is limited to cells that have passed the
G2/M cell cycle checkpoint and are at the meta-
phase stage of mitosis at the time of harvesting.
Furthermore, the metaphase plate quality of solid
tumors, in particular of epithelial neoplasms, is
often sub-optimal, resulting in partial karyotypic
information. In contrast to the hematological disor-
ders, which usually contain few cytogenetic
changes, most solid tumors already have, at the
time of analysis, a multitude of aberrations, thus
making it difﬁcult to discriminate between primary
changes and secondary events (Mitelman et al.,
1997; Mitelman, 2000).
Methods such as interphase multicolor ﬂuores-
cence in situ hybridization (FISH), comparative
genomic hybridization (CGH), and microarray
technologies have been used to partially bypass
these problems and obtain reliable cytogenetic in-
formation from cells in interphase. Considering the
notion that chromosomal instability is a hallmark of
cancer even at the precursor cancer level (Mitel-
man, 2000; Hagmar et al., 2001; Tallini et al., 2002),
it is of great importance to devise a method of
comprehensive chromosome analysis of cancer and
cancer precursor cells that can bypass culturing
problems as much as possible and that can provide
informative karyograms of cells at non-M stages of
the cell cycle.
The technique of premature chromosome con-
densation (PCC) ﬁrst described by Johnson and
Rao (1970), in principle, enables preparation of
chromosome spreads independent of cell cycle
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stage and with minimal culturing artifacts. Conven-
tionally, PCC is induced by fusion of test cells with
mitotic cells in the presence of virus or fusing
agent. In these protocols, Sendai virus (Johnson
and Rao, 1970; Aula, 1973; Cornforth and Bedford,
1983) or polyethylene glycol (Pantelias and Maillie,
1983; Darroudi and Natarajan, 1989; Vyas et al.,
1991; Darroudi et al., 1998a,b) is used to alter
membrane permeability, to generate channels be-
tween cells, and subsequently to reorganize mem-
branes that may lead to cell fusion in mammalian
cells (i.e., human and monkey lymphocytes and
Chinese hamster ovary cells) as well as in plant
cells (Szabados and Dudits, 1980). Consequently,
diffusion of mitosis-promoting factors (MPFs) can
occur from mitotic cells into the test cells to induce
PCC. However, these methods of cell fusion are
technically difﬁcult and laborious, particularly for
tumor cells, and the PCC yield can be inconsistent.
Mechanisms regulating the onset of M phase
were reviewed by Nurse (1990). Chromosome con-
densation at mitosis correlates with the activation
of p34cdc2 kinase, the hyperphosphorylation of
histone H1, and the phosphorylation of histone H3
(Nurse, 1990). Treatment of mouse mammary tu-
mor cells with fostriecin or okadaic acid resulted in
full chromosome condensation in the absence of
p34cdc2 kinase activity or histone H1 hyperphos-
phorylation. However, phosphorylation of histones
H2A and H3 was strongly stimulated, partly
through inhibition of histone H2A and phospha-
tase, and cyclins A and B were degraded (Guo et
al., 1995).
Alternative PCC methods have been introduced
that involve inhibitors of types I and 2A protein
phosphatases (PPs). Okadaic acid (OA) and calycu-
lin A (CA) have both been used as potent inhibitors
of PP types 1 and 2A and for p34cdc2/cyclin B
(Gotoh et al., 1995; Kanda et al., 1999; Prasanna et
al., 2000) to induce PCC. OA and CA have shown
to induce PCC in various cell systems such as
Xenopus, rodent cells, human lymphocytes, and ﬁ-
broblasts (Steinmann et al., 1991; Gotoh et al.,
1995; Kanda et al., 1999). Furthermore, the induc-
tion of PCC with OA and CA in human tumor cell
lines has been attempted (Coco-Martin and Begg,
1997; Begg et al., 2002). Here we present results of
a study concerning the standardization and valida-
tion of chemically induced PCC with CA in differ-
ent cell types. We have obtained chromosome con-
densations from different phases of the cell cycle of
which G1 and G2 phases are suitable for molecular
karyotyping by use of COmbined Binary RAtio
labeling–ﬂuorescence in situ hybridization (pq-
COBRA-FISH) (Tanke et al., 1999; Wiegant et al.,
2000). This combined method permits full molec-
ular karyotyping of cells in G1 and G2 of the cell
cycle and with minimal culturing artifacts.
MATERIALS AND METHODS
Cell Lines
To validate the PCC assay, different cell lines
were selected mainly on the basis of their applica-
tion in different research areas (for normal cells),
and as representatives of different types of cancer
cells (for tumor cell lines).
Two wild-type human ﬁbroblast cell lines (VH16
and VH25), lymphoblastoid cells (TK6), and dif-
ferent tumors cell lines, hepatocellular carcinoma
(Hep G2), head and neck, squamous cell carcinoma
from human pharynx (FaDu), nasal septum carci-
noma squamous cells (RPMI 2650), tongue carci-
noma squamous cells (SCC-15), breast cancer
(MCF7), cervical carcinoma cells (HeLa), colorec-
tal cancer cell lines HCT116, Caco-2, LS411N [all
purchased from American Type Culture Collection
(ATCC), Manassas, VA], and a human chondrosar-
coma cell line OUMS-27 (Kunisada et al., 1998)
were used in this study (Tables 1 and 2).
Cells were grown as monolayers (except TK6
cells that were grown in suspension) in DMEM
medium (Boehringer-Roch, Germany) supple-
mented with 15% FCS, 100 U/ml penicillin, 100
TABLE 1. Inﬂuence of Concentration and Treatment Time of CA on PCC index (%) in Human Normal and Tumor Cell Lines*
Cell
type
Calyculin A tested concentrations (nM) and treatment times (hr)
40 nM 80 nM 120 nM
0.5 hr 1 hr 2 hr 0.5 hr 1 hr 2 hr 0.5 hr 1 hr 2 hr
VH16 15 18 25 28 52 50 25 44 35
VH25 18 22 28 25 55 50 21 50 38
Hep G2 10 15 20 23 45 40 19 35 38
*For each cell line, 1,000 cells were analyzed. Among the observed PCCs, 25–35% were S-PCCs that could not be analyzed.
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g/ml streptomycin, and 2 mM glutamine (all sup-
plied by Gibco-Invitrogen, Belgium). All cells were
kept at 37°C and 5% CO2. Cells were washed with
phosphate-buffered saline (PBS), and fresh reac-
tion medium (F10, without any supplement) was
added before treatment with CA.
Tumor Samples
Five tumor samples were isolated, after surgical
resection, from a familial adenomatous polyposis
(FAP) patient and placed in transport medium con-
sisting of high-glucose DMEM medium supple-
mented with 20% FCS, 100 U/ml penicillin, 100
g/ml streptomycin, 25 g/ml gentamycin, 1 g/ml
fungizone, and 2 mM glutamine (all from Gibco-
Invitrogen). The tumor samples were cut in small
pieces and digested overnight at 37°C in high-
glucose DMEM supplemented with 0.14 U/ml col-
lagenase/dispase enzyme solution (Blendzyme I;
Roche), 0.5% FCS (Gibco-Invitrogen), 100 U/ml
penicillin (Gibco-Invitrogen), 100 g/ml strepto-
mycin (Gibco-Invitrogen), 25 g/ml gentamycin, 1
g/ml fungizone (Gibco-Invitrogen), and 2 mM
glutamine (Gibco-Invitrogen).
After the digestion, samples were dislodged by
pipetting the tissue up and down and centrifuged
for 5 min at 68g. The supernatant was removed and
the pellet was resuspended in a wash medium
containing high-glucose DMEM supplemented
with 5% FCS, 100 U/ml penicillin, 100 g/ml strep-
tomycin, and 2 mM glutamine (all from Gibco-
Invitrogen). The samples were centrifuged for 5
min at 6.6g and by removing the supernatant,
mainly loose cells and bacteria were removed. This
washing step was repeated once. The remaining
organoids were transferred to collagen (Sigma Al-
drich, The Netherlands) and ﬁbroblast-coated
(Swiss 3T3 feeders cells mitotically inactivated
with mitomycin C) plates in high-glucose DMEM
supplemented with 20% FCS, 100 U/ml penicillin,
100 g/ml streptomycin, 25 g/ml gentamycin, 1
g/ml fungizone, and 2 mM glutamine (all from
Gibco-Invitrogen), and incubated at 37°C, 5% CO2
for 2 days before the PCC assay was applied to the
samples.
Induction of PCC and Harvesting
Calyculin A (CA; Sigma-Aldrich) and okadaic
acid (OA; Sigma-Aldrich) were dissolved in ethanol
(Baker analytical grade) as stock solution of 4 mM
and stored at 20°C. The effect of CA was inves-
tigated by use of VH16 and VH25 in monolayer
culture as well as in suspension at three different
concentrations of 40, 80, and 120 nM for 0.5, 1, and
2 hr, in F10 medium (Boehringer-Roche, Ger-
many), without any supplements. The highest fre-
quency of PCC was typically obtained at 80 nM
and after 1-hr treatment. Therefore, for the other
cell types, CA was used at a ﬁnal concentration of
80 nM, by use of F10 as reaction medium.
During the treatment with CA, cells were mon-
itored by use of phase-contrast microscopy. The
majority (at least 95%) of the cells were found to
round up and detach after 1-hr treatment with 80
nM CA. Cells were then collected and treated
according to standard cytogenetic procedures to
obtain chromosome spreads. Brieﬂy, cell pellets
were collected by centrifugation and treated with a
hypotonic solution of KCl (0.075 M) for 5 min at
37°C and ﬁxed in three changes of ﬁxative (acetic
acid:methanol, 1:4 v/v). Finally, the ﬁxed cells were
dropped onto pre-cleaned slides and air-dried.
A comparison was made between chromosome
preparations made with CA-induced PCCs (ﬁnal
concentration of 80 nM in F10, for 1 hr) and met-
aphases obtained by use of standard Colcemid
treatment. Colcemid was added at a ﬁnal concen-
tration of 0.08 g/ml for 3 hr and 0.03 g/ml for 12
hr before harvesting of mitotic cells.
Analysis and Multicolor FISH Karyotyping
The overall quality of the slides and the PCC
and mitotic indices were determined on the basis
of 4,6-diamidino-2-phenylindole dihydrochloride
hydrate (DAPI; Sigma-Aldrich, Germany) staining.
TABLE 2. Comparative Study Between PCC Index (%)
Induced by CA (80 nM for 1 hr) and Mitotic Index (%)
Obtained After Colcemid Treatment (3 hr) in
Normal Human and Tumor Cell Lines
Cell type
Colcemid
mitotic
index (%)
Calyculin A
PCC
indexa (%)
VH 16 8 52
VH 25 7 55
TK6 12 41
Hep G2 16 45
Nasal septum (RPMI 2650) 5 20
Tongue carcinoma squamous cells
(SCC-15) 5 25
Human pharynx (FaDu) 5 38
Mammary tumor (MCF 7) 15 60
Cervical carcinoma (HeLa) 20 58
HCT116 2 18
Caco-2 1 10
LS411N 3 16
OUMS27 3 23
aAmong the observed PCCs, 25%–35% were S-PCCs that cannot be
analyzed.
87
A detailed cytogenetic analysis of the four cell lines
HCT116, Caco-2, LS411N, and OUMS-27 was
performed by use of pq-COBRA-FISH as de-
scribed (Tanke et al., 1999; Wiegant et al., 2000)
from CA-treated and Colcemid-treated cells, and a
comprehensive karyotype was made based on 25
PCC spreads to determine the mainline present in
the samples.
Figure 1. Three-color ratio images of combined binary ratio label-
ing–ﬂuorescence in situ hybridization (COBRA-FISH) of premature
chromosome condensation (PCC) spreads with distinct morphological
characteristics (63 objective), and DAPI counterstaining images as
well. G1-PCC with univalent chromosomes morphology analyzed by
COBRA-FISH (A) and DAPI counterstaining (B). C and D present
S-PCC, where chromosomes show univalent and fragmented morphol-
ogy, COBRA-FISH, and DAPI counterstaining images, respectively. E
and F illustrate G2-PCC, where chromosomes are bivalent, COBRA-
FISH, and DAPI counterstaining images, respectively.
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Slides prepared from colon tumor biopsy speci-
mens were also analyzed by use of pq-COBRA-
FISH, and the chromosomal constitution of each
sample was determined based on all scorable PCC
spreads.
RESULTS
Morphological characteristics of PCC allow judg-
ing the stage of the cells in the cell cycle at the
time of induction of PCC (Fig. 1A–D). Chromo-
somes condensed in the G1 phase are univalent
(Fig. 1A). As a consequence of the many nicks in
the DNA, chromosomes in S phase are highly frag-
mented and look pulverized (Fig. 1B, C). G2 chro-
mosomes are bivalent after PCC (Fig. 1D) and look
like metaphase chromosomes obtained after mi-
totic arrest by use of Colcemid.
Table 1 presents the PCC index [(number of
PCCs)/(number of interphases  number of
PCCs)  100] of the exponentially growing normal
human ﬁbroblast cell lines VH16 and VH25, and a
cancer cell line of liver origin (Hep G2) in relation
to CA concentration. The highest yield of PCC was
obtained at 80 nM and after 1-hr treatment. The
cells were frequently monitored during the incu-
bation with CA; the effect of PCC induction was
noted as rounding up of the cells and detachment
from the surface. The majority of cells (95%)
rounded up and detached within 1 hr of incubation.
At the conﬂuent stage, this frequency was 70%
where an additional 30-min treatment time was
used to increase the number of detached cells and
the PCC index (includes not only G1/G2 but also
S-phase cells). In exponentially growing cells, pre-
dominantly G2- and S-PCC were observed. In con-
ﬂuent cells, G1-PCC was apparent.
In normal human ﬁbroblasts, the PCC index
decreased at 120 nM and during a 2-hr treatment,
which may reﬂect the cytotoxic effect of CA. OA,
also included in this study, proved much less efﬁ-
cient in inducing PCC (results not shown).
Table 2 compares CA-induced PCC with stan-
dard Colcemid treatment for chromosome prepara-
tions in ﬁbroblasts and established tumor cell lines.
The PCC index was variable and ranged from 10 to
60%, but in all cases was sufﬁcient for molecular
karyotyping with pq-COBRA-FISH. In contrast,
Colcemid treatment gave mitotic indices that were
low and for several cell types even too low to allow
an accurate karyotyping. By use of the PCC assay,
the most suitable fraction for molecular karyotyp-
ing is G2 (Fig. 1E, F), G1 PCC (Fig. 1A, B) can also
be assessed, but the S-phase PCC cannot be used
because of the intertwining of chromosomes and
the numerous gaps in continuity (Fig. 1C, D). In
the case of tumor samples from the FAP patient,
the Colcemid treatment resulted in no metaphases
at all, whereas CA induced PCC in all samples with
PCC indices ranging from 2 to 5%. In these sam-
ples, predominantly G2-PCC was observed.
To see whether PCC as such induces chromo-
some aberrations, pq-COBRA-FISH was applied to
chromosome spreads of four cancer cell lines pre-
pared with Colcemid and PCC. Figure 2 shows
representative examples of G2-PCCs of Caco-2
cells in which FISH staining could distinguish all
human chromosomes. The mainline karyotypes
obtained with the two different preparation proto-
cols were identical (Table 3).
Table 4 lists the results of FISH analysis of the
fresh FAP colon tumor samples, in terms of PCC
index, the number of diploid, tetraploid, aneuploid
(Fig. 3), and S-PCC spreads. Structural aberrations
were not observed. Colcemid treatment of these
samples failed to produce chromosome spreads.
DISCUSSION
Comprehensive chromosome analysis is limited
to cells in the mitotic stage of the cell cycle. The
use of drugs that arrest cells in mitosis such as
colchicine and Colcemid has proved to be valuable
for increasing the mitotic index. However, for
many clinical samples, the cell cycling rate is very
low, and low mitotic indices are obtained even with
the use of mitosis-blocking agents. The induction
of PCC enables one to study structural and numer-
ical chromosomal alterations at the G1 and G2
stages of the cell cycle, thus not only greatly en-
hancing the number of analyzable cells, but also
providing the possibility of analyzing the chromo-
somal composition of cells that cannot pass the
G2/M transition.
Classical PCC combined with either banding
techniques or FISH has been attempted earlier.
Human lymphocytes, bone marrow cells, and nor-
mal ﬁbroblasts have been analyzed in different
studies by use of PCC and banding techniques to
detect asymmetrical exchanges (i.e., dicentrics)
(Vyas et al., 1991) and/or symmetrical aberrations
(i.e., translocations) (Aula, 1973). FISH technique
has been combined with either conventional or
chemical PCC for the identiﬁcation of chromosome
exchanges in human ﬁbroblasts and lymphocytes
after exposure to ionizing radiation (Evans et al.,
1991; Pandita and Hittelman, 1994; Sasai et al.,
1994; Darroudi et al., 1998a) and in interphase cells
of tumors (Coco-Martin and Begg, 1997; Begg et
al., 2002).
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Figure 2. Comprehensive molecular karyotyping of Caco-2 cell line
by use of pq-COBRA-FISH. A: The three-color ratio image of a cell
(right) and the binary image from p- and q-arm–speciﬁc painting probes
(left), by use of a 63 objective lens. B: The karyograms of the above
cell without the binary images (for the typical COBRA-FISH karyotype
refer to image 3). C: The digitized image from signal of the p and q
painting probes, distinguishing the short and the long arm of each
chromosome. D: Karyogram of the aberrant chromosomes found in
this spread.
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In the present study, we have explored further
the possibility of the use of PCC, chemically in-
duced by CA, in a variety of human normal and
tumor cells (established cultures) as well as cells
directly obtained from tumor specimens (Table 4).
Furthermore, we have combined chemical PCC
with multicolor FISH assay for all human chromo-
somes (Tanke et al., 1999; Wiegant et al., 2000),
enabling a comprehensive study of chromosome
spreads in G1 and G2 phase of the cell cycle.
TABLE 3. Karyotype of the Four Cell Lines Analyzed by Use of pq-COBRA-FISH*
Cell line Karyotypea
Modal
range
G2 PCC
b
index
Mitoticc
index
Mitoticd
index
HCT116 3nXX, Y, 16, 72 17.8 2.1 5.2
der(16)t(8;16)(q?;p?)x2,
18, der(18)t(17;18)(q?;p?)x2, 21,
21, 21, del(21)(q?)
Caco-2 4nXX, Y, Y, 94 9.9 0.9 4.5
der(1)t(1;19)(q10;q10),
der(2)t(2;9)(q?;q?)x2, i(9)(q10),
inv(9)(p?;q?),
der(10)t(10;16)(q?;q?)x2,
der(12)t(10;12)?(q?;q?)x2,
der(15)t(15;20),
der(11;17)(q10;q10), del(18)x2,
der(20;21)(q10;q10)x3, 21
OUMS27 3nXX, Y, del(1)(p?), 76 22.8 3.2 5.8
der(2)t(2;18)(q?;q?), 4, 5,
i(5)(p10), 6, 6,
der(6)t(6;21)(q?;q?), 7, i(7)(p10),
9, del(9)(p?)x2,
der(12)t(7;12)(q?;q?)x2, 13, 13,
der(13;13)(q10;q10), del(15)(q?),
trc(X;19;21), der(19)t(19;21), 20,
20, 21
LS411N 3nX, X, Y, 78 15.6 2.6 4.5
der(5)t(5;12;15)(q?;q?;q?),
i(6)(p10), del(6)(q?),
der(7)t(7;12)(q?;q?),
der(12)t(12;21)(q?;q?),
del(12)(q?)x2,
der(14)t(X;14)(p?;q?),
der(14;14)(q10;q10), ?del(17), 18,
del(18)(q?)x2, der(21)t(3;21)(q?;q?)
*25 PCC spreads were used to constitute the mainline from each cell line. Non-clonal rearrangements and numerical abnormalities are not described.
aNo difference was observed in the karyotype of the cells main lines between G2-PCC and mitotic (colcemid) spreads.
bPCC using 80 M calyculin A, in F10 for 75 min.
c80 ng/ml Colcemid, 3 hr.
d20 ng/ml Colcemid, 12 hr.
TABLE 4. Results of FISH Analysis of Tumor Biopsies From a FAP Patient
Polyp
No.
No. of cells
analyzed in
different polyps
PCC
index
(%)
Diploid
(%)
Hyperdiploidya
(%)
Tetraploidy
(%)
Hyper-
tetraploidyb
(%)
S-phase
PCCc
(%)
1 20 1.7 45.0 0 25.0 5.0 25.0
2 30 3.8 63.4 0 17.6 6.7 12.3
3 35 4.2 45.7 3.0 22.7 14.3 14.3
4 23 4.1 65.3 4.3 13.1 4.3 13.0
5 28 4.8 53.6 0 21.4 7.2 17.8
aIn this category, in polyp 3 and polyp 4 in one cell each, a trisomy chromosome 7, and three trisomies, chromosomes 7, 13, and 20, were observed,
respectively.
bThe chromosome number varied between 94 and 97.
cThe non-analyzable fraction of PCC spreads, consisting of S-phase cells.
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With the present protocol, CA was capable of
inducing PCC in all cell types, including the
tumor specimens. A difference of up to 10-fold
was found between PCC index and mitotic index
obtained after Colcemid treatment. The varia-
tion in the PCC index between cell lines can be
attributed to differences in the biology of cells in
terms of the relative presence or activity of ki-
nases important for chromosome condensation,
in the sensitivity, permeability, and/or toxicity of
the drug. In earlier studies, a similar variation
was reported either in human or in mouse cell
types (Gotoh et al., 1995).
To make a comparative analysis between data
obtained by use of chromosome spreads made by
CA-induced PCC and those obtained with Col-
cemid, preparations made from four cell lines
were subjected to pq-COBRA-FISH. The karyo-
types obtained by use of both techniques proved
to be identical. Thus, CA-induced PCC does not
introduce structural and/or numerical alterations.
It was also shown that CA is capable of inducing
PCC in 2–5% of cells isolated from polyps of an
FAP patient, where Colcemid arrest failed com-
pletely. Molecular karyotyping of PCC spreads
showed that all polyps contained aneuploid (in-
cluding tetraploid) cells. No structural aberra-
tions were observed.
In addition to CA, we tested OA as a phospha-
tase inhibitor (data not shown). The PCC index
was signiﬁcantly lower, even up to the ﬁnal con-
centration of 400 nM for up to 2 hr. The difference
Figure 3. Karyograms of cells isolated
from a polyp of a familial adenomatous pol-
yposis (FAP) patient. Three classes of chro-
mosomal constitution were revealed by use
of CA-induced PCC and pq-COBRA-FISH.
Diploid (A): this image is a typical karyogram
generated by use of pq-COBRA-FISH analyz-
ing software; each chromosome is presented
as a ratio image or a composed color image;
binary 1 image-discriminating odd- (magenta)
and even-numbered chromosomes (no signal)
and binary 2 image of p-arm (no signal) and
q-arm (cyan) image, with the exception of
chromosomes 4 and 7, which are p-arm-pos-
itive. Hypotetraploidy (B) has 87 chromo-
somes, 3, 18, 19, 21, and 22; and
hypertetraploidy (C) has 95 chromosomes,
with an excess of numerical aberrations for
chromosomes 1, 7, and 14.
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between both drugs might be caused by different
activities on the two protein serine/threonine phos-
phatase inhibitors. OA strongly inhibits PP2A, to a
lesser extent PP1, and even to a much lesser extent
PP2B. This is different from CA, which inhibits
PP1 and 2A to the same extent and to a much lower
extent PP2B (Macintosh and Macintosh, 1994).
The hallmark of solid tumors in general is the
presence of chromosomal abnormalities resulting
from chromosomal instability (CIN) (Mitelman et
al., 1997; Sanchez-Garcia, 1997; Lengauer et al.,
1998). The consistent nature of the chromosomal
evolution in speciﬁc tumor types and subtypes
points to the fact that tumor progression might
correlate with CIN. However, analytical and meth-
odological problems in cancer cytogenetics hamper
the strengthening of this view (Mitelman et al.,
1997).
Our results indicate that the chemical PCC assay
is very useful to generate chromosome preparations
from normal and established tumor cell lines as
well as cells isolated from biopsy specimens. It has
the advantage over other PCC assays by use of
MPFs by generating merely condensed chromo-
somes of the target cells without contaminating
chromosomes or interphase nuclei from the cells
donating MPFs. This chemical PCC technique in
combination with molecular karyotyping permits a
comprehensive chromosomal analysis of freshly
isolated cells in the G1 and G2 phases of the cell
cycle and will facilitate the study of the phenom-
enon of chromosome instability.
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Cell cycle phase dependency of Calyculin A induced premature chromosome 
condensation 
 
Abstract 
Premature chromosome condensation (PCC) permits karyotypic analysis of 
mammalian cells that are not in mitosis. Traditionally, PCC is achieved by fusion of the cells 
of interest with mitotic cells of another species of which the mitosis promoting factors force 
the test cells to condense their chromosomes. The technical and analytical difficulties 
associated with this fusion-based PCC technique have been solved to a large extent by use of 
protein phosphatase inhibitors such as calyculin A. Chemically induced PCC facilitates cancer 
cytogenetics because it remarkably increases the number of analysable chromosome spreads. 
PCC results in chromosome spreads with morphological features characteristic of the distinct 
cell cycle phases. In order to investigate to what extent frequencies of the distinct PCC spread 
morphologies (PCC indices) reflect the various cell cycle fractions, we analysed mouse 
embryonic fibroblasts (MEFs) and mouse embryonic stem (ES) cells by DNA flow cytometry 
to estimate the G1/G0, S and G2/M fraction and correlated the data with the distinct PCC 
indices of unsynchronised cells and cells synchronized by mitosis blockers (colchicine and 
nocadazole), a G1 blocker (L-mimosine) and an S-phase blocker (camptothecin). Taken 
together the results show that chemically induced chromosome condensation permits 
molecular cytogenetic analysis of G0/G1 and G2 cells with low (~ 5 - 20 %), respectively 
high (~ 20 - 40 %) efficiency. The technique will be of value in chromosomal instability 
studies because it permits to analyse chromosomal composition of cells that are not fit to 
cycle through mitosis. 
 
Introduction 
Premature chromosome condensation (PCC) was first reported by Johnson and Rao 
(Johnson and Rao, 1970). They showed that premature chromosome condensation of G0/G1, 
S and G2 interphase cells can be induced by fusion with Chinese hamster ovary mitotic cells. 
Such prematurely condensed chromosomes are amenable to cytogenetic analysis and PCC has 
found early application in radiation genetics to visualise in absence of in vitro culture the 
initial chromosome damage directly in interphase cells (Hittelman and Rao, 1974). Mitosis 
promoting factors (MPFs) of the mitotic cells are held responsible for condensation of the 
fusion partner’s chromosomes which may involve activation of p34cdc2, hyperphosphorylation 
of histone H1 as well as phosphorylation of histone H3 (Nurse, 1990). In spite of its ability to 
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analyse the chromosome composition of cells in interphase, the classical cell fusion-based 
PCC technique has not found wide spread application in clinical and cancer cytogenetics. This 
is presumably a consequence of technical and analytical difficulties including the low fusion 
frequency of the mitotic inducers cells with the cells of cytogenetic interest.   
It has been known for many years that inhibitors of type 1 and 2A protein 
phosphatases (PP) can induce mitosis-like processes, including chromosome condensation. 
Not surprisingly cytogeneticists have pursued the use of such inhibitors to overcome the 
difficulties of the classical mitotic cell fusion technique. Okadaic acid (OA) and calyculin A 
(CA) have both been used as potent inhibitors of PP 1 and 2A and provoke phosphorylation of 
histones H2A and H3 even in the absence of p34cdc2 kinase activity and H1 
hyperphosphorylation (Guo et al., 1995; Gotoh et al., 1995; Kanda et al., 1999b; Prasanna et 
al., 2000). In the last few years several studies have emerged that describe PCC with these 
inhibitors on a variety of cell systems (Gotoh et al., 1995; Kanda et al., 1999a; Steinmann et 
al., 1991), including tumour biopsies (Begg et al., 2002; Bezrookove et al., 2003; Coco-
Martin and Begg, 1997). 
A universal feature of PCC is the induction of chromatin condensation in different 
phases of the cell cycle, resulting in distinct chromosomal morphologies, correlating with 
G0/G1-, S- or G2-phases of the cell cycle. G0/G1-PCC spreads bare monovalent chromosome 
morphology. S-PCC spreads have a pulverised morphology and G2-spreads are metaphase 
like chromosomes and have bivalent chromatid structure. Since true M-phase spreads would 
be identical in morphology with G2-PCC spreads, they will contribute to the G2-PCC 
fraction, but generally this contribution is low. Except for the S-phase PCC spreads, G0/G1- 
and G2/M-phase PCC spreads are suitable for chromosomal analysis particularly in 
combination with molecular karyotyping. Hence chemical PCC greatly facilitates diagnostic 
cytogenetic analyses, by obviating the need for culture and mitotic arrest. 
Chemically induced PCC can also be very useful in basic chromosome instability 
studies as it permits comprehensive assessment of the chromosomal composition of cells at 
other phases of the cell cycle than mitosis. It is important then to know whether the distinct 
PCC indices can quantitatively reflect the frequency of each phase of the cell cycle. We used 
synchronised and non-synchronized mouse embryonic fibroblasts (MEFs) as well as 
embryonic stem cells (ES cells) to create cell populations with different fractions of the 
G0/G1-, S- and G2/M-phase of the cell division cycle and determined the distinct PCC 
indices. Results were compared with DNA-based cell cycle analysis using flow cytometry 
(FCM). The incorporation of 5-bromo-2-deoxyuridine (BrdU) into DNA has been very useful 
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in different biological systems to determine the fraction of S phase cells, the banding pattern 
of early and late replicating regions of chromosomes and their subnuclear localization, as well 
as the size and distribution of replicons on individual DNA fibers (Drouin et al., 1990). In this 
study we have therefore also pulse-labelled the cells with BrdU to not only verify the status of 
S-PCC spreads, but also to evaluate the possibility to recognise, with the aid of molecular 
karyotyping, early or late replicating chromosomal regions.   
 
Material and methods 
Cell culture and synchronisation 
Mouse embryonic stem (ES) cells were derived from 129/Ola mouse; blastocysts were 
harvested at 3.5 d after fertilization. The flushed pre-implantation blastocysts were plated in 
96-well dishes coated with mitomycin C inactivated mouse embryonic fibroblasts and 
cultured to isolate undifferentiated ES-cell lines according standard procedure. Mouse 
embryonic fibroblasts (MEF) cells were isolated from mouse embryos at day 14 of gestation 
and cultured as proliferating monolayers on 6-wells plates in DMEM with 10% FCS, 0.1 
mg/ml streptomycin (Sigma-Aldrich). During the experiments ES cells were cultured on 
immortalized mouse embryonic feeder layers on 6-wells plate in DMEM with 10% FCS, 0.1 
mg/ml streptomycin (Sigma-Aldrich) and leukaemia-inhibiting factor. 
To enrich the cells in a given cell cycle phase they were treated with colchicine, 
nocodazole, L-mimosine and camptothecin (all drugs were purchased from Sigma-Aldrich) in 
culture medium. All tested concentrations and periods of treatments are indicated in Table 1. 
After treatment cells were harvested according to standard procedures and 1 sample was used 
for PCC and 1 sample for flow cytometric analysis.  
 
PCC, microscopic analysis and PCC efficiency calculations 
Prior to PCC procedures, cells were incubated with 5 µM 5-bromo-2-deoxyuridine 
(BrdU) for 15 min. After refreshing the medium with F10 (Boehringer-Roche), without any 
supplements, PCC was then performed as described (Bezrookove et al., 2003b) using 
calyculin A (Sigma-Aldrich) at concentration of 80 nM for 1hr. Cells were then harvested and 
treated according to standard cytogenetic procedures and used to prepare microscopic slides. 
Slides were then stained with 4’,6-diamidino-2-phenylindole dihydrochloride hydrate (DAPI; 
Sigma-Aldrich) and analysed by systematically scanning the slide and counting total number 
of cells and the distinct PCC spreads. S-PCC was verified on basis of BrdU incorporation. 
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Cells that did not respond to PCC treatment were designated as Gx. At least 1500 cells were 
counted.  
Exemplified with the S-phase, the efficiency of PCC for each phase of the cell cycle 
was calculated as (S-PCC-index / S-DNA-FCM) x 100.  There is a level of uncertainty in the 
accuracy of the determination of the S-PCC-indices and S-DNA-FCM fractions. Particularly 
at low values, this will result in unreliable efficiency data (e.g. because of divison by 0), To 
calculate average PCC efficiencies we therefore purged the PCC efficiency data set arbitrarily 
by elimination of data resulting from divisions with both numerator and denominator ≤ 3 as 
well as data resulting from division with both numerator and denominator ≤ 10. 
On some preparations mouse COBRA-FISH was performed as described (Tanke et al., 
1999) to examine the quality of PCC spreads for molecular cytogenetic techniques and 
identify early and  late replication chromosomal regions.  
Digital fluorescence imaging of pqCOBRA-FISH was performed using a Leica DM-
RXA epifluorescence microscope (Leica, Wetzlar, Germany) equipped with a 100-W mercury 
lamp and computer-controlled filter rotor with excitation and emission filters matching the 
fluorochromes used. Image analysis was performed with software implemented on a Power 
Macintosh 8100 microcomputer designed to recognize and use ratio labelling as base of 
chromosome classification.  
 
Flow cytometric analysis  
The DNA content of the cells was quantified by DNA flow cytometry after staining 
with propidium iodide (DNA con 3, DAKO). Cytometric analysis was performed using a 
FACSort flow cytometer (Becton Dickinson, Mountain View, CA, USA) equipped with a 
Cyonics 15-mW, 488 nm, air-cooled, argon-ion laser. Propidium iodide fluorescence was 
measured using a 585/42 nm bandpass filter (FL-1).   
In general, at least 20.000 events per sample were acquired and stored in list mode 
files. Data analysis was performed using CELLQuest software (Becton Dickinson 
Immunocytometry Systems (BDIS), San José, CA, USA). Parameters evaluated for 
determining cell cycle fractions were FSC, FL-1-height, -area and width.  
 
Results 
Upon CA treatment the prematurely condensed chromosomes exhibited distinct 
morphological features: univalent G0/G1-phase chromosomes, S-phase chromosomes with a 
pulverised morphology and bivalent G2/M-phase chromosomes resembling mitotic 
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chromosomes. A 15 min pulse of BrdU before PCC enabled extra confirmation of the S-
phase. Figure 1 shows a typical morphological pattern of a PCC-spread for each phase of the 
cell cycle.  
Table 1 give the PCC indices and the fraction of cells in a particular cell cycle phase 
as assessed by DNA flow cytometry for the different cells and treatments. MEFs treated with 
colchicine, which inhibits microtubule assembly (Andreu et al., 1998) responded as expected; 
G2/M-PCC index increased from 8.4% to 15.3%, at 0.75 mM colchicine, in line with FCM 
which showed an increase from  18.9% to 46.7%. In case of mouse ES cells treated with 
colchicine, the G2/M-PCC index also reflected the increase in frequency of G2/M fraction as 
measured by DNA flow cytometry. It increased from 7.3% in absence of synchronising agents 
to 20.9%, at 1.5 mM colchicines. G1/G0- and S-PCC indices decreased accordingly, with 
notable reduction of S-phase frequency from 25.5%, in control, to 6.8% in mouse ES cells 
treated with 1.5 mM colchicine (see figure 3A). 
Nocodazole, an anti-mitotic agent that disrupts microtubules by binding to β-tubulin 
(Luduena and Roach, 1991), also increased the G2/M-phase population with inversed effect 
on G1/G0- and S-phase population. MEFs responded with an increase of G2/M-PCC index of 
up to 16.9%, which was again reflected by FCM measurements (see figure 3B). Mouse ES 
cells treated with nocodazole exhibited the same response as MEFs, with G2/M-PCC index 
increasing from 7.3% to 26.6%, correlating with the sharp increase measured by FCM. 
L-mimosine, a plant amino acid that has been reported to block cell cycle progression 
in the late G1-phase prior to unset of DNA synthesis (Krude, 1999) was used to enrich the G1 
fraction of MEFs and mouse ES cells. Only a small enrichment for the G0/G1 -phase was 
measured by FCM; 63.9% to 65.7% in case of MEFs and from 24.3% to 28.2% in case of 
mouse ES cells with 1.0 mM L-mimosine. G0/G1-PCC indices did not reflect this marginal 
enrichment. 
Camptothecin, a DNA topoisomerase I inhibitor that block DNA relegation of 
topoisomerase I cleavage complexes (Strumberg et al., 2000) enriching S-phase in low doses, 
was used in this study on MEFs which have a low fraction of S-phase cells. The effect of this 
drug was moderate with S-PCC-indices of 11.0% in absence and 14.8% in presence of the 
drug. FCM measurement showed an increase from 17.1% to 21.2%. A clear decline of G2/M-
PCC index from 8.4% to 2.6%, points to the fact that the cells are indeed blocked in the DNA 
synthesis phase and could not enter the G2-phase of the cell cycle.  
We operationally defined PCC efficiency for a given cell cycle phase as the fraction of 
PCC-spreads of a given phase divided by the fraction of the same phase as measured by DNA 
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flow cytometry. Results are also given in Table 1. From these data it is clear that S and G2 
cells condense their chromosomes relatively efficiently following CA addition whereas 
G0/G1-cell react less efficiently. We estimate the efficiency of G0/G1-PCC to be ~ 5 – 10 % 
and G2-PCC  ~ 20 – 40 %. 
PCC in combination with pq-COBRA molecular karyotyping and BrdU-S-phase 
detection also revealed sub-stages of the S-phase. This was very much apparent in 
unsynchronised mouse ES cells which have a large S-phase fraction, where pulverised 
chromatin morphology in presence of univalent or bivalent chromosomes indicated early or 
late S-phase. For example, the late replicating Y chromosome was often seen as the sole BrdU 
positive region in G2-PCC spreads (see Figure 3). Early anaphase morphology was also 
frequently seen.  
 
Discussion 
PCC with protein phosphatase inhibitors yields many more chromosome spreads 
amenable to cytogenetic analysis than does metaphase arrest with inhibitors of tubulin 
polymerisation such as colcemid and colchicine.  Also it has been shown that PCC can induce 
chromosome condensation at the G0/G1- and G2-phases of tumour cells with minimum 
culture time, thus reducing culture artefacts. Therefore, PCC increases efficiency of 
cytogenetic analysis. In principle PCC should also allow an inventory of the chromosomal 
composition of cells in the G0/G1- and G2-phases of the cell cycle. This ability may prove of 
great value in cancer chromosome instability studies in comparison to karyotypes of M-cells 
obtained with e.g. colcemid because analysis of G0/G1- and G2-cells (obtained with PCC) 
will give a view on the chromosomal composition of cells that do not reach metaphase.  
Quantitative information of the capacity of PCC morphologies to reflect the G0/G1-, 
S- and G2/M-phases has been lacking thus far. We quantified the frequency of each 
morphologically distinct condensed chromosome structures; designating univalent 
chromosomes as G0/G1-PCCs, pulverised chromatid structure as S-PCCs and bivalent 
chromosomes, resembling the mitotic chromosomes as G2/M-PCCs. As expected, the G1/G0-
, S-phase population was diminished and the G2/M increased after colchicine treatment, as 
revealed by both analytical techniques. Nocodazole also increased the G2/M-phase population 
with inverse effect on G1/G0- and S-phase population. 
L-mimosine was used to enrich the G1 fraction of mouse ES cells and MEFs. 
However the effect was very mild and a slight increase of G1/G0 fraction was measured by 
DNA flow cytometry, but PCC did not reflect the effect of L-mimosine on both cell types. 
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This may be a consequence of the difference in the total number of cells analysed (20,000 for 
DNA and 1,500 for PCC), but also of lower protein phosphatase activities in G1/G0.   
Camptothecin, blocks cell in S-phase in low doses. Because unsynchronised MEFs, 
have a low fraction of S-phase the strongest effect was expected on these cells. The effect of 
this drug on MEFs was moderate both in DNA-FCM measurements and PCC-indices. 
However a clear decline of G2/M-PCC index can be correlated with the fact that the cells are 
blocked in the synthesis phase and could not enter the G2-phase of the cell cycle.  
PCC spreads frequently showed mixed morphological characteristics allowing 
recognition of early or late S-phase as well as early anaphase. For example univalent 
chromosomes in the presence of pulverised chromosomes (and BrdU signal) indicated the fact 
that that a particular cell was in early S-phase upon PCC induction. Bivalent chromosomes in 
spreads with slightly pulverised morphology report late S-phase as evidenced by the fact that 
the late replicating mouse chromosome Y was found to be BrdU positive.  PCC spreads with 
almost separated sister chromatids are characteristics of an early anaphase cell.  
Taken together, the (average) PCC efficiencies (Table 1) show that they are cell cycle 
phase and cell-type dependent.  The 3-fold lower PCC efficiency of G0/G1 of MEF cells, 
compared to mouse ES cells, is best explained by presence of more diploid cells in MEFs that 
are not susceptible to CA. Most likely these are non-cycling G0 cells. Indeed, compared with 
MEFs, mouse ES cells have, according to DNA-FCM, small G0/G1 and G2/M fractions and a 
high S-phase fraction. This is indicative of a more rapid traverse through the cell cycle and 
lower G0 content of the mouse ES cell populations making it reasonable to assume that 
reduced G0 content of ES cells explains part of the higher G0/G1-PCC index of mouse ES 
cells.  
The mechanism and pathway along which CA induces chromosome condensation are 
complex and not fully understood molecularly. If we assume on basis of the above that G0 
cells are not amenable to CA induced PCC it then appears that in G1-, S- and G2-cells, PP 
activity prevents chromosome condensation during interphase and that in G0 other 
mechanisms are operational to prevent chromosome condensation. 
It is concluded that calyculin A induction of chromosome condensation, in 
combination with molecular karyotyping allows analysis of G1 and G2 interphase cells. As 
such the approach is of value for chromosome instability studies, because the differential of 
the karyotypic make-up of mitotitc and interphase cells identifies cells that are 
chromosomally not fit to reach metaphase. 
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Legends to the figures 
 
Figure 1: Morphology of premature condensed chromosomes. This distinct morphology can 
be used to assess the each phase of the cell cycle and determine the PCC indices. G0/G1-PCC 
spread has univalent chromosomes (A), S-PCC spread have pulverised morphology (B) and 
G2/M-PCC spreads are bivalent (C). 
 
Figure 2: PCC indices and DNA-FCM histograms of MEFs treated with nocodazole (A). 
PCC indices and FACS flow charts of mouse ES cells treated with colchicine (B). 
 
Figure 3: PCC-COBRA images of different phases of the cell cycle from mouse ES cells. (A) 
Represents G0/G1-phase, with corresponding lack of BrdU signal (B). (C) Depicts S-phase 
and a late S-phase, which not only has a weak BrdU signal but also resembles G2-phase cell. 
(E) A S-phase with clear BrdU signal (F). A G2-phase cell, with BrdU signal from Y 
chromosome (H), indicating that Y chromosome is a late replicating chromosome. (I and J) 
Depicts G2/M-phase and  (K and L) show an early anaphase cell, with clear separation of 
chromatids. 
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DISCUSSION 
 
The development of chromosome banding techniques [62] revolutionized cytogenetic 
analysis. It allowed the unique identification of all human chromosomes and greatly 
improved the description of chromosome abnormalities. Consequently, banding analysis has 
been pivotal to our understanding of chromosomal abnormalities in constitutional and 
acquired human diseases.  
The advent of FISH in the 1980s revolutionized cytogenetic analysis once more. In the early 
days, FISH analysis, aimed at finding the affected locus and characterizing its (candidate) 
gene content, required some pre-knowledge of the chromosomal abnormality, because a 
whole genome screen by repetitive FISH experiments was impractical. The chromosomal 
lesion usually was narrowed down by targeted hybridisation with a limited number of probes. 
Chromosomal comparative genomic hybridisation (CGH) [17] and 24-color combinatorial 
FISH [21,22] took away impracticalities of genome wide screening for DNA copy number 
changes and allowed whole genome screening for structural and numerical chromosome 
aberrations. As with any technique, these whole genome screening techniques met their 
limitations as well [103,104]. Genomic resolution is a fundamental one in this respect. 
Matrix- or array-based CGH approaches [28,105] with ever increasing resolution and 
coverage have essentially resolved the resolution problem for genome-wide DNA copy 
number analysis, but because array-CGH cannot detect balanced chromosomal aberrations, 
nor ploidy [106], the need to improve the genomic resolution of FISH, by increasing 
multiplicity, remained important. 
 
pq-COBRA-FISH 
COBRA-FISH was developed to increase multiplexing capacity of FISH in the face of 
limited availability of spectrally distinct fluorochromes [31]. This generic approach combined 
the ratio labelling strategy with a combinatorial scheme to detect 24 whole chromosomal 
targets with only 4 fluorochromes. As shown in Chapter 2, by addition of a second binary 
label, specific for all q arms to the 24 colour WCP-COBRA-FISH set, all human 
chromosome arms can be uniquely identified in a single experiment. Thus, this variant of 
COBRA-FISH, termed pq-COBRA-FISH, has a higher genomic resolution, which simplifies 
some of the downstream analysis required for narrowing down the location of breakpoints.  
Also the generic nature of COBRA–FISH allows the use of additional fluorochromes as 
binary codes that can be assigned to supplementary probes either to map single genomic 
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probes or alien sequences such as DNA sequences of integrated viruses in the context of a pq-
COBRA-FISH karyotype [107,108], or to increase the multiplicity of COBRA-FISH to e.g. 
96, 192 and more. For the latter there are practical limits, which amongst others, are set by 
spectral properties of fluorescent reporter molecules, spatial resolution of the imaging 
hardware and efficiency of hybridisation. For diagnostic purposes, such higher multiplicities 
are likely not to be useful, but they may be valuable for basic research aiming at 
understanding chromosome organisation during cell cycle and differentiation. 
 
Applications of pq-COBRA-FISH in clinical cases 
In Chapter 3, an investigation is presented where pq-COBRA-FISH analysis revealed a novel 
translocation in an AML patient, which led to identification of a novel candidate gene. The 
patient, upon G-banding analysis of chromosomes, had additional material on long arm of 
chromosome 14, but the nature of the rearrangement could not be elucidated. The pq-
COBRA-FISH analysis revealed on the basis of a small but visible variation in the colour 
coding along the length of the chromosome, a reciprocal translocation between 6q2? and 
14q3? in a single experiment. A combination of WCPs and subtelomeric probes and analysis 
with combination of genomic BAC probes verified and narrowed down the translocation to 
6q25~27 and 14q32. Further analysis on chromosome 14q narrowed down the locus to a 
region of 0.68 Mb, which after cross-referencing with the available gene map of the region 
(http://genome.usc.edu), a novel gene, BCL11B (14q32; OMIM 606558) was implicated in 
this translocation. Unfortunately due to lack of material, the identification of partner gene on 
chromosome 6q was not possible.   
Cytogenetic analysis of patients with AML have unveiled a large number of recurrent 
chromosome abnormalities [73]. Several of the more common abnormalities have been 
associated with specific laboratory and clinical characteristics and are being used as 
diagnostic and prognostic markers that guide the clinician in selecting the most effective 
treatment regimens. The prognostic importance of less frequent, recurrent aberrations, both 
primary and secondary is still unknown [109]. This case revealed rearrangement of the 
BCL11B gene, a homologue to BCL11A (2p13; OMIM 600557). BCL11A is rearranged and 
over-expressed in some chronic lymphocytic leukaemia (CLL) [59,60]. Such translocation, 
involving chromosomes 6q and 14q has been reported in childhood acute mixed lineage 
leukaemia (AMLL) [110,111] and acute nonlymphoblastic leukaemia (ANLL) [112].  
Considering the French-American-British (FAB) classification of all these patients were M1 
and the cytogenetic classification is compatible, not only this report draws attention to 
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possible role of BCL11B in the aetiology of leukaemia but also it provides a new candidate 
gene for AML, AMLL and ANLL with clear implications regarding patient management. 
 It is not only in haematological malignancies that genome wide screening for structural 
aberrations with pq-COBRA-FISH can offer insight in cryptic cases. Identification of 
abnormal karyotypes in cases of (multiple) congenital abnormalities is of importance for 
genetic counselling, estimation of recurrence risk and prenatal diagnosis. In chapter 3, a 
report was presented where pq-COBRA-FISH was applied on 10 familial and 11 isolated 
cases with abnormal phenotype, but normal G-banding. In two cases pq-COBRA-FISH 
detected unequivocally chromosomal abnormalities involving subtelomeric regions. 
Subsequent hybridisations with WCPs in combination with subtelomeric probes confirmed 
the chromosomal abnormalities, which solely based on GTG-banding would have been 
classified as with genetically unknown origin. This frequency, corroborates data of a similar 
study by Uhrig et al. [113].  
Cryptic aberrations involving the termini of human chromosomes are a significant cause of 
mild to severe idiopathic mental retardation and dysmorphic features or congenital 
abnormalities [114-116]. These findings emphasize the clinical importance of sophisticated 
techniques for a genome-wide screening. However, the resolution of molecular cytogenetic 
screening methods such as multi-colour FISH is limited due to the fact that telomere regions 
are often poorly represented in whole chromosome painting probes [117,118],  
To facilitate a comprehensive molecular cytogenetic analysis of these extremely gene-rich 
and mutation-prone chromosome regions, Engels et al. introduced a novel subtelomeric FISH 
technique which not only increased the multiplicity but also omitted the necessity of multiple 
hybridisations per patient and consequently enhanced the scope of analysable chromosome 
mutation types, such as pericentric inversions or very small aberrations [119]. This 
Subtelomere COBRA FISH method (S-COBRA-FISH) is capable of detecting 41 BAC and 
PAC FISH probes, necessary for a complete subtelomere screening in only two 
hybridisations. The ability of S-COBRA FISH to efficiently detect all types of balanced and 
unbalanced subtelomeric chromosome aberrations makes it a comprehensive diagnostic 
procedure for human subtelomeric chromosome regions. 
However, apart from research purposes, the use of sophisticated molecular cytogenetic 
techniques remains cytogenetic laboratories prerogative, where not only costs are major 
factors, but also the variety of different techniques such as multiprobe FISH and multiplex 
FISH telomere integrity assays (M-TEL and TM-FISH) have proved to be very sensitive for 
the detection of cryptic chromosome aberrations [120-122].  
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Also in Chapter 3 a study is presented where pq-COBRA-FISH was used to identify the 
origin of multiple supernumerary ring chromosomes. The occurrence of single 
supernumerary chromosomes is a relatively rare event in which rings and non-acrocentric 
markers present a minority amongst them [69,123]. Instability of ring chromosomes is a 
possible mechanism for duplication or rearrangement of chromosomes, and accounts for 
some reported cases of patients with two chromosomes of the same origin [124,125]. 
Initially, it was considered as a possible explanation for multiple markers of different 
morphology [126,127], but when the application of fluorescence in situ hybridisation allowed 
determination of the origin of these supernumerary markers, it became clear that nearly all 
cases with multiple markers involved different chromosomes and, accordingly, independent 
origins. 
 
Role of COBRA-FISH in chromosomal instability studies 
It is a widely accepted view that accumulation of mutations in the DNA of genes that control 
cellular proliferation triggers cancer development [71]. Human solid tumours very often 
exhibit abnormalities at a higher level of organization: chromosome aberrations. The 
constituent cells of cancers are often aneuploid, albeit to a variable extent. This is a 
phenomenon that is conceptualised in the chromosome instability theory of cancer 
development. However, aneuploidy being cause or consequence of cancer is subject to fierce 
scientific discussions. It is well beyond the scope of this thesis to discuss the various views 
and experimental observations. To simplify the issue and following the proposal of Loeb et 
al. that mutations in genes for DNA repair or replication create a DNA mutator phenotype 
[82], one could postulate that a class of genes creates a “chromosome mutator phenotype” 
when mutated. Such genes are to be found among those involved in control and execution of 
chromosome segregation. A sophisticated molecular karyotyping method as developed in this 
thesis is obviously an important aid in characterizing the involvement of such genes in 
chromosome miss-segregation mechanisms, underlying chromosome instability. As a 
relevant example, the multifunctional adenomatous polyposis coli (APC) tumour suppressor 
gene has been shown to bind to microtubules with the C-terminal basic domain and has 
microtubule-nucleating activity in vitro [128,129]. Also, the C-terminal domain of APC binds 
EB1 [130]. EB1 associates at the growing plus ends of cytoplasmatic and spindle 
microtubules, but also with the centrosomes [131]. Indeed, the experimental test for the 
hypothesis that loss of the functional domains encoded by the C terminus of APC underlies 
chromosomal instability in colorectal cancer relied on advanced molecular cytogenetics [79].  
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In the same context and as reported in Chapter 4, pq-COBRA-FISH was employed to study 
hSNF5 (a.k.a. Ini1, Baf47 or SmarcB1) as a “chromosome mutator”. A closely related yeast 
chromatin remodelling complex RSC (for remodels the structure of chromatin), has been 
implicated in sister chromatid cohesion and segregation [132-135]. RSC is one of the two 
subclasses of the yeast SWI/SNF-related chromatin remodeling complexes. The human 
counterpart of RSC, called PBAF, has hSNF5 as one of its core components [136-138].  
We report that malignant rhabdoid tumours (MRT) associated mutations in hSNF5 cause 
polyploidisation and aneuploidisation due to failure in interaction between mitotic spindles 
and kinetochores and abrogated chromosome segregation. Restoration of wild type hSNF5 
expression in MRT-derived cells resulted in a marked reduction of cells containing 
aneuploidy. This is suggestive of a new function of hSNF5 in ploidy control. When mutated 
(a single amino acid substitution; serine 284 to leucine; hSNF5-S284L), it promotes 
tumourigenesis through induction of chromosomal instability, next to already published 
compromised transcriptional activation of p16INK4a-mediated proliferation control [139-141]. 
Our results show that aneuploidy of tumour cells can result from a specific single mutation in 
a chromatin-remodelling factor. 
This study once more draws the attention to the fact that tetraploidisation precedes 
aneuplodisation [142]. Indeed tetraploid cells have a greater chance of aberrant cellular 
division than diploid cells. An important aspect that should be addressed here is the much-
discussed relationship between centrosome aberrations and aneuploidy [143-145]. In our 
study we have seen a distinct cleavage failure or untimely exit from mitosis and abnormal 
mitotic spindle poles formation in MRT cells with cancer associated hSNF5 mutation. The 
phenomenon of cleavage failure will not only result in tetraploid cells but also a doubled 
centrosome number, consequently increasing the chances that the subsequent mitosis will be 
multipolar and chromosomes will be unequally distributed to multiple daughter cells. Sluder 
and Nordberg have discussed the mechanism in which cells with a chaotic mitosis and 
centrosome amplification can survive [145] and Uetake and Sluder have offered an inroad in 
understanding how such cells can pass through G1 checkpoints [146]. Therefore it is not 
improbable to assume that hSNF5 can play the role of a chromosome mutator, where, the loss 
of its function increases the chromosome mutation rate of MRT cells providing them with 
evolutionary properties that drive tumour progression.  
Of note in this respect, pq-COBRA-FISH with its ability to rapidly create detailed karyotypes 
allowed us to identify cell that were hypodiploid to near-triploid, probably derived from 
tetraploid cells. Among the MRT-derived cancer cells studied in Chapter 4 there were 
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hypertriploid cells with 4 sex chromosomes and/or 4 autosomes of a given number, which 
points to the fact that these aneuploid cells descent from a tetraploid precursors, which 
undergo an unbalanced cell division. Also the presence of near-octaploid and near-pentaploid 
cells indicates that tetraploid cells do undergo reduplication priory to cell division (see Figure 
4 and the article in Chapter 4).   
Figure 4: Examples of chromosome complements of cells with MRT-associated mutation 
(hSNF5-S284L). (A) A hypertriploid metaphase (n = 73) with 4 sex chromosomes and some 
of the autosomes in 4 copies. (B) A hypopentaploid metaphase with 114 chromosomes as an 
example of an unbalanced chromosomes complement. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Karyotyping non-M-phase cells  
pq-COBRA-FISH can provide relevant information on the heterogeneity of chromosomal 
composition of cells and can detect several abnormalities in a single cell. However, it is 
limited to the analysis of mitotic cells. In order to tackle this problem, calyculin A (CA) 
[101], a potent phosphatase inhibitor, was employed to study its ability to induce so-called 
premature chromosome condensation (PCC) in different cell types. Chemical PCC using 
phosphatase inhibitors such as CA, is an alternative to the fusion-based PCC introduced by 
Johnson and Rao in 1970 [92]. The onset of M phase and the fusion based PCC are 
considered to be associated with p34cdc2/cyclin B kinase activity, hyperphosphorylation of 
histone H1, and phosphorylation of histone H3 [93]. In contrast, chemical PCC induces 
premature chromosome condensation through inhibition of type-1 and type-2A protein 
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phosphatases (PP1 & PP2A). Treatment of cells with phosphatase inhibitors, such as okadaic 
acid, fostriecin and CA, results in PCC due to phosphorylation of histones H2A and H3 even 
in the absence of p34cdc2 kinase activity and H1 hyperphosphorylation [147,148].  
As shown in Chaper 5, CA can be employed to produce chromosome spreads amenable to 
cytogenetic analysis from established cell cultures. In the cell lines, a difference of up to 10-
fold was found between frequency of CA induced PCC spreads (PCC-index) and the mitotic 
index after treatment with colcemid. Thus CA induced PCC in combination with pq-
COBRA-FISH can significantly enhance the efficiency of molecular karyotyping.  
Importantly, also cells from human colorectal cancer biopsy material proved to be amenable 
to PCC by CA. We have shown that after a limited culture time of 2 days, karyotypes from 
polyps can be established using, CA induced PCC-spreads and pq-COBRA-FISH. Expansion 
of such work is of great importance in understanding the sequence of events in the genesis of 
colon cancer. 
An important aspect of the PCC techniques is that the resulting chromosome spreads have 
distinct morphological characteristics, which can be related to the different stages of the cell 
cycle. Chromosomes of G1-PCC spreads are monovalent, G2-PCC spread chromosomes are 
bivalent as in metaphase, while S-phase PPC spreads have a pulverized appearance, due to 
the presence of many nicks in the DNA of the replicating genome [149,150]. The ability to 
analyse the chromosomal constitution of cells in G1- and G2-phases of the cell cycle is quite 
exciting as it creates a sophisticated interphase cytogenetics, which is of significance for 
chromosome instability studies. 
According to our unpublished results concerning the role of mutant hSNF5 in causing 
chromosomal instability, there can be a significant difference in the variability of 
chromosomal constitution between G2- and M-phase of the cell cycle. As presented in 
Chapter 4, re-introduction of wild type hSNF5 in MRT derived cells that are devoid of hSNF5 
purges cells with abnormal number of chromosomes to the extent that only cells with correct 
ploidy (46) are present at M-phase. This finding is based on metaphase arrest using colcemid, 
which reveals the chromosomal constitution of dividing cells, i.c. cells that are “fit” to pass 
G2/M checkpoints. Histogram of the ploidy of the MRT-cells with WT hSNF5 shows that the 
majority of the cells have 46 chromosomes, with minor random losses, related to technical 
flaws in slide preparation (Figure 5A and 5B). However after CA-PCC, where G2-phase cells 
are prematurely condensed, COBRA-FISH analysis revealed cells with abnormal number of 
chromosomes. It must be stated that PCC results in a mixed population of G2- and M-phase, 
since the distinction of true G2-cells from M-phase, in active cells, is impossible. However 
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comparing the mitotic index with G2- or G2/M-PCC index can give an indication of 
percentages involved. The histogram for G2-cells from the same type of cells reveals the 
presence of near-diploid and near-tetraploid cells (Figure 5C and 5D).  
 
Figure 5: Histograms and individual chromosome gains and losses after expression of WT 
hSNF5 in MRT derived cell lines. (A and B) M-phase analysis after colcemid treatment (n = 
40). (C and D) G2/M-phase COBRA-FISH analysis, after the induction of PCC (n  =  40).  
 
The degree of chromosomal gains and losses in G2/M-cells with WT hSNF5 is significantly 
different compared to M-cells (p≈0.031, Mann-Whitney U test). This indicates that by 
introducing WT hSNF5 in MRT-cells, devoid of hSNF5, activates certain G2/M checkpoints 
that do not allow cells with abnormal chromosomal composition to complete the cell cycle.  
Also MRT-cells with cancer associated mutation (hSNF5-S284L) revealed significant 
differences in chromosomal composition between M- and G2/M-cells. As presented in 
Chapter 4, cancer associated hSNF5 mutation introduces enodredulpication and increased 
frequency of chromosomal gains and losses. G2/M-phase analysis of the same cells revealed 
higher degree of chromosomal unbalance; emergence of near-triploid cells and increase in 
gains and losses frequency. Figure 6A shows the ploidy histogram of M-cell population with 
hSNF5-S284L mutation. Figure 6C shows the ploidy histogram of G2-cells with the same 
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mutation. The higher frequency of hyperdiploid and near-triploid in G2/M-cells compared to 
M-phase cells is obvious.  
 
Figure 6: Histograms and individual chromosome gains and losses after expression of 
hSNF5-S284L in MRT derived cell lines. (A and B) M-phase analysis, after colcemid 
treatment (n = 40). (C and D) G2/M-analysis after CA-PCC (n = 40).  
 
 
This indicates that there are populations of cells, which do not complete the cell cycle 
possibly as a consequence of a highly unbalanced chromosomal composition. Figure 6B and 
6D presents the degree of chromosomal gains and losses of M- and G2/M-cells, with 
statistically significant difference (p≈0.003, Mann-Whitney U test).  
In reference to Cahill et al.’s theory of Darwinian selection in tumours [151] it is conceivable 
that in absence of cellular checkpoint only those cells that are (just) fit will be allowed 
through the cell cycle phases. A high degree of chromosomal imbalance can be seen as the 
result of accumulation of damage from multipolar cell division, which can rapidly rise above 
the threshold for viability.  
In relation to mixed population of G2- and M-cells in PCC, G2/M-PCC index have always 
been higher than the mitotic index after colcemid treatment. At least 3 fold higher PCC index 
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has been observed which indicates that the above study is based on an enrichment of G2-
cells. 
In order to further explore the cell cycle phase dependence of CA induction of PCC, we 
carried out a preliminary study to see whether the distinct PCC chromosome spread 
morphologies, reflect the magnitude of the different phases of the cell cycle. To this end in 
vitro cultures of mouse embryonic fibroblast (MEF) and cells mouse embryonic stem (ES) 
cells, in absence and presence of various synchronising agents, were used to vary the 
proportions of the cell cycle phases. G1/G0, S and G2/M fractions were quantified by DNA 
flow cytometry (DNA-FCM) parallel to a visual quantification of different PCC spreads 
based on morphology of prematurely condensed chromosomes. Complicating matters in such 
analysis are that not all cells undergo chromosome condensation and that DNA flow 
cytometry does not discriminate between G2 and M as well as G0 and G1. The latter holds a 
priori also true for PCC. Nevertheless, a careful evaluation of the data, indicate that the 
frequencies of the distinct CA-PCC spreads reflect the magnitude of the different phases of 
the cell cycle as determined by DNA flow cytometry, and that G0 cell have very low 
efficiencies of CA-induced premature chromosome condensation.  
Also there is certain efficiency within which different cells in different phases of the cell 
cycle undergo chromosome condensation, which might relate to cytotoxicity effect of CA and 
the PP1 and PP2A activity in the cells.  
 
Conclusion 
Cytogenetics has a history of methodological innovation. Yet “classical” banding techniques 
remain important in first assessment of chromosomal aberrations. As such, it provides an 
important entry for further molecular (cyto)genetics analysis. It is the need to know that 
drives scientists to develop and apply novel techniques that help in unravelling the mysteries 
of human diseases. In this context I have developed pq-COBRA-FISH and PCC techniques, 
creating new research potential as evidenced by their application in clinical and cancer 
cytogenetics. They complement novel array-based techniques for chromosome analysis in 
that they permit rapid identification of unbalanced and balanced chromosomal 
rearrangements, karyotyping of G1, G2 and M cells as well as assessment of ploidy and 
levels of karyotypic heterogeneity.  
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SUMMARY 
 
Human chromosomes have been studied for over a century, but it took until the 1950s that the 
correct human chromosome number was determined. The development of chromosome pre-
treatment procedures and modification of DNA staining techniques some 20 years later, 
allowed more precise chromosome identification based on banding patterns. This landmark-
advance in human cytogenetics allowed researchers to address specific clinical and research 
questions and make rapid progress in understanding the chromosomal basis of many genetic 
diseases and cancer.  
Although banding methodologies allow the distinction of individual chromosome pairs and 
the detection of gross karyotype aberrations, the analysis is heavily dependent on the 
accumulated experience and sometimes subjective interpretation of cytogeneticists. The low 
mitotic index, poor growth rate and sub-optimal chromosome morphology, which are 
hallmarks of tumour metaphase chromosome preparations, make cancer cytogenetics a 
particularly difficult discipline. 
Introduction of fluorescent in situ hybridisation (FISH) in combination with recombinant 
DNA technology opened a new chapter in detection and investigation of chromosomal basis 
of human genetic diseases in the 1990s.  The success of this new discipline, molecular 
cytogenetics, in gene mapping and precise characterisation of chromosomal abnormalities, 
hinged on development of nucleic acids modification to incorporate fluorescent reporter 
molecules into nucleic acid hybridization probes.  
This thesis contributes to further advancement of molecular cytogenetics. The pq-COBRA-
FISH method presented in Chapter 2, employs a combination of binary and ratio-labelling to 
discriminate in one experiment all human chromosome arms, thus enhancing and objectifying 
the detection of chromosomal abnormalities. In Chapter 3, it has been used to detect 
chromosomal rearrangements in individuals with abnormal phenotype and normal G-banding 
patterns. It also aided in identification of a novel cancerous gene alteration by discovering 
BCL11B, as a new candidate gene in acute myelocytic leukaemia.  
pq-COBRA-FISH readily  resolves complex karyotypes, characteristic of solid tumours. As 
such it was instrumental to discovery of a novel function of the chromatin remodelling 
complex, hSNF5, in maintenance of chromosome stability and ploidy (Chapter 4).  
Although molecular cytogenetics with its sophisticated multicolour FISH technology has 
allowed significant advancement in cancer and has become an intricate part of diagnosis and 
research there are still analytical and methodological problems in cancer cytogenetics. Full 
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karyotyping, for example, is still restricted to mitotic cells. Chapter 5 of this thesis presents 
studies where a potent phosphatase inhibitor, calyculin A, was employed to prematurely 
condense the chromosomes of non-mitotic cells. This premature chromosome condensation 
technique or PCC increases the number of analysable chromosome structures compared to 
classical mitotic arrest, with minimum culture. This greatly improves the capacity of 
researchers to cytogenetically study solid tumours, where the success of comprehensive 
karyotyping of biopsy material has always been problematic. The specific morphological 
characteristics of PCC chromosomes furthermore allow distinction of the G1 and G2 phases 
of the cell cycle. The possibility to assess (differences in) chromosomal abnormalities of cells 
in the various cell cycle phases can offer valuable insight into the mechanisms underlying the 
tumorigenesis processes, including the much debated chromosome instability. 
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SAMENVATTING 
 
Al meer dan een eeuw worden menselijke chromosomen onderzocht in relatie tot ziekten. Pas 
zo’n 50 jaar geleden is het correcte aantal menselijke chromosomen vastgesteld. De 
ontwikkeling van speciale voorbehandelings en kleurprocedures van chromosomen in de jaren 
70 van de vorige eeuw heeft geleid tot een veel betere herkenningsmogelijkheid van de 
chromosomen en wel op basis van zogenaamde banderingspatronen. Door deze doorbraak in 
de cytogenetica is er snel vooruitgang geboekt in kennis en begrip van de chromosomale basis 
van erfelijke ziekten en kanker. Hoewel met banderingstechnieken de individuele 
chromosomen goed onderscheiden kunnen worden en de ontdekking van karotypische 
afwijkingen aanzienlijk verbeterd is, blijft analyse van gebandeerde chromosomen sterk 
afhankelijk van de expertise en soms subjectieve interpretatie van de cytogeneticus. In het 
bijzonder bij tumorcytogenetica komen daar nog eens een aantal complicerende factoren bi nl. 
lage mitotische indices, sub-optimale chromosoommorfologie en complexe chromosomale 
samenstellingen. 
Met de introductie van in situ hybridisatie en DNA recombinant technologie in de jaren 
negentig, is er weer een flinke slag geslagen in de ontrafeling van de chromosomale basis van 
genetische ziekten. Het succes van het vakgebied dat ook wel moleculaire cytogenetica wordt 
genoemd, was afhankelijk van de ontwikkeling van nucleinezuurmodificaties waarmee 
fluorescerende reporter moleculen in de nucleinezuur sequenties konden worden ingebouwd. 
Een betrekkelijk nieuwe nucleinezuurmodificatie op basis van cis-platina verbindingen is in 
dit proefschrift gebruikt en met de resultaten van dit proefschrift wordt een bijdrage geleverd 
aan verdere ontwikkeling van de moleculaire cytogenetica.  
De pq-COBRA-FISH methode van Hoofdstuk 2 gebruikt een combinatie van binaire- en 
ratio-labelling om in één enkel experiment alle menselijke chromosoomarmen te identificeren. 
Ze draagt bij aan objectieve herkenning van chromosoomafwijkingen en kan ook door niet-
cytogenetici worden toegepast. 
In Hoofstuk 3 is pq-COBRA-FISH met succes toegepast om chromosomale herschikkingen te 
vinden in personen met abnormale fenotypes, maar met normale 
chromosoombanderingspatronen. Ook kon met de techniek snel een potentieel kankergen 
geïdentificeerd worden in een geval van acute myeloide leukemie.  
Ingewikkelde karyotypes kunnen met pq-COBRA-FISH snel en gemakkelijk opgehelderd 
worden. Dit is van groot belang gebleken bij de ontdekking van een nieuwe functie van het 
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chromatine remodelling complex hSNF5: handhaving van chromosomale stabiliteit en ploidie 
(Hoofdstuk 4).  
Hoewel de geavanceerde meerkleuren FISH methodologie belangrijke vooruitgang heeft 
helpen boeken in het kankeronderzoek en een integraal onderdeel geworden is van klinisch-
cytogenetische diagnose en kankeronderzoek, zijn er nog steeds fundamentele beperkingen 
met name in het kankeronderzoek. Het volledige moleculair karyotyperen is bijvoorbeeld nog 
steeds beperkt tot mitotische cellen, een kleine minderheid van de cellen aanwezig in een 
monster. Om deze patstelling  te doorbreken is een remmer van eiwitfosfatases gebruikt, 
calyculine A, om cellen die in de interfase van de celcyclus zijn hun chromosomale materiaal 
tot condensatie te dwingen en daarmee karyotypische analyse mogelijk te maken van cellen 
die niet in mitose zijn. Deze zg. premature chromosoom condensatie (PCC) techniek geeft 
veel meer analyseerbare chromosoomstructuren dan klassieke mitose blokkers en dat met 
minimale kweekperioden. Hiermee is er een belangrijk hulpmiddel ter beschikking gekomen 
voor het bestuderen van kankerchromosomen van vaste tumoren.  
Binnen de interfase is het met de PCC techniek mogelijk onderscheid te maken tussen cellen 
die in de G1 en G2 fase verkeren. Deze eigenschap is van groot belang in verder onderzoek 
naar mechanismen van ontstaan van kanker met name het veel bediscussieerde mechanisme 
van chromosoominstabiliteit. 
 
134
CURRICULUM VITAE 
 
 
30 May 1968  Born in Teheran, Iran 
 
1982-1984 Mariami Secundary School, Teheran, Iran 
 
1984-1986 American Community School, Athens, Greece 
 
1990-1992 Preparation for VWO examination, Leiden, The Netherlands 
 
1992-1996 Hogeschool Leiden, Leiden, The Netherlands 
BA, Medical Biology 
 
1995-1996  Trainee student at Leiden University Medical Center 
   Department of Molecular Cell Biology 
   Laboratory for Cytochemistry and Cytometry 
Involved in project for detection of unique sequences by FISH using a 
single HRP-oligonucleotide and tyramide signal amplification 
 
1996-2000  Research assistant at Leiden University Medical Center 
   Department of Molecular Cell Biology 
   Laboratory for Cytochemistry and Cytometry 
Involved in project for developing new multi-color FISH technique, 
COBRA, in combination with chemical labeling strategies using 
Universal Linkage System (ULS) 
 
2000-present  PhD student at Leiden University Medical Center 
   Department of Molecular Cell Biology 
   Laboratory for Cytochemistry and Cytometry 
 
 
 
 
 
135
 136
LIST OF PUBLICATIONS 
 
1. Wiegant,J., Brouwer,K., Bezrookove,V., Smits,S., Raap,A.K., Bout,A., and Tanke,H.J. 
(2004). Molecular cytogenetic characterization by combined COBRA-FISH and fiber-
FISH: application to PER.C6 cells. Biotechniques 37, 188, 190, 192. 
 
2. Bezrookove,V., Zelderen-Bhola,S.L., Brink,A., Szuhai,K., Raap,A.K., Barge,R., 
Beverstock,G.C., and Rosenberg,C. (2004). A novel t(6;14)(q25-q27;q32) in acute 
myelocytic leukemia involves the BCL11B gene. Cancer Genet. Cytogenet. 149, 72-76. 
 
3. Beverstock,G.C., Bezrookove,V., Mollevanger,P., van de Kamp,J.J., Pearson,P., 
Kouwenberg,J.M., and Rosenberg,C. (2003). Multiple supernumerary ring chromosomes 
of different origin in a patient: a clinical report and review of the literature. Am. J. Med. 
Genet. 122A, 168-173. 
 
4. Bezrookove,V., Smits,R., Moeslein,G., Fodde,R., Tanke,H.J., Raap,A.K., and Darroudi,F. 
(2003). Premature chromosome condensation revisited: a novel chemical approach 
permits efficient cytogenetic analysis of cancers. Genes Chromosomes Cancer 38, 177-
186. 
 
5. Silva,F.P., Morolli,B., Storlazzi,C.T., Anelli,L., Wessels,H., Bezrookove,V., Kluin-
Nelemans,H.C., and Giphart-Gassler,M. (2003). Identification of RUNX1/AML1 as a 
classical tumor suppressor gene. Oncogene 22, 538-547. 
 
6. Wagner,A., van der Klift,H., Franken,P., Wijnen,J., Breukel,C., Bezrookove,V., Smits,R., 
Kinarsky,Y., Barrows,A., Franklin,B., Lynch,J., Lynch,H., and Fodde,R. (2002). A 10-Mb 
paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for 
hereditary nonpolyposis colorectal cancer in a North-American kindred. Genes 
Chromosomes Cancer 35, 49-57. 
 
7. Darroudi,F., Bezrookove,V., Fomina,J., Mesker,W.E., Wiegant,J., Raap,A.K., and 
Tanke,H.J. (2002). Insights into the sites of X ray and neutron induced chromosomal 
aberrations in human lymphocytes using COBRA-MFISH. Radiat. Prot. Dosimetry. 99, 
189-192. 
 
8. Wiegant,J., Bezrookove,V., Rosenberg,C., Tanke,H.J., Raap,A.K., Zhang,H., Bittner,M., 
Trent,J.M., and Meltzer,P. (2000). Differentially painting human chromosome arms with 
combined binary ratio-labeling fluorescence in situ hybridization. Genome Res. 10, 861-
865. 
 
9. Bezrookove,V., Hansson,K., van der,B.M., van der Smagt,J.J., Hilhorst-Hofstee,Y., 
Wiegant,J., Beverstock,G.C., Raap,A.K., Tanke,H., Breuning,M.H., and Rosenberg,C. 
(2000). Individuals with abnormal phenotype and normal G-banding karyotype: 
improvement and limitations in the diagnosis by the use of 24-colour FISH. Hum. Genet. 
106, 392-398. 
 
10. van Gijlswijk,R.P., van de Corput,M.P., Bezrookove,V., Wiegant,J., Tanke,H.J., and 
Raap,A.K. (2000). Synthesis and purification of horseradish peroxidase-labeled 
oligonucleotides for tyramide-based fluorescence in situ hybridization. Histochem. Cell 
Biol. 113, 175-180. 
137
11. Szuhai,K., Bezrookove,V., Wiegant,J., Vrolijk,J., Dirks,R.W., Rosenberg,C., Raap,A.K., 
and Tanke,H.J. (2000). Simultaneous molecular karyotyping and mapping of viral DNA 
integration sites by 25-color COBRA-FISH. Genes Chromosomes Cancer 28, 92-97. 
 
12. Wiegant,J.C., van Gijlswijk,R.P., Heetebrij,R.J., Bezrookove,V., Raap,A.K., and 
Tanke,H.J. (1999). ULS: a versatile method of labeling nucleic acids for FISH based on a 
monofunctional reaction of cisplatin derivatives with guanine moieties. Cytogenet. Cell 
Genet. 87, 47-52. 
 
13. Koopman,L.A., Szuhai,K., van Eendenburg,J.D., Bezrookove,V., Kenter,G.G., 
Schuuring,E., Tanke,H., and Fleuren,G.J. (1999). Recurrent integration of human 
papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell 
lines. Cancer Res. 59, 5615-5624. 
 
14. Tanke,H.J., Wiegant,J., van Gijlswijk,R.P., Bezrookove,V., Pattenier,H., Heetebrij,R.J., 
Talman,E.G., Raap,A.K., and Vrolijk,J. (1999). New strategy for multi-colour 
fluorescence in situ hybridisation: COBRA: COmbined Binary RAtio labelling. Eur. J. 
Hum. Genet. 7, 2-11. 
 
15. Vries,R.G., Bezrookove,V., Zuijderduijn,L.M., Houweling,A., Oruetxebarria,I., 
Raap,A.K., and Verrijzer,C.P. (2004). Cancer–associated mutations in chromatin-
remodeler hSNF5 cause chromosomal instability. Submitted. 
 
16. Bezrookove,V., Darroudi,F. Alberici,P., and Raap,A.K. (2004). Cell cycle phase 
dependency of calyculin A induced chromosome condensation. In progress. 
 
 
138
Fig. 1. Chromosomal arms differentially painted by PQ-COBRA-FISH. PQ-COBRA-FISH to normal 
male metaphase chromosomes. (A) shows the superimposed, pseudocolor images of the three 
fluorophores used for ratio labeling the WCPs in a karyogram format. The first binary label (B) 
differentiates the two identically ratio-labeled WCP sets. The karyogram was generated automatically on 
the basis of chromosomal WCP-FISH ratios and the presence (odd numbered chromosomes plus Y) or 
absence (even numbered chromosomes plus X) of the first binary color. The second binary label, 
differentiating p and q arms, is displayed in C. All q arm paints were labeled with the second binary label, 
except for chromosomes 4 and 7, for which p arm paints were used. Note the disturbance of the COBRA-
FISH signals on the X chromosome by the Y paint.
Fig. 2. Intrachromosomal rearrangements detected by PQ-COBRA -FISH. (A) An inversion of chromosome 12 
in a normal carrier. In this balanced rearrangement, the distal region of the long arm is positioned on the end of 
the short arm of the rearranged chromosome. The segment of the short arm transferred to the long arm of the 
inv(12) could not be detected by us, nor in the original study by conventional cytogenetics or FISH with distal 
markers (Speleman et al 1993). (B) A der(1), composed exclusively of 1q material in a cervical cancer cell line 
with a complex karyotype. For each normal and rearranged homolog, the sequence of display is ratio image, the 
q arm paint (second binary label) and the thresholded image of the q-arm paint.
A B
Wiegant,J. et al. / Genome research 10 (2000) 861-865
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Fig. 3. PQ-COBRA-FISH of a complex cancer karyotype This near-tetraploid cancer cell shows a range 
of 2-6 copies of each chromosome and 10 structural rearrangements. (A,B,C) The ratio-, first- and 
second-binary images of PQ- COBRA-FISH of the nonrearranged chromosomes. In contrast to Fig. 1, 
the first binary label is on the even numbered and X chromosomes. (D) The rearranged chromosomes 
present in the same cell. The rearrangements include two isochromosomes, a deletion, the two products 
of a reciprocal translocation [t(2;3)], four unbalanced translocations involving two chromosomes, and 
one three-way translocation. The composition of the rearranged chromosomes is shown next to the 
chromosomes. The t(2;5) illustrates how the binary colors discriminate chromosome number and arm 
identity of chromosomes that carry the same ratio-label.
Wiegant,J. et al. / Genome research 10 (2000) 861-865
A
B
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Fig. 2. Characterization of the t(6;14) using multicolor FISH. (A) Image of a metaphase 
from the patient hybridized with COBRA-FISH probes; the arrows point to der(6) and 
der(14). (B) detailed image of the der(6), der(14), and their normal homologs. (C) Results 
of the hybridization using WCPs for chromosomes 6 (red) and 14 (blue) in combination 
with subtelomeric probes for 6q (green) and 14q (white). Panels B and C show the normal 
homologs on the left and rearranged chromosomes on the right.
Fig. 3. FISH results of WCPs for chromosomes 6 (cyan) and 14 (blue), in combination with 
genomic probes spanning the BCL11B region. (A) RP11-782I5 (green) and RP11-450C22 (red). 
The probe RP11-450C22 maps to the normal 14 homolog, but it is absent on der(14) and fully 
translocated to the der(6). The more centromeric probe RP11-782I5 can be seen on the normal 14 
homolog, on the der(6), but also on der(14) in metaphases with optimal spread. The split signal 
from RP11-782I5 indicates that the breakpoint on chromosome 14 is within this BAC, and that 
most of the signal is translocated to der(6). (B) Hybridizations with RP11-50K24 (green) and 
RP11-876E22 (red) show that both signals are on chromosomes 14.
Bezrookove,V. et al. / Cancer Genetics and Cytogenetics 149 (2004) 72-76
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Fig. 1a-e Characterization of the der(4)t(4;5) found in the affected girl and in her mother in case 
7. a Twenty-four colour karyotype of the mother. b The der(4) (right) and its normal homologue 
by 24-colour FISH. c Subtelomeric probes for 4p (green) and 4q (red) showing that the 4qter 
sequence is absent on the der(4) (right). d Band-specific probe for 5p15.32-15.33, demonstrating 
the presence of 5p sequences on der(4) (right). e der(4) (right) and its normal homologue (left), 
showing that an extra faint dark band can be visualised on the terminal long arm of der(4) by 
high resolution G-banding.
Fig.2a-d Characterization of the der(1)t(1;3) in patient 21. a Twenty-four colour karyotype. b 
The der(1) (right) and its normal homologue by 24-colour FISH. c Subtelomeric probes for 3p 
(blue), 3q (green) and 1q (red) showing that 1qter is lost and 3qter is present in the der(1)  
(right). d der(1) and its normal homologue showing that no detectable difference can be seen 
between them by high resolution G-banding.
Bezrookove,V. et al. / Hum Genet 106 (2000) 392-398
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Figure 2
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Fig. 3. MulticolorFISH (COBRA) to a metaphase of the patient. Each chromosome is identified 
by a different color. The supernumerarymarkers (arrows) display fainter colors due to the small 
amounts of euchromatic material and, therefore, they are difficult to identify.
Fig. 2. Metaphase of the patient hybridized with 
all-chromosomes telomere-repeat (PNA) probe. 
Every chromosome in the picture shows signals 
in the terminal regions of the short and long 
arms, except for the two supernumerary 
chromosomes (arrows). The lack of telomeric 
signal on the supernumerary chromosomes 
supports the assumption that they are rings.
Beverstock,G.C. et al. / American Journal of Medical Genetics 122A (2003) 168-173 
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Fig. 5. A metaphase spread showing hybridization with three different probes. Arrows show the 
supernumerary chromosomes. Because two of the probes partially overlap, two images of the 
metaphase in different combinations of fluorescence filters are shown: (a) chromosome painting 
probes for 19 (pink) and 22 (green), demonstrating that one of the supernumerary chromosomes is 
derived from 19, while the other 3 do not show hybridization signals. b: Long-arm painting probes 
(blue) for chromosomes 19 and 22, demonstrating that the der(19) is composed mostly or totally of 
long arm chromosome material.
a b
Fig. 4. Multicolor hybridization with centromere-specific probes. The centromeres of chromosomes 10 
(pink) and 18 (green) showed only two signals each (in the normal homologues), while three signals 
were detected for chromosomes 6 (blue) and 12 (red) (two in the normal homologues and one in a 
marker). The arrows indicate the supernumerary chromosomes which were shown to be der(6) and 
der(12), and one which did not hybridize with any of these centromeric sequences.
Beverstock,G.C. et al. / American Journal of Medical Genetics 122A (2003) 168-173
144
hSNF5-S284L ON
hSNF5-S284L OFF
hSNF5-S284L ON
hSNF5-S284L OFF
MRC5 cells, hSNF5-S284L-GFP
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Fig. 2. hSNF5-S284L expression induces polyploidisation. (a) DNA staining with DAPI revealed 
the presence of cells with multi-lobed nuclei following induction of hSNF5-S284L. (b) Co-
staining of DNA with DAPI (blue), and cytoskeletal alpha-Tubulin (red). (c) GFP-hSNF5-S284L, 
but not GFP-hSNF5 induces multi-lobed nuclei in MRC5 cells. The GFP signal (green) identifies 
the transfected cells. (d) Representative examples of pq-COBRA-FISH analysis of Lac-hSNF5-
S284L cells. di-, tri, tetra- and near octaploid methaphases are shown. Four Y-chromosomes, 
indicative of octaploidy, are indicated by arrows. (e) Representative examples of Lac-hSNF5-
S284L cells with 1, 2 or more mitotic spindles identified by immunofluorescence staining of a-
Tubulin and DNA. (f) Visualisation of centrosomes (arrows) by alpha-Tubulin staining.   
d
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 Vries,R.G.J. and Bezrookove,V. et al. / Submitted
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                                             Distribution of mitotic cells
                               Metaphase (%)         Anaphase (%)              Telophase (%)
No hSNF5  59 ± 2.0  21 ± 1.9  20 ± 1.0
hSNF5-WT  66 ± 8.0  22 ± 3.9  12 ± 4.1
hSNF5-S284L  88 ± 5.1  8.5 ± 4.0  4.0 ± 2.5
hSNF5-S284L hSNF5-S284L hSNF5-WT
hSNF5-S284L ON
NO hSNF5
a
b
c
 Vries,R.G.J. and Bezrookove,V. et al. / Submitted
Fig. 3. hSNF5-S284L induction causes an abortive cell cycle. (a) Time-lapse microscopy 
revealed that cells expressing hSNF5-S284L enter mitosis but exit prior to cell division. 
Arrows indicate the position of the condensed chromatin. (b) Under-representation of ana- and 
telophase relative to metaphase in cells expressing hSNF5-S284L. A representative example of 
each mitotic stage is shown. (c) Failure of microtubule-kinetochore association in cells 
expressing hSNF5-S284L. Kinetochores were identified with CREST (red) antibodies and 
mitotic spindles with alpha-tubulin (green) antibodies. 
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Fig. 1. Three-color ratio images of combined binary ratio labeling-fluorescence in situ 
hybridization (COBRA-FISH) of premature chromosome condensation (PCC) spreads with distinct 
morphological characteristics (63X objective), and DAPI counterstaining images as well. G1-PCC 
with univalent chromosomes morphology analyzed by COBRA-FISH (A) and DAPI 
counterstaining (B). C and D present S-PCC, where chromosomes show univalent and fragmented 
morphology, COBRA-FISH, and DAPI counterstaining images, respectively. E and F illustrate G2-
PCC, where chromosomes are bivalent, COBRAFISH, and DAPI counterstaining images, 
respectively
Bezrookove,V. et al. / Genes, Chromosomes & Cancer 38 (2003) 177-186 
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Fig. 2. Comprehensive molecular karyotyping of Caco-2 cell line by use of pq-COBRA-
FISH. A: The three-color ratio image of a cell (right) and the binary image from p- and q-
arm-specific painting probes (left), by use of a 63X objective lens. B: The karyograms of 
the above cell without the binary images (for the typical COBRA-FISH karyotype refer to 
image 3). C: The digitized image from signal of the p and q painting probes, distinguishing 
the short and the long arm of each chromosome. D: Karyogram of the aberrant 
chromosomes found in this spread.
Bezrookove,V. et al. / Genes, Chromosomes & Cancer 38 (2003) 177-186
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Fig. 3. Karyograms of cells isolated from a polyp of a familial adenomatous polyposis (FAP) 
patient. Three classes of chromosomal constitution were revealed by use of CA-induced PCC 
and pq-COBRA-FISH. Diploid (A): this image is a typical karyograms generated by use of pq-
COBRA-FISH analyzing software; each chromosome is presented as a ratio image or a 
composed color image; binary 1 image-discriminating odd- (magenta) and even-numbered 
chromosomes (no signal) and binary 2 image of p-arm (no signal) and q-arm (cyan) image, with 
the exception of chromosomes 4 and 7, which are p-arm-positive. Hypotetraploidy (B) has 87 
chromosomes, -3, -18, -19, -21, and -22; and hypertetraploidy (C) has 95 chromosomes, with an 
excess of numerical aberrations for chromosomes 1, 7, and 14.
Bezrookove,V. et al. / Genes, Chromosomes & Cancer 38 (2003) 177-186
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Fig. 3. PCC-COBRA images of different phases of the cell cycle from mouse ES cells. (A) 
Represents G0/G1-phase, with corresponding lack of BrdU signal (B). (C) Depicts S-phase and 
a late S-phase, which not only has a weak BrdU signal but also resembles G2-phase cell. (E) A 
S-phase with clear BrdU signal (F). A G2-phase cell, with BrdU signal from Y chromosome (H), 
indicating that Y chromosome is a late replicating chromosome. (I and J) Depicts G2/M-phase 
and  (K and L) show an early anaphase cell, with clear separation of chromatids.
Bezrookove,V. et al. / In progress
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Fig. 4. Examples of chromosome complements of cells with MRT-associated mutation 
(hSNF5-S284L). (A) A hypertriploid metaphase (n=73) with 4 sex chromosomes and some of 
the autosomes in 4 copies. (B) A hypopentaploid metaphase with 114 chromosomes as an 
example of an unbalanced chromosomes complement.
Discussion
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